000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1765|3393|lyfalmen|V0045|1588|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1765||1765|3393||1
000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|35566|46518|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||35566||35566|46518||2
000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|53430|68937|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||53430||53430|68937||2
000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|11307|16446|lyfalmen|V0457|4460|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||11307||11307|16446||2
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|32956|43905|lyfalmen|V0475|16545|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||32956||32956|43905||2
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|42860|56334|lyfalmen|V0540|32727|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||42860||42860|56334||2
000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|23054|31478|lyfalmen|V0456|8622|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23054||23054|31478||2
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|5351|7723|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||5351||5351|7723||1
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|8094|15714|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||8094||8094|15714||1
000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|14333|19870|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||14333||14333|19870||1
000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|21557|29599|lyfalmen|||1|0,36|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||21557||21557|29599||1
000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|41842|55057|lyfalmen|||1|0,72|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||41842||41842|55057||1
000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|0|0|0|0|E|0|MSD|0|0|0|100|DKK|5689|8761|lyfalmen|||1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5689||5689|8761||1
000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||1|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657||1
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139||1
000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3493|5757|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3493|5757||1
000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|29860|40019|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||29860||29860|40019||2
000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|1986|3696|lyfalmen|||1|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1986||1986|3696||1
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|5200|8092|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||5200||5200|8092||1
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|4045|6512|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4045||4045|6512||1
000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|0|0|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||||1
000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|5899|9048|lyfalmen|V0583|9048|1|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5899||5899|9048||1
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7575|10933|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||7575||7575|10933||2
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|3278|5463|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3278||3278|5463||1
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4036|6500|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4036||4036|6500||1
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|186325|235720|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||186325||186325|235720||2
000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|23913|31893|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||23913||23913|31893||1
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|6102|8807|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||6102||6102|8807||1
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1557|3109|lyfalmen|V0037|2228|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1557||1557|3109||1
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6802|10284|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6802||6802|10284||1
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|22507|30791|lyfalmen|V0115|6423|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||22507||22507|30791||1
001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2585|4515|lyfalmen|V0050|2480|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2585||2585|4515||1
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|30511|40174|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||30511||30511|40174||1
001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|2547|1846|lyfalmen|V0278|1771|2|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||634||634|1846||2
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6532|9914|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6532||6532|9914||1
001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|4682|7384|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4682||4682|7384||1
001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|883|2101|lyfalmen|V0038|2066|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||820||820|2101||1
001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2456|3701|lyfalmen|V0039|3564|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||1990||1990|3701||1
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23514|31393|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||23514||23514|31393||2
001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|0|0|0|0|E|0|VIF|0|0|1|100|CHF|15957|22571|lyfalmen|V0034|20008|1|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||15957||15957|22571||1
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|34263|44883|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||34263||34263|44883||2
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|2593|3742|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2593||2593|3742||1
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|4319|6887|lyfalmen|V0444|6887|0|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4319||4319|6887||1
001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|928|2248|lyfalmen|V0004|516|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||928||928|2248||1
001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|1946|3373|lyfalmen|V0291|3373|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373||1
001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|6936|10467|lyfalmen|V0294|10467|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467||1
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|4757|7486|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||4757||4757|7486||2
001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|3353|5566|lyfalmen|V0292|5566|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566||1
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4836|7594|lyfalmen|V0004|2066|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4836||4836|7594||1
001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|5263|8178|lyfalmen|V0293|8178|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178||1
001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9601|14113|lyfalmen|V0011|2862|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9601||9601|14113||1
002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1524|3064|lyfalmen|V0005|529|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1524||1524|3064||1
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6767|10236|lyfalmen|V0005|2114|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6767||6767|10236||1
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|1|0|0|0|B|0|TIL|0|0|0|100|SEK|5903|9054|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5903|9054||2
002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5925|9084|lyfalmen|V0011|2556|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5925||5925|9084||1
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27680|36621|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||27680||27680|36621||2
002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14715|7853|lyfalmen|V0011|5111|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5025||5025|7853||1
002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10792|15742|lyfalmen|V0012|2556|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10792||10792|15742||1
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3346|5556|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3346||3346|5556||1
002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|19567|27102|lyfalmen|V0012|5111|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||19567||19567|27102||1
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|18355|25581|lyfalmen|V0492|16649|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||18355||18355|25581||1
002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|111314|141582|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||111314|141582||2
002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|56738|73089|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||56738|73089||2
002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|29375|38748|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||29375|38748||2
002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3619|5930|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3619|5930||2
002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3619|5930|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3619||3619|5930||2
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2202|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2202||1
002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3839|6697|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3839||3839|6697||2
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1352|2828|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1352||1352|2828||2
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|33723|44205|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||33723||33723|44205||1
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|15170|16394|lyfalmen|V0089|2099|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||11269||11269|16394||1
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|11213|16318|lyfalmen|V0515|4687|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||11213||11213|16318||1
003099|L01DB0104|Myocet|irţ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|ZEP|0|0|0|100|DKK|263764|332906|lyfsjukr|||1|2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||263764||263764|332906||2
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|19360|26842|lyfalmen|V0253|7416|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||19360||19360|26842||1
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|37617|49754|lyfalmen|V0516|14743|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||37617||37617|49754||1
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|*|0|PFP|0|0|0|100|SEK|11424|16606|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||11424||11424|16606||1
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|*|0|PFP|0|0|0|100|SEK|16982|23858|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||16982||16982|23858||1
003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|215091|271822|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||215091||215091|271822||2
003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|10327|15106|lyfalmen|V0356|13808|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10327||10327|15106||1
003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|9572|14073|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9572||9572|14073||1
003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|0|0|0|1|*|0|WTE|0|0|0|100|DKK|63731|82528|lyfalmen|V0567|82528|1|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||63731||63731|82528||2
003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000|28.02.2013|R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|4790|7531|lyfalmen|||1|28|0|14,0000|Vistor hf|Takeda Europe -|Píóglítazón||4790||4790|7531||1
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|3467|5722|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3467||3467|5722||1
003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|16827|12456|lyfalmen|V0572|11864|1|98|0|49,0000|Vistor hf|Takeda Europe -|Píóglítazón||8390||8390|12456||1
003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000|28.02.2013|R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|7244|10888|lyfalmen|||1|28|0|28,0000|Vistor hf|Takeda Europe -|Píóglítazón||7244||7244|10888||1
003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TGR|0|0|0|100|SEK|25142|26903|lyfalmen|V0573|25650|1|98|0|98,0000|Vistor hf|Takeda Europe -|Píóglítazón||19409||19409|26903||1
003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|940|2265|lyfalmen|||1|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||940||940|2265||1
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1017|1850|lyfalmen|V0151|1773|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||637||637|1850||1
003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|633|1845|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||633||633|1845||1
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2389|3629|lyfalmen|V0322|3514|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1937||1937|3629||1
003974|J05AR1001|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AR10|01.08.2003||R|0|0|0|1|0|1|ABL|0|0|0|100|DKK|78348|100209|lyfsjukr|||1|300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopínavír og ritónavír||78348||78348|100209||1
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|2293|4116|lyfalmen|V0469|2559|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2293||2293|4116||1
004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|23504|31380|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||23504||23504|31380||1
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|8532|12650|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8532||8532|12650||1
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1
004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|4356|6938|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4356||4356|6938||1
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|638|1852|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||638||638|1852||1
004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1330|2798|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1330||1330|2798||1
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5900|9050|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5900||5900|9050||1
004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|8048|11988|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8048||8048|11988||1
004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|11305|16444|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||11305||11305|16444||1
004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|684|1915|lyfalmen|V0366|869|1|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||684||684|1915||1
004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|6390|9720|lyfalmen|||1|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||6390||6390|9720||1
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|22708|30381|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||22708||22708|30381||1
004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|1783|3418|lyfalmen|V0366|2607|1|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1783||1783|3418||1
004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|ţpakki||A04AA01|01.01.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|7519|5188|lyfalmen|V0381|5014|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3077||3077|5188||1
004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|4993|7809|lyfalmen|V0458|5690|1|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4993||4993|7809||1
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5170|10100|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5170||5170|10100||1
004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|3500|5767|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3500||3500|5767||2
004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|711|1952|lyfalmen|||1|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||711||711|1952||1
004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|4669|7366|lyfalmen|V0226|2932|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4669||4669|7366||2
004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|6594|9999|lyfalmen|V0227|4498|1|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6594||6594|9999||2
004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|E|0|NOP|0|0|1|100|DKK|8777|12985|lyfalmen|V0228|5383|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8777||8777|12985||2
004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2309|4137|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||2309||2309|4137||1
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|3936|3053|lyfalmen|V0494|3053|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1516||1516|3053||1
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2556|2620|lyfalmen|V0318|2607|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1200||1200|2620||1
004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|39944|52012|lyfsjukr|||1|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||39944||39944|52012||2
004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1529|3070|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1529||1529|3070||1
004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3408|5641|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||3408||3408|5641||1
004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1836|2164|lyfalmen|V0071|2164|2|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164||1
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|5614|5083|lyfalmen|V0320|5069|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||3000||3000|5083||1
004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|776|1451|lyfalmen|V0062|1373|2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||345||345|1451||1
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2703|2484|lyfalmen|V0317|2470|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1100||1100|2484||1
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|926|1451|lyfalmen|V0067|1373|2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||345||345|1451||1
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1823||1
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|41083|53442|lyfsjukr|||1|4,69|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||41083||41083|53442||1
004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1778|3411|lyfalmen|V0318|1460|2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411||1
004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||||1
004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|199722|252534|lyfsjukr|||1|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||199722||199722|252534||2
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|0|0|0|0|*|0|SDE|0|0|0|100|NOK|11678|16954|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11678||11678|16954||1
004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|7419|7950|lyfalmen|V0250|4701|1|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||5096||5096|7950||1
004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009|28.02.2013|R|1|0|0|0|E|0|PER|0|0|0|100|DKK|8893|3969|lyfalmen|||1|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||2186||2186|3969||1
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|700|1936|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||700||700|1936||1
004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|14905|6215|lyfalmen|V0282|5492|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||3828||3828|6215||2
004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5838|8426|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5838||5838|8426||1
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|403|1530|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||403||403|1530||1
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|707|1946|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||707||707|1946||1
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1338|2809|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1338||1338|2809||1
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1870|3537|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1870||1870|3537||1
005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2502|4402|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2502|4402||2
005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|9472|7574|lyfalmen|V0148|3002|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4821||4821|7574||1
005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2389|4247|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2389||2389|4247||1
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2751|4742|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2751||2751|4742||1
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3761|6124|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3761||3761|6124||1
005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|30979|41424|lyfalmen|V0356|41423|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||30979||30979|41424||1
005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|56917|73976|lyfalmen|V0287|44612|1|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||56917||56917|73976||1
005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|E|0|ASZ|0|0|0|100|SEK|3733|6085|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3733||3733|6085||1
005330|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|0|0|0|0|E|0|LEP|0|0|1|100|DKK|1214|2640|lyfalmen|||1|2,4|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1214||1214|2640||1
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|*|0|AZA|0|0|0|100|SEK|68842|88942|lyfalmen|V0451|84320|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||68842||68842|88942||1
005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|B|0|BOI|0|0|0|100|DKK|1602|3170|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1602||1602|3170||1
005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|31928|19688|lyfalmen|V0283|7853|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13660||13660|19688||2
005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|40607|53507|lyfalmen|V0281|23274|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||40607||40607|53507||2
005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1404|2900|lyfalmen|V0545|2867|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1404||1404|2900||2
005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||||1
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6745|10206|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6745||6745|10206||1
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7108|10702|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||7108|10702||1
005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|BAX|0|0|0|100|USD|4341|6917|lyfalmen|||1|0,5|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4341||4341|6917||2
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|1722|3335|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1722||1722|3335||2
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|3001|5084|lyfalmen|V0020|3960|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||3001||3001|5084||2
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|7968|11879|lyfalmen|V0020|11879|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7968||7968|11879||2
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|4379|6969|lyfalmen|V0020|5939|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4379||4379|6969||2
005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007|28.02.2013|L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||||1
005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1926|3614|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1926||1926|3614||1
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7161|9711|lyfalmen|V0324|3258|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6383||6383|9711||1
005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3396|5267|lyfalmen|V0035|3853|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3135||3135|5267||1
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|19387|33820|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||19387||19387|33820||1
005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6750|10213|lyfalmen|V0325|2303|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6750||6750|10213||1
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11388|15233|lyfalmen|V0325|4112|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||10420||10420|15233||1
005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5454|7986|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5122||5122|7986||1
005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|3766|6131|lyfalmen|||1|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3766||3766|6131||2
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|953|2283|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||953||953|2283||2
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17630|22291|lyfalmen|V0326|4273|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15734||15734|22291||1
005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3846|6240|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3846||3846|6240||1
005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6967|9369|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6133||6133|9369||1
005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13651|19677|lyfalmen|V0327|2226|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13651||13651|19677||1
005954|C09CA0301|Diovan|filmhtfl|160|mg|28|stk|1|ţpakki||C09CA03|01.01.2001|28.02.2013|R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4979|7790|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4979||4979|7790||1
005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|ţpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|XEU|2104|2229|lyfalmen|V0169|2229|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||914||914|2229||2
006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|90692|115701|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||90692||90692|115701||1
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6230|9501|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6230||6230|9501||1
006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|112478|143042|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||112478||112478|143042||1
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6044|9247|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||6044||6044|9247||1
006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|168883|213831|lyfsjukr|||1|3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||168883||168883|213831||1
006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|85899|109686|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||85899||85899|109686||1
006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2855|4884|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2855||2855|4884||1
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|8480|16455|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||8480|16455||1
006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|6902|10420|lyfalmen|||1|5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6902||6902|10420||1
006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|7526|11274|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7526||7526|11274||1
006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|0|0|100|XEU|584475|735399|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||584475||584475|735399||1
006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|15780|22349|lyfalmen|||1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||15780||15780|22349||1
007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5046|7882|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||5046||5046|7882||1
007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|27382|52750|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim Danmark|||27382||27382|52750||1
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15257|21693|lyfalmen|V0117|11422|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15257||15257|21693||1
007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7610|11389|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7610||7610|11389||1
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|23030|31448|lyfalmen|V0118|16843|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||23030||23030|31448||1
007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|5888|9033|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5888||5888|9033||1
007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9564|14062|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9564||9564|14062||1
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|28810|38702|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||28810||28810|38702||1
007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|186705|236197|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||186705||186705|236197||2
007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|356292|449029|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||356292||356292|449029||2
007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|3337|5544|lyfalmen|V0377|4806|1|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3337||3337|5544||1
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|105895|134781|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||105895||105895|134781||1
007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|1|0|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||||1
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|302741|381822|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||302741||302741|381822||1
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|3480|5739|lyfalmen|V0374|4582|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3480||3480|5739||1
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|9591|13842|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||9591||9591|13842||2
007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|127791|162260|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||127791||127791|162260||3
007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABS|0|0|0|100|DKK|25191|33497|lyfsjukr|||1|250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||25191||25191|33497||1
007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2121|3700|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||2121||2121|3700||2
007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6730|10185|lyfalmen|||1|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6730||6730|10185||1
007538|R03BA0701|Asmanex Twisthaler|innönddu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|0|0|0|0|0|0|SPL|0|0|0|100|DKK|5342|8286|lyfalmen|||1|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5342||5342|8286||1
007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4842|6988|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4842||4842|6988||1
007549|R03BA0701|Asmanex Twisthaler|innönddu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|0|0|0|0|B|0|SPL|0|0|0|100|DKK|10412|15222|lyfalmen|||1|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||10412||10412|15222||1
007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6910|10431|lyfalmen|||1|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6910||6910|10431||1
007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|23458|31985|lyfalmen|V0589|27933|1|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||23458||23458|31985||1
007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|1728|3099|lyfalmen|V0290|3099|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099||1
007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4312|6878|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||4312||4312|6878||1
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.02.2006||L|0|0|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALC|0|0|0|100|USD|1380|2867|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Ólópatadín||1380||1380|2867||1
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1
007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|22163|29697|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|Nituroxíđ||22163||22163|29697||5
007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|ţpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976||3
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|1|0|0|0|*|0|MCK|0|0|0|100|SEK|675|1902|lyfalmen|V0502|1581|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||675||675|1902||2
008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|26451|35079|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||26451||26451|35079||2
008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|32818|43069|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||32818||32818|43069||2
008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|0|0|0|0|E|0|MSD|0|0|0|100|DKK|5934|9096|lyfalmen|||1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5934||5934|9096||1
008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|59502|76558|lyfsjukr|||1|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||59502||59502|76558||1
008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|119005|151234|lyfsjukr|||1|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||119005||119005|151234||1
008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|94833|120898|lyfsjukr|||1|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||94833||94833|120898||1
008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|140289|177945|lyfsjukr|||1|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||140289||140289|177945||1
008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|164799|208705|lyfsjukr|||1|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||164799||164799|208705||1
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1649|3235|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1649||1649|3235||1
008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|303|1393|lyfalmen|||1|20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||303||303|1393||1
008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|40925|53243|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||40925||40925|53243||2
008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|32046|42100|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||32046||32046|42100||2
008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|593|1790|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||593||593|1790||1
008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|37444|48875|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||37444||37444|48875||2
008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|963|2133|lyfalmen|||2|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||844||844|2133||1
008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|1337|2808|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1337||1337|2808||1
008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|3111|5235|lyfalmen|V0226|5235|2|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||3111||3111|5235||1
008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|5156|8032|lyfalmen|V0227|8032|2|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||5156||5156|8032||1
008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|E|0|ACA|0|0|1|100|XEU|6958|9612|lyfalmen|V0228|9612|2|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6311||6311|9612||1
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|XEU|166114|210356|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||166114||166114|210356||1
008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|B|0|MKA|0|0|0|100|SEK|915|2231|lyfalmen|V0153|2231|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||915||915|2231||2
008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|B|0|MKA|0|0|0|100|SEK|796|2068|lyfalmen|V0154|2068|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||796||796|2068||2
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|USD|5319|9279|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5319||5319|9279||2
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|13717|26511|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||13717||13717|26511||2
008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|E|0|RGM|0|0|1|100|XEU|||lyfalmen|V0575|4038|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||4377||2
008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3114|5239|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3114||3114|5239||1
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|117609|149482|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||117609||117609|149482||2
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|124064|157583|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||124064||124064|157583||2
008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2087|3834|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2087||2087|3834||1
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6526|9906|lyfalmen|V0145|9341|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6526|9906||2
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12857|18681|lyfalmen|V0145|18681|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12857|18681||2
008959|R01AA0706|Naso-ratiopharm|nefúđi|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2
009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|1893|3278|lyfalmen|V0064|3278|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||1681||1681|3278||2
009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|9468|13665|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9468||9468|13665||2
009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|4659|6798|lyfalmen|V0063|6798|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||4254||4254|6798||2
009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|9468|13665|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9468||9468|13665||2
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|15405|21878|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||15405||15405|21878||1
009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|9468|13665|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9468||9468|13665||2
009270|R01AA0706|Naso-ratiopharm|nefúđi|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|56196|72408|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||56196||56196|72408||1
009282|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1876||2
009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|5884|9028|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5884||5884|9028||1
009340|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1229|2660|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1229||1229|2660||1
009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1356|2834|lyfalmen|V0130|1810|1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1356||1356|2834||1
009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1568|3124|lyfalmen|V0131|2667|1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1568||1568|3124||1
009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1964|3666|lyfalmen|V0132|2964|1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1964||1964|3666||1
009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8007|11556|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8007||8007|11556||2
009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8007|11556|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8007||8007|11556||2
009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8007|11556|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8007||8007|11556||2
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|214520|271105|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||214520||214520|271105||1
009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|5699|8775|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5699||5699|8775||1
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GIS|0|0|0|100|DKK|64193|82445|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||64193||64193|82445||3
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|10302|15072|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||10302||10302|15072||1
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9407|13847|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9407||9407|13847||1
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8689|12865|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8689||8689|12865||1
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|10818|15777|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10818||10818|15777||1
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8871|13114|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8871||8871|13114||1
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9573|14074|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9573||9573|14074||1
009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1335|2329|vetorma|||0|3|0||Icepharma hf|Pfizer Oy Animal Health|||1335||1335|2329||2
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2341|4181|lyfalmen|V0329|2593|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2341||2341|4181||1
010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4456|7074|lyfalmen|V0330|2995|1|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4456||4456|7074||1
010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|6369|9691|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||6369||6369|9691||1
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|244064|308183|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||244064||244064|308183||2
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|7827|11296|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7827||7827|11296||1
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|13833|19906|lyfalmen|V0331|5566|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||13833||13833|19906||1
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|19504|27023|lyfalmen|V0332|9192|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||19504||19504|27023||1
010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|0|0|0|0|E|0|LBK|0|0|0|100|DKK|15417|21893|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15417|21893||1
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|24993|33911|lyfalmen|||1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||24993||24993|33911||1
010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1995||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7967|11877|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||7967||7967|11877||2
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|13521|19514|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||13521||13521|19514||1
010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|79786|139183|vetorma|||0|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||79786||79786|139183||2
010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|1|0|0|0|B|0|TIL|0|0|0|100|SEK|7628|11414|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||7628|11414||2
010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8083|11666|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||8083||8083|11666||2
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9928|14329|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||9928||9928|14329||2
010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1283|2734|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1283||1283|2734||2
010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6634|9575|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||6634||6634|9575||2
010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10202|14686|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||10202||10202|14686||2
010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4513|6513|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4513||4513|6513||2
010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2587|3734|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2587||2587|3734||2
010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|9824|14418|lyfalmen|V0377|14418|1|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||9824||9824|14418||1
010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10188|14668|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||10188||10188|14668||2
010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|IKR|2373|2785|lyfalmen|V0006|2145|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1320||1320|2785||2
010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7314|10556|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7314||7314|10556||2
010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4440|6408|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4440||4440|6408||2
010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|16139|6419|lyfalmen|V0207|2340|1|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3977||3977|6419||1
010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2390|3449|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2390||2390|3449||2
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACT|0|0|0|100|DKK|381102|480166|lyfsjukr|||1|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||381102||381102|480166||3
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACL|0|0|0|100|DKK|381102|480166|lyfsjukr|||1|56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||381102||381102|480166||3
010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1269|1470|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||359||359|1470||1
010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1
010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|4614|4385|lyfalmen|V0006|3831|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||2490||2490|4385||1
010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|2975|2842|lyfalmen|V0006|2145|2|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1362||1362|2842||1
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|54494|70272|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||54494||54494|70272||2
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|3528|5092|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3528||3528|5092||1
010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004|28.02.2013|R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3153|5292|lyfalmen|||1|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||3153||3153|5292||1
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|21825|29936|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21825||21825|29936||1
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|21571|29617|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21571||21571|29617||1
010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|37160|49181|lyfalmen|||1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37160||37160|49181||1
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|36907|48863|lyfalmen|||1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||36907||36907|48863||1
011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|21251|29215|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||21251||21251|29215||1
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4875|7648|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4875||4875|7648||1
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|5065|7908|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||5065||5065|7908||1
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|21932|28371|lyfalmen|V0327|3975|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||20578||20578|28371||1
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|1293|2748|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1293||1293|2748||1
011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|0|0|0|0|*|0|POF|0|0|0|100|IKR|7436|4460|lyfalmen|V0457|4460|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||2545||2545|4460||2
011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|13155|19055|lyfalmen|||1|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||13155||13155|19055||1
011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1150|2552|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1150||1150|2552||1
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3173|1897|lyfalmen|V0069|1882|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||671||671|1897||1
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|10355|15144|lyfalmen|V0357|13844|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10355||10355|15144||1
011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|7994|11914|lyfalmen|||1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7994||7994|11914||1
011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2627|3791|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2627||2627|3791||1
011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|10493|15333|lyfalmen|||1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10493||10493|15333||1
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|2088|4153|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||2088||2088|4153||2
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|5355|7729|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||5355||5355|7729||1
011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|0|0|0|0|E|0|OYL|0|0|0|100|DKK|1782|3417|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1782||1782|3417||1
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|95447|121668|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||95447||95447|121668||2
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|3145|6211|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||3145||3145|6211||2
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1486|1972|lyfalmen|V0152|1972|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|1972||1
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|4738|5417|lyfalmen|V0323|5328|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||3244||3244|5417||1
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|4931|7117|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4931||4931|7117||1
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2853|4118|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2853||2853|4118||1
011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|8634|12790|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8634|12790||1
012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|43891|56966|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||43891||43891|56966||1
012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1421|1991|lyfalmen|V0551|1991|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||740||740|1991||2
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|4809|7557|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4809||4809|7557||1
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6504|9876|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6504||6504|9876||2
012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|2022|2783|lyfalmen|V0556|2783|2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1319||1319|2783||2
012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|13368|19322|lyfalmen|||1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||13368||13368|19322||1
012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|4263|5237|lyfalmen|V0552|5237|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||3113||3113|5237||2
012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|483294|608416|lyfsjukr|||1|1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||483294||483294|608416||2
012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961||1
012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|5231|8135|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||5231||5231|8135||1
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|E|0|LBI|0|0|0|100|DKK|7719|11538|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||7719||7719|11538||2
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|E|0|RGM|0|0|0|100|XEU|3635|4701|lyfalmen|V0250|4701|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2721||2721|4701||2
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|E|0|RGM|0|0|0|100|XEU|3958|5408|lyfalmen|V0251|5408|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||3238||3238|5408||2
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|6667|10099|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6667||6667|10099||1
013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|7530|14631|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||7530||7530|14631||2
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|10066|14749|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||10066||10066|14749||1
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1896|3771|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1896||1896|3771||2
013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|24018|32025|lyfsjukr|||1|2|0||Ísaga ehf|AGA AB|Nituroxíđ||24018||24018|32025||5
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|7842|11318|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7842||7842|11318||2
013259|B02BD0901|BeneFIX|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|31948|41977|lyfsjukr|||1|1|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||31948||31948|41977||2
013270|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|54076|69748|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||54076||54076|69748||2
013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|1|0|0|0|E|0|ANO|0|0|0|100|XEU|3650|5001|lyfalmen|V0042|5001|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2940||2940|5001||1
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4946|9670|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||4946||4946|9670||2
013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|11541|22333|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||11541||11541|22333||2
013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1211|2409|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1211||1211|2409||2
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BAL|0|0|0|100|SEK|166972|211432|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||166972|211432||3
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|0|0|100|SEK|455183|506013|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||401698||401698|506013||1
013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|29368|38739|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||29368|38739||3
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|111314|141582|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||111314|141582||3
013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|56738|73089|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||56738|73089||3
013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5860|8995|lyfalmen|||1|28|0||Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5860||5860|8995||1
013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|19952|27585|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||19952||19952|27585||1
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1422|2924|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1422||1422|2924||2
013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510||1
013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|825|2080|lyfalmen|V0562|2080|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||805||805|2080||2
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2719|4698|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2719||2719|4698||2
013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978|28.02.2013|R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1594|3070|lyfalmen|||1|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1529||1529|3070||1
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|456|1603|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||456||456|1603||1
013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|40439|52633|lyfsjukr|||1|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||40439||40439|52633||1
013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|5076|7923|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||5076||5076|7923||1
013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1043|2406|lyfalmen|||1|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||1043|2406||1
013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641||1
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6707|10154|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6707||6707|10154||1
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|2793|4800|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2793||2793|4800||1
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|5010|7832|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5010||5010|7832||1
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|192024|242873|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||192024||192024|242873||1
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|408190|514161|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||408190||408190|514161||1
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|2703|4676|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2703||2703|4676||1
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|10087|14542|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10087||10087|14542||1
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|19613|27159|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||19613||19613|27159||1
014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|61969|80316|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||61969||61969|80316||2
014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32196|42288|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||32196||32196|42288||2
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|31066|41533|lyfalmen|V0357|41533|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||31066||31066|41533||1
014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1759|3385|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1759||1759|3385||2
014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21386|28722|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||21386||21386|28722||2
014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27996|37017|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||27996||27996|37017||2
014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|397|1522|lyfalmen|V0563|1522|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||397||397|1522||2
014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2888|4930|lyfalmen|||0|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2888||2888|4930||1
014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2482|4937|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2482|4937||2
014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|20986|28883|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||20986||20986|28883||2
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|89434|114122|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||89434|114122||3
014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|XEU|6169|12018|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||6169||6169|12018||2
014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|260606|328943|lyfsjukr|||1|60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||260606||260606|328943||2
014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|1001|2321|lyfalmen|V0564|2321|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||981||981|2321||2
014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|2484|4377|lyfalmen|||1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2484||2484|4377||2
014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|1494|3023|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1494||1494|3023||1
014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|68114|87366|lyfsjukr|||1|2,5|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||68114||68114|87366||1
014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|108980|138652|lyfsjukr|||1|2,5|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||108980||108980|138652||1
014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|1289|2742|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||1289|2742||1
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|20871|28738|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||20871||20871|28738||1
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|62978|81583|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||62978||62978|81583||1
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|41920|55155|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||41920||41920|55155||1
015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2
015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|859|2154|lyfalmen|||1|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||859||859|2154||1
015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3460|5712|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3460||3460|5712||1
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|9299|13699|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9299||9299|13699||1
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1198|2593|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1180||1180|2593||1
015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754||3
015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1178|2590|lyfalmen|V0129|1833|1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1178||1178|2590||1
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|2036|2250|lyfalmen|V0234|2211|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||929||929|2250||1
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|2908|2719|lyfalmen|V0233|2719|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1272||1272|2719||1
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|11079|16134|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||11079||11079|16134||1
015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|373723|470905|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||373723||373723|470905||3
015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|99334|126547|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||99334||99334|126547||3
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5745|8838|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5745||5745|8838||1
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|14605|20874|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14605||14605|20874||1
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5745|8838|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5745||5745|8838||1
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|15788|22359|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15788||15788|22359||1
015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005|31.01.2013|R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|72570|92958|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||72570||72570|92958||1
015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|76197|97510|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||76197||76197|97510||1
015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008|31.01.2013|R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|63104|81078|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||63104||63104|81078||1
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5745|8838|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5745||5745|8838||1
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|14451|20681|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14451||14451|20681||1
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|76197|97510|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||76197||76197|97510||1
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|24433|33209|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||24433||24433|33209||1
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|50894|66417|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||50894||50894|66417||1
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4372|7627|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||4372||4372|7627||2
015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5691|9928|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||5691||5691|9928||2
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3657|6379|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||3657||3657|6379||2
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4952|8639|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||4952||4952|8639||2
015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|4912|7698|lyfalmen|V0200|5885|1|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4912||4912|7698||3
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5445|9499|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||5445||5445|9499||2
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|2175|3954|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||2175|3954||1
015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|2443|4321|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2443||2443|4321||1
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1650|3236|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1650||1650|3236||2
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4332|7557|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||4332||4332|7557||2
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|2106|3860|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2106||2106|3860||1
016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16547|23312|lyfalmen|V0117|11655|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16547||16547|23312||1
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1226|2656|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1226||1226|2656||2
016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|24777|33640|lyfalmen|V0118|17187|1|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||24777||24777|33640||1
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1299|2756|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1299||1299|2756||2
016038|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|ţpakki||N02CC05|01.05.2001||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|2830|4850|lyfalmen|V0236|4219|1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2830||2830|4850||1
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2958|5025|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2958||2958|5025||1
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|7711|11527|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||7711||7711|11527||1
016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|5708|8787|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5708||5708|8787||2
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11690|16970|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||11690||11690|16970||1
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1953|3651|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1953||1953|3651||1
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17105|24012|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||17105||17105|24012||1
016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|9571|14072|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||9571||9571|14072||1
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|104144|132583|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||104144||104144|132583||1
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|4611|6655|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4611||4611|6655||1
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3061|5166|lyfalmen|||1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||3061||3061|5166||1
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|19023|26419|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19023||19023|26419||1
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||8354||1
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|37160|49181|lyfalmen|||1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37160||37160|49181||1
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|1911|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367||1
016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|200339|253308|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||200339||200339|253308||2
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|8481|12580|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8481||8481|12580||1
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|E|0|LVR|0|0|0|100|DKK|3320|5520|lyfalmen|V0240|5520|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3320||3320|5520||3
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|E|0|LVR|0|0|0|100|DKK|6127|9360|lyfalmen|V0433|9360|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||6127||6127|9360||3
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|66290|85739|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||66290||66290|85739||1
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|97678|125131|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||97678||97678|125131||1
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|31566|42160|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||31566||31566|42160||1
016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|0|0|100|XEU|85461|109136|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||85461||85461|109136||1
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3853|6250|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3853|6250||1
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GIS|0|0|0|100|XEU|43187|56082|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||43187||43187|56082||3
016979|N02AE0103|Norspan|forđapl|5|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|3413|5648|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3413||3413|5648||2
016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|20387|39319|vetalmen|||0|60|0||Icepharma hf|Pfizer Oy Animal Health|||20387||20387|39319||2
017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27680|36621|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27680||27680|36621||2
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|1660|3250|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1660||1660|3250||1
017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|1|0|0|0|E|0|DSG|0|0|0|100|XEU|1560|3113|lyfalmen|||1|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1560||1560|3113||2
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|0|0|100|DKK|286611|361579|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||286611||286611|361579||2
017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|8581|12717|lyfalmen|||1|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||8581||8581|12717||1
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|AGT|0|0|0|100|XEU|6565|9959|lyfalmen|||2|500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||6565||6565|9959||1
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|200289|253245|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||200289||200289|253245||1
017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|43745|56782|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||43745||43745|56782||2
017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|1481|3005|lyfalmen|V0046|2354|2|100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1481||1481|3005||1
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|139226|176611|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||139226||139226|176611||2
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|51989|67791|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||51989||51989|67791||2
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|161447|205161|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||161447||161447|205161||2
017266|N02AE0103|Norspan|forđapl|10|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|5924|9083|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5924||5924|9083||2
017326|N02AE0103|Norspan|forđapl|20|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|11281|16411|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||11281||11281|16411||2
017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|2928|4984|lyfalmen|||2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2928||2928|4984||1
017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|9802|14147|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||9802||9802|14147||1
017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|965|2299|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||965||965|2299||1
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|3351|5563|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3351||3351|5563||1
017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2641|lyfalmen|V0168|2641|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2641||1
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7276|14144|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7276||7276|14144||1
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11325|16471|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||11325||11325|16471||1
017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|48572|63503|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||48572||48572|63503||1
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10343|15128|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||10343||10343|15128||1
018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005|28.02.2013|R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|2427|4299|lyfalmen|||1|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2427||2427|4299||1
018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005|28.02.2013|R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|3564|5854|lyfalmen|||1|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3564||3564|5854||1
018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005|28.02.2013|R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|11503|16714|lyfalmen|||1|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||11503||11503|16714||1
018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005|28.02.2013|R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|8006|11931|lyfalmen|||1|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8006||8006|11931||1
018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4324|6894|lyfalmen|||1|0,25|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4324||4324|6894||2
018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4723|7440|lyfalmen|||1|0,5|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4723||4723|7440||2
018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005|28.02.2013|R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|9514|13994|lyfalmen|||1|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||9514||9514|13994||1
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|1499|1800|lyfalmen|V0243|1529|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||600||600|1800||1
018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005|28.02.2013|R|1|0|0|0|0|0|DSH|0|0|0|100|DKK|2981|5057|lyfalmen|||1|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2981||2981|5057||1
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|8992|13280|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8992||8992|13280||1
018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|14859|20531|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||14859||14859|20531||2
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|22046|30213|lyfalmen|V0441|30213|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||22046||22046|30213||1
018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3172|5318|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3172||3172|5318||1
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|1|0|0|0|B|0|MKA|0|0|1|100|SEK|1082|2459|lyfalmen|||1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||1082||1082|2459||2
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|6368|9690|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6368||6368|9690||1
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|17950|25072|lyfalmen|V0440|25072|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17950||17950|25072||1
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|37384|49462|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||37384||37384|49462||1
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|136861|173643|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||136861||136861|173643||1
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|63182|81176|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||63182||63182|81176||1
018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|647|1864|lyfalmen|||2|100|0|50,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||647||647|1864||1
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1463|2910|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1463||1463|2910||2
018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|11430|16615|lyfalmen|V0221|8649|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||11430||11430|16615||1
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23818|31774|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23818||23818|31774||2
019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|8170|12155|lyfalmen|V0220|6779|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||8170||8170|12155||1
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26881|35618|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||26881||26881|35618||2
019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|4530|7176|lyfalmen|V0219|4116|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4530||4530|7176||1
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37319|48718|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||37319||37319|48718||2
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|38266|49906|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||38266||38266|49906||2
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46756|60561|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||46756||46756|60561||2
019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|10633|15524|lyfalmen|V0223|9873|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||10633||10633|15524||1
019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15754|22316|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||15754||15754|22316||1
019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5403|8370|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5403||5403|8370||1
019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|56363|72618|lyfsjukr|||2|1|0||Vistor hf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||56363||56363|72618||1
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|807480|1015270|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||807480||807480|1015270||1
019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||4877||4877|9537||1
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dćlur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|22947|44234|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||22947|44234||2
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|7427|11139|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7427||7427|11139||2
019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|56807|73175|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||56807||56807|73175||2
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|7427|11139|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7427||7427|11139||2
019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|650|1868|lyfalmen|||2|100|0|100,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||650||650|1868||1
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005|31.12.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|4067|5870|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||4067||4067|5870||2
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005|31.12.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|679|1908|lyfalmen|||2|250|0|250,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||679||679|1908||1
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|17864|24302|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||17864||17864|24302||2
019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|210952|266627|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||210952||210952|266627||2
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1245|2682|lyfalmen|V0159|2340|2|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1245||1245|2682||1
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|215348|272144|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||215348||215348|272144||2
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|14003|20119|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14003||14003|20119||2
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|14003|20119|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14003||14003|20119||2
019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|60369|78308|lyfalmen|||1|1,08|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||60369||60369|78308||1
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|14003|20119|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14003||14003|20119||2
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|14003|20119|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14003||14003|20119||2
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|14003|20119|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14003||14003|20119||2
019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|852181|1071370|lyfsjukr|||1|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||852181||852181|1071370||1
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|417|1549|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||417|1549||1
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|71597|91737|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||71597||71597|91737||1
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1865|3469|lyfalmen|V0160|2965|2|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1820||1820|3469||1
020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005|31.12.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|3167|5311|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3167||3167|5311||1
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|27916|37580|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||27916||27916|37580||1
020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|3112|5236|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||3112||3112|5236||3
020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|626|1835|lyfalmen|V0333|1835|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||626||626|1835||1
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|7394|11094|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||7394||7394|11094||1
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|57711|74972|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||57711||57711|74972||1
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|6629|4526|lyfalmen|V0530|4526|1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2593||2593|4526||1
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|14770|5280|lyfalmen|V0531|5280|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3144||3144|5280||1
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|26043|35229|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||26043||26043|35229||1
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|656|1876|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||656||656|1876||1
020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|6172|9422|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||6172||6172|9422||2
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1997|3711|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1997||1997|3711||1
020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|17975|25104|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||17975||17975|25104||2
020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2413|4209|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2413||2413|4209||1
020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|169272|214319|lyfsjukr|||1|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||169272||169272|214319||2
020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2822|4923|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2822||2822|4923||2
020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2189|3973|lyfalmen|V0174|3332|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2189||2189|3973||2
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|3262|5441|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||3262||3262|5441||2
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2779|4780|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2779||2779|4780||2
021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen|||3|12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956||2
021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|1025|2381|lyfalmen|V0169|1911|3|12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1025||1025|2381||2
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|E|0|ACA|0|0|1|100|IKR|453|1491|lyfalmen|V0188|1491|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1491||1
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|E|0|GEM|0|0|0|100|XEU|1104|2489|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1104||1104|2489||1
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|E|0|ACA|0|0|1|100|IKR|1187|2322|lyfalmen|V0189|2322|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||982||982|2322||1
021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|0|0|LVR|0|0|0|100|GBP|10098|14565|lyfalmen|V0437|14565|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9932||9932|14565||3
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|18569|25849|lyfalmen|V0490|7810|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||18569||18569|25849||1
021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|0|0|LVR|0|0|0|100|GBP|7194|10820|lyfalmen|V0436|10820|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7194||7194|10820||3
021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.11.2004||R|0|0|0|0|E|0|DAC|0|0|1|100|SEK|1870|3480|lyfalmen|V0443|3480|3|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1828||1828|3480||2
021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1
021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|18864|26219|lyfalmen|V0491|15236|1|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||18864||18864|26219||1
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1713|2472|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1713||1713|2472||2
021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|4760|7490|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4760||4760|7490||1
021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|14570|20830|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14570||14570|20830||1
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16177|22847|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16177||16177|22847||1
021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|7700|11512|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||7700||7700|11512||1
021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|16361|23078|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16361||16361|23078||1
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|17127|23377|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||17127||17127|23377||2
021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|24526|33325|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||24526||24526|33325||1
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|17127|23377|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||17127||17127|23377||2
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|26363|35631|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||26363||26363|35631||1
021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5043|7877|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||5043||5043|7877||1
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9849|14215|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||9849||9849|14215||2
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4970|7173|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4970||4970|7173||1
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|21106|29033|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||21106||21106|29033||1
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|4159|6668|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4159||4159|6668||2
021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23380|31224|lyfsjukr|||1|2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||23380||23380|31224||2
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|5748|8842|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5748||5748|8842||2
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|19806|27402|lyfalmen|||1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||19806||19806|27402||2
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|88539|112999|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||88539||88539|112999||3
022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|21106|29033|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||21106||21106|29033||1
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|90884|115942|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||90884||90884|115942||2
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|138327|175483|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||138327||138327|175483||2
022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||||1
022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7800|11649|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7800||7800|11649||1
022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|9141|13483|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||9141||9141|13483||1
022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|28030|37723|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||28030||28030|37723||1
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|0|0|0|0|*|0|SAA|0|0|0|100|NOK|6074|9288|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6074||6074|9288||1
022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|9748|14314|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||9748||9748|14314||1
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|318060|401048|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||318060||318060|401048||2
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|351005|442394|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||351005||351005|442394||2
022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12234|21342|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||12234||12234|21342||2
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|27564|37138|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||27564||27564|37138||1
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2459|4290|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2459||2459|4290||2
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1406|2902|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1406||1406|2902||1
022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1497|2611|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1497|2611||2
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|4154|2860|lyfalmen|V0056|1711|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1375||1375|2860||1
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|7303|3962|lyfalmen|V0057|2101|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2181||2181|3962||1
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2329|4063|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||2329||2329|4063||2
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|683|1913|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||683||683|1913||1
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|2049|3782|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2049||2049|3782||1
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1508|2631|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1508||1508|2631||2
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|5074|7920|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||5074||5074|7920||1
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2129|2993|lyfalmen|V0321|2993|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993||1
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1554|2046|lyfalmen|V0321|1796|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046||1
022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||5099||2
022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|27465|37014|lyfalmen|||1|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||27465||27465|37014||1
022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|13733|19780|lyfalmen|||1|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13733||13733|19780||1
022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|20621|28424|lyfalmen|||1|6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||20621||20621|28424||1
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||3039||2
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827||1
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|||2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196|28.2.2013|1
022962|V01AA1104|Alutard SQ, hrossavćrur|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999|28.02.2013|R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|25968|35135|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||25968||25968|35135||1
022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999|28.02.2013|R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||20790||20790|28637||1
023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005|28.02.2013|R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|6044|9247|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||6044||6044|9247||1
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|90877|115933|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||90877||90877|115933||3
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|27901|37561|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||27901||27901|37561||3
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|43561|57214|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||43561||43561|57214||3
023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|22059|30229|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||22059||22059|30229||1
023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005|28.02.2013|R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|6104|9329|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||6104||6104|9329||1
023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|22283|30510|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||22283||22283|30510||1
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|5440|4720|lyfalmen|V0250|4701|2|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2735||2735|4720||1
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|4073|6551|lyfalmen|V0251|5408|2|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||4073||4073|6551||1
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|21343|29331|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||21343||21343|29331||1
023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|8027|11585|lyfsjukr|||1|0,5|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||8027||8027|11585||1
023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|30867|40621|lyfsjukr|||1|0,4|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||30867||30867|40621||1
023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|23374|31217|lyfsjukr|||1|0,3|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||23374||23374|31217||1
023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|55667|71745|lyfsjukr|||1|0,3|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||55667||55667|71745||1
023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|37616|49091|lyfsjukr|||1|0,5|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||37616||37616|49091||1
023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|9502|13714|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||9502||9502|13714||2
023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|112117|142589|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||112117||112117|142589||1
023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|23756|31696|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||23756||23756|31696||2
023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|16135|22132|lyfsjukr|||1|0,4|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16135||16135|22132||1
023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|44130|57266|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||44130||44130|57266||2
023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|88259|112648|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||88259||88259|112648||2
023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|195388|247094|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||195388||195388|247094||1
023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|176518|223413|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||176518||176518|223413||2
023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|146570|185828|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||146570||146570|185828||1
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|1|0|0|0|E|0|SBM|0|0|0|100|NOK|29904|34511|lyfalmen|V0029|8555|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||25471||25471|34511||1
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3919|6340|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3919||3919|6340||2
023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|174194|220496|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||174194||174194|220496||2
023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|61460|79015|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||61460||61460|79015||2
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|83208|106309|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||83208||83208|106309||1
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|E|0|MSD|0|0|0|100|DKK|3181|5330|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3181||3181|5330||1
024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|2884|4924|lyfalmen|V0222|4053|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2884||2884|4924||1
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|E|0|TPG|0|0|0|100|DKK|21023|28929|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||21023||21023|28929||1
024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2035|2937|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2035||2035|2937||2
024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24594|32748|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||24594||24594|32748||2
024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|0|0|0|0|*|0|POF|0|0|0|100|IKR|14561|8622|lyfalmen|V0456|8622|2|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||5587||5587|8622||2
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|1|0|0|0|E|0|TPG|0|0|0|100|DKK|69339|89566|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||69339||69339|89566||1
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|26363|35631|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||26363||26363|35631||1
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8299|12332|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8299||8299|12332||1
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|487|1645|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||487||487|1645||1
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8299|12332|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8299||8299|12332||1
024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13984|20095|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13984||13984|20095||1
024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|14007|20124|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||14007||14007|20124||1
024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|14151|20305|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||14151||14151|20305||1
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5984|9165|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5984||5984|9165||1
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|76029|97962|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||76029||76029|97962||1
024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|14151|20305|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||14151||14151|20305||1
024603|V04CL0001|Soluprick  Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1704|3310|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1704||1704|3310||1
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5984|9165|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5984||5984|9165||1
024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8299|12332|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8299||8299|12332||1
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|8299|12332|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||8299||8299|12332||1
024681|V04CL0002|Soluprick  Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1704|3310|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1704||1704|3310||1
024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|1|0|0|0|E|0|OPF|0|0|1|100|XEU|411|1522|lyfalmen|V0563|1522|2|30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||397||397|1522||2
025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|1|0|0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen|||||||2
025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|E|0|OPF|0|0|1|100|XEU|823|2094|lyfalmen|V0562|2080|2|100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||815||815|2094||2
025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|E|0|OPF|0|0|1|100|XEU|1000|2335|lyfalmen|V0564|2321|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||991||991|2335||2
025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|692|1926|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||692||692|1926||1
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|21106|29033|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||21106||21106|29033||1
025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994|28.02.2013|R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|2076|3819|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2076||2076|3819||1
025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|21106|29033|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||21106||21106|29033||1
025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14987|21354|lyfalmen|||1|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||14987||14987|21354||1
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|91252|116404|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||91252||91252|116404||1
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|85233|108850|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||85233||85233|108850||1
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|10459|20255|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||10459||10459|20255||1
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|18104|25266|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||18104||18104|25266||1
025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki||C09CA03|01.04.2007||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|21488|29513|lyfalmen|||1|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||21488||21488|29513||1
025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2515|2935|lyfalmen|V0462|2904|2|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1430||1430|2935||2
025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2737|3080|lyfalmen|V0471|3046|2|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1536||1536|3080||2
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|5727|8813|lyfalmen|V0205|1219|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5727||5727|8813||2
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|15348|21807|lyfalmen|V0205|3656|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||15348||15348|21807||2
025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2942|3332|lyfalmen|V0472|3293|2|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1720||1720|3332||2
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|58154|75528|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||58154||58154|75528||1
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|8296|11973|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||8296||8296|11973||1
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|26363|35631|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||26363||26363|35631||1
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|62950|80885|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||62950|80885||2
025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|14595|16926|lyfalmen|V0492|16649|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||11658||11658|16926||2
025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|17703|15513|lyfalmen|V0491|15236|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||10625||10625|15513||2
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|5145|8975|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||5145||5145|8975||1
025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|14930|8088|lyfalmen|V0490|7810|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||5197||5197|8088||2
025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||||2
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|SEK|2985|5904|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2985||2985|5904||1
026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|||2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101|31.1.2013|2
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|10136|17682|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||10136||10136|17682||1
026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|IKR|23430|16545|lyfalmen|V0475|16545|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||11379||11379|16545||2
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|21106|29033|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||21106||21106|29033||1
026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|46552|60305|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||46552||46552|60305||1
026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|232790|294034|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||232790||232790|294034||1
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|1983|3692|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1983|3692||1
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|7515|11259|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||7515|11259||1
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|3918|6339|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3918|6339||1
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|15519|22021|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||15519|22021||1
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|23255|31730|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||23255|31730||1
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|30992|41440|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||30992|41440||1
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1631|3210|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1631||1631|3210||1
026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
026702|C10AA0505|Atorvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|4560|3687|lyfalmen|V0114|3687|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||1980||1980|3687||2
026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1820|3469|lyfalmen|V0160|2965|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1820||1820|3469||2
026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1293|2681|lyfalmen|V0159|2340|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1244||1244|2681||2
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|485|1642|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||485||485|1642||1
027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|2947|5010|lyfalmen|V0199|3777|1|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2947||2947|5010||3
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|*|0|ALA|0|0|0|100|USD|2592|4525|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2592||2592|4525||1
027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|*|0|MYL|0|0|0|100|SEK|7973|11886|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7973||7973|11886||1
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|32310|13000|lyfalmen|V0341|12327|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||8788||8788|13000||1
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|36260|14466|lyfalmen|V0342|13792|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||9859||9859|14466||1
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|8236|12245|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||8236||8236|12245||1
027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|10853|15825|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||10853||10853|15825||1
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|B|0|NYC|0|0|0|100|DKK|917|2233|lyfalmen|V0153|2231|2|100|0|33,3300|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||917||917|2233||1
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|B|0|NYC|0|0|0|100|DKK|916|2232|lyfalmen|V0154|2068|2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||916||916|2232||1
027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|*|0|OPF|0|0|0|100|IKR|2109|2853|lyfalmen|V0284|2853|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1370||1370|2853||2
027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|0|0|0|1|0|1|SPE|0|0|0|100|DKK|109695|139550|lyfsjukr|||1|105|0|5,2500|Vistor hf|SP Europe|Posacónazól||109695||109695|139550||1
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|22382|30635|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22382||22382|30635||1
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|34921|45708|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||34921|45708||2
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|25868|35009|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25868||25868|35009||1
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|51456|66460|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||51456||51456|66460||2
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|64819|83230|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||64819|83230||2
028045|G03AB0801|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|5798|8910|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5798||5798|8910||2
028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|*|0|MLD|0|0|0|100|DKK|24789|33655|lyfalmen|V0387|33655|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||24789||24789|33655||1
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||||1
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|26493|35794|lyfalmen|V0386|35794|1|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||26493||26493|35794||1
028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|4065|5203|lyfalmen|V0364|5203|2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3088||3088|5203||1
028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009|28.02.2013|R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|20191|27885|lyfalmen|||1|196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||20191|27885||1
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|61878|79539|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||61878||61878|79539||1
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2765|4761|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2765||2765|4761||2
028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|49341|64468|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||49341||49341|64468||2
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|23210|31674|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||23210||23210|31674||2
028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|11672|16946|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaćđi, dauđ veira||11672||11672|16946||2
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2127|3889|lyfalmen|V0202|3889|2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||2127||2127|3889||1
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2385|4241|lyfalmen|V0428|3722|2|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2385||2385|4241||1
028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|5740|8831|lyfalmen|||1|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5740||5740|8831||1
028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727||1
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|5812|4467|lyfalmen|V0245|4292|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2550||2550|4467||1
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|10358|9187|lyfalmen|V0232|8771|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||6000||6000|9187||1
028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|871|1437|lyfalmen|V0266|1329|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||335||335|1437||2
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|8680|16839|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||8680||8680|16839||2
028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|5017|7842|lyfalmen|||2|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||5017||5017|7842||2
028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|5669|2700|lyfalmen|V0267|2686|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1258||1258|2700||2
028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|20134|21211|lyfalmen|||2|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||11075||14873|21211|28.2.2013|2
028739|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|B|0|BGB|0|0|0|100|DKK|2656|4612|lyfalmen|V0085|4612|1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||2656|4612||2
028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|2075|lyfalmen|V0551|1991|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||801||801|2075||2
028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|5676|lyfalmen|V0552|5611|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||3434||3434|5676||2
028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0554|1768|2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768||2
028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0555|1749|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749||2
028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2828|lyfalmen|V0556|2783|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||1352||1352|2828||2
029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|1162|2568|lyfalmen|||1|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1162|2568||1
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|8285|12312|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Agómelatín||8285||8285|12312||2
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|23634|32206|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Agómelatín||23634||23634|32206||2
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|3162|5304|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3162||3162|5304||1
029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|0|0|0|0|E|0|AUK|0|0|0|100|GBP|272|1351|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||272|1351||1
029307|A07EA0603|Entocort enema (D.A.C.)|endaţ.dr|0,02|mg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.01.2007||R|||0|0|B|0|DAC|0|0|0|100|SEK|8562|12691|lyfalmen|V0591|12691||7|0|7,0000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||||8562|12691||
029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005|31.12.2012|R|1|0|0|0|0|0|LVR|0|0|0|100|XEU|7674|9367|lyfalmen|||3|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6288||6132|9367||3
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|73119|93647|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||73119||73119|93647||1
029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|24661|32832|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||24661||24661|32832||1
029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|6377|9204|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||6377||6377|9204||1
029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4898|7069|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4898||4898|7069||1
029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5777|8882|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5777|8882||1
029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|18143|25315|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||18143|25315||1
029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010|28.02.2013|R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5681|8750|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5681|8750||1
029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|18143|25315|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||18143|25315||1
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|7349|11032|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||7349||7349|11032||2
029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|109598|139428|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||109598||109598|139428||1
029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|219194|276971|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||219194||219194|276971||1
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
030108|R06AX2701|Aerius|filmhtfl|5|mg|10|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|684|1915|lyfalmen|V0366|869|1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||684||684|1915||1
030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|5468|3596|lyfalmen|V0148|3002|2|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||1913||1913|3596||2
030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|25794|34917|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||25794||25794|34917||1
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|*|0|NOH|0|0|0|100|DKK|10088|14779|lyfalmen|V0277|14777|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||10088||10088|14779||1
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|*|0|NOH|0|0|0|100|IKR|2884|4924|lyfalmen|||1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2884||2884|4924||1
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|17652|30793|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||17652|30793||2
030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1576|3135|lyfalmen|V0051|3135|2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1576||1576|3135||1
031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|2490|4385|lyfalmen|||2|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2490||2490|4385||1
031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2820||1
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|3452|5701|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3452||3452|5701||2
031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3386|5611|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3386||3386|5611||2
031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|71645|91797|lyfsjukr|||1|20|0||Vistor hf|Schering-Plough|Temozolomid||71645||71645|91797||1
031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|87288|111429|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||87288||87288|111429||1
031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|192443|243398|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||192443||192443|243398||1
031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|2392|4251|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2392||2392|4251||1
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6492|9860|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||6492||6492|9860||1
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|25425|33791|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||25425||25425|33791||1
031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|2282|4101|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2282||2282|4101||1
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|*|0|OTS|0|0|0|100|DKK|23077|31507|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23077||23077|31507||1
032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|4163|7262|vetorma|||0|50|0||Vistor hf|Merial (MSD)|Ivermectinum||4163||4163|7262||1
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|16247|28342|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||16247||16247|28342||1
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|*|0|FER|0|0|0|100|DKK|23390|31900|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||23390|31900||1
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|*|0|FER|0|0|0|100|DKK|46651|61092|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||46651|61092||1
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|1342|2341|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1342||1342|2341||2
033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|3371|5590|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||3371||3371|5590||2
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|10046|19462|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||10046|19462||2
033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|11487|16693|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||11487||11487|16693||2
033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6746|10207|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||6746||6746|10207||2
033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|19912|27535|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||19912||19912|27535||2
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|E|0|ALC|0|0|1|100|USD|1333|2802|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Dexametasón||1333||1333|2802||1
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|0|0|0|0|*|0|WIH|0|0|0|100|XEU|51110|23671|lyfalmen|V0185|23645|2|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||16833||16833|23671||2
033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|91778|117064|lyfsjukr|||1|60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||91778||91778|117064||1
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|119710|152119|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||119710||119710|152119||1
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2714|5384|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2714|5384||2
034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|819|2099|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||819||819|2099||2
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|26407|35023|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||26407||26407|35023||2
034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|0|0|0|0|0|0|IAG|0|0|0|100|SEK|17090|23993|lyfalmen|||1|0,5|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||17090||17090|23993||2
034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|E|0|ELD|0|0|0|100|XEU|8916|13176|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8916|13176||2
034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|E|0|ELD|0|0|0|100|XEU|8916|13176|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8916|13176||2
034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|83998|107300|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||83998||83998|107300||1
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|E|0|NOL|0|0|1|100|SEK|2009|3727|lyfalmen|V0367|3727|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2009||2009|3727||1
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|E|0|NOL|0|0|1|100|SEK|3361|5577|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||3361||3361|5577||1
034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|197525|249776|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||197525||197525|249776||2
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|8170|11791|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||8170||8170|11791||1
035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2482|3582|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2482||2482|3582||2
035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|B|0|FER|0|0|0|100|DKK|17512|24523|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17512||17512|24523||1
035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4059|6531|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||4059|6531||1
035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|1097|2480|lyfalmen|V0050|2480|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1097||1097|2480||2
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1844|2575|lyfalmen|V0244|2575|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1167||1167|2575||1
035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|1463|2980|lyfalmen|V0048|2980|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1463||1463|2980||2
035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|2612|4552|lyfalmen|V0049|4552|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2612||2612|4552||2
035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11639|16900|lyfalmen|V0080|13549|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||11639||11639|16900||1
035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|5709|8356|lyfalmen|V0054|8356|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||5393||5393|8356||2
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|XEU|33535|40579|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||30306||30306|40579||1
036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|161959|205141|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||161959||161959|205141||2
036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|6767|10236|lyfalmen|||1|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6767||6767|10236||1
036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3321|5522|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3321||3321|5522||1
036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9672|14210|lyfalmen|V0081|11423|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9672||9672|14210||1
036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|1|0|0|1|0|1|ABV|0|0|0|100|DKK|6649|9596|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||6649||6649|9596||1
036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|215648|272521|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||215648||215648|272521||1
036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|430128|541693|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||430128||430128|541693||1
036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|858448|1079235|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||858448||858448|1079235||1
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|926|2246|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||926||926|2246||1
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1628|3206|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1628||1628|3206||1
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|3212|5373|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||3212||3212|5373||1
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|974|2311|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||974||974|2311||1
037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|12931|11033|lyfalmen|V0532|10006|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7350||7350|11033||1
037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|23739|18652|lyfalmen|V0533|17707|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12834||12834|18652||1
037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|46425|34297|lyfalmen|V0534|32996|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||25300||25300|34297||1
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|2754|4746|lyfalmen|V0434|4746|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2754||2754|4746||2
037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1260|2703|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1260||1260|2703||1
037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|1079|1900|lyfalmen|V0151|1900|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||673||673|1900||2
037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|2577|3586|lyfalmen|V0322|3586|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1906||1906|3586||2
037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|4853|5437|lyfalmen|V0323|5437|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||3259||3259|5437||2
037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2373||1
037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3904||1
037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9531|14017|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||9531|14017||1
038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|0|0|GSK|0|0|0|100|IKR|664|1499|lyfalmen|||1|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499||1
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|B|0|GSK|0|0|0|100|IKR|2667|3155|lyfalmen|V0321|2993|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155||1
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|1140|2538|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1140||1140|2538||2
038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2926|4982|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2926||2926|4982||1
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|191309|241975|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||191309||191309|241975||1
038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|82687|105655|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||82687||82687|105655||2
039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|46456|60185|lyfsjukr|||1|10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||46456||46456|60185||1
039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|77658|99343|lyfsjukr|||1|20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||77658||77658|99343||1
039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|18042|25188|lyfalmen|||1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||18042|25188||2
039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|46444|60170|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||46444||46444|60170||2
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|7541|11182|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7459||7459|11182||1
039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|5168|8048|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||5168|8048||1
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|25321|34323|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||25321|34323||1
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|ţpakki||N06AX03|01.06.2010||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|4069|6545|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||4069||4069|6545||1
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|650|1729|lyfalmen|V0541|1620|2|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||548||548|1729||1
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|731|1789|lyfalmen|V0542|1670|2|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||592||592|1789||1
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1413|2912|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1413||1413|2912||1
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|2037|3765|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2037||2037|3765||1
039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1508|2176|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1508||1508|2176||2
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|1630|1984|lyfalmen|V0110|1951|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||735||735|1984||1
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|E|0|AGP|0|0|1|100|GBP|9048|9240|lyfalmen|V0182|9240|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6039||6039|9240||1
039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3779|5454|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3779||3779|5454||2
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|E|0|AGP|0|0|1|100|GBP|1960|2132|lyfalmen|V0033|2132|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||843||843|2132||1
040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|7540|10882|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||7540||7540|10882||2
040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|E|0|APC|0|0|1|100|XEU|1430|2607|lyfalmen|V0366|2607|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1190||1190|2607||1
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||0|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723||1
040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|ţpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1720|3332|lyfalmen|V0174|3332|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1720||1720|3332||1
040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|4539|2449|lyfalmen|V0112|2449|2|100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1075||1075|2449||2
041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3831|6220|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3831||3831|6220||2
041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|2521|2607|lyfalmen|V0318|2607|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1190||1190|2607||2
041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|IPF|1|0|0|100|DKK|30615|53406|vetorma|||0|240|0||Icepharma hf|Pfizer Limited|gonadotropin releasing factor analogue, conjugated||||30615|53406||2
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4795|8365|vetorma|||0|100|0||Vistor hf|Intervet International BV|||4795||4795|8365||1
041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009|31.12.2012|L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak|||||||2
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1344|2817|lyfalmen|||2|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1344|2817||1
041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|4399|2132|lyfalmen|V0005|2114|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||843||843|2132||1
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||||1
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|1728|3343|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1728||1728|3343||1
042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|14545|20136|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||14545||14545|20136||1
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2768|3995|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2768||2768|3995||2
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3346|4829|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3346||3346|4829||2
042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4737|6837|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4737||4737|6837||2
042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4855|7007|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4855||4855|7007||2
042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6185|8927|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||6185||6185|8927||2
042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7634|11018|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7634||7634|11018||2
042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4137|5971|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4137||4137|5971||2
042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3166|4569|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3166||3166|4569||2
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2420|3493|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2420||2420|3493||2
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3029|4372|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3029||3029|4372||2
042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3975|5737|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3975||3975|5737||2
042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2715|3918|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2715||2715|3918||2
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1956|2823|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1956||1956|2823||2
042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6638|9580|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6638||6638|9580||2
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2215|3197|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2215||2215|3197||2
042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|845|2135|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||845||845|2135||2
042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3136|4526|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3136||3136|4526||2
042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|16146|22808|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||16146||16146|22808||2
042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|1463|2910|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1463||1463|2910||2
042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2181|4338|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2181||2181|4338||2
042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2924|5787|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2924||2924|5787||2
042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|5849|11404|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5849||5849|11404||2
042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|6726|13087|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6726||6726|13087||2
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2640|3810|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2640||2640|3810||2
042669|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|ICE|0|0|0|100|GBP|2410|4276|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2410||2410|4276||2
043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|649|1867|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||649||649|1867||1
043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3603|5200|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3603||3603|5200||1
043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|26101|14911|lyfalmen|V0516|14743|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||10185||10185|14911||2
043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|5217|6281|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3876||3876|6281||1
043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6661|9613|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||6661||6661|9613||1
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|615|1820|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||615||615|1820||1
043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|1337|2808|lyfalmen|||1|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1337||1337|2808||1
043919|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
043935|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1
044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|0|0|0|0|E|0|LVR|0|0|1|100|CHF|13915|20008|lyfalmen|V0034|20008|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||13915||13915|20008||3
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|415540|523385|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||415540|523385||1
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|586401|737816|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||586401|737816||1
044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|25235|34215|lyfalmen|||1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||25235||25235|34215||1
044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|96389|123513|lyfalmen|||1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||96389||96389|123513||1
044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|2920|4973|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2920||2920|4973||1
044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2275|4525|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2275||2275|4525||2
045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|8072|12021|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||8072||8072|12021||2
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|1050|1636|lyfalmen|V0109|1603|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||480||480|1636||1
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|868|1501|lyfalmen|V0108|1469|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||382||382|1501||1
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|3252|4693|lyfsjukr|||1|10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||3252||3252|4693||3
045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|6503|9385|lyfsjukr|||1|10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||6503||6503|9385||3
045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|411|1541|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||411||411|1541||1
046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|PFV|0|0|0|100|DKK|23062|44455|vetalmen|||0|10|0||Icepharma hf|Pfizer vet.|||23062||23062|44455||2
046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|*|0|THA|0|0|0|100|SEK|1860|3523|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1860||1860|3523||1
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1123|2515|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1123||1123|2515||1
046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|E|0|VIS|0|0|0|100|DKK|4288|6845|lyfalmen|V0382|6730|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||4288||4288|6845||2
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|740|1900|lyfalmen|V0021|1893|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||673||673|1900||1
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|1215|2373|lyfalmen|V0022|2362|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1019||1019|2373||1
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|1528|2760|lyfalmen|V0023|2744|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1302||1302|2760||1
046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|E|0|VIS|0|0|0|100|DKK|7141|10747|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||7141||7141|10747||2
046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|E|0|POF|0|0|0|100|GBP|5359|4526|lyfalmen|V0530|4526|2|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||2593||2593|4526||2
046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|E|0|POF|0|0|0|100|GBP|6723|5280|lyfalmen|V0531|5280|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3144||3144|5280||2
046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|10558|7853|lyfalmen|V0283|7853|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||5025||5025|7853||2
046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|10969|3656|lyfalmen|V0205|3656|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3656||2
046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|3407|2434|lyfalmen|V0279|2159|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1064||1064|2434||2
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1152|2555|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1152||1152|2555||1
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684||5
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564||5
047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|160287|203043|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||160287||160287|203043||2
047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|27270|36769|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||27270||27270|36769||1
047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|13777|7195|lyfalmen|V0420|7154|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||4544||4544|7195||2
047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|26090|18648|lyfalmen|V0421|18393|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||12831||12831|18648||2
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5987|8641|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||5987||5987|8641||2
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9541|13770|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||9541||9541|13770||2
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9450|13639|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||9450||9450|13639||2
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|2951|3307|lyfalmen|V0324|3258|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1702||1702|3307||1
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2741|3853|lyfalmen|V0035|3853|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2101||2101|3853||1
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|8508|4173|lyfalmen|V0325|4112|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2335||2335|4173||1
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|8358|4337|lyfalmen|V0326|4273|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2455||2455|4337||1
048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|4223|4738|lyfalmen|||2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4223||2748|4738|28.2.2013|1
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|16714|4034|lyfalmen|V0327|3975|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2233||2233|4034||1
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|E|0|MAB|0|0|0|100|SEK|1416|2916|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1416||1416|2916||1
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|15170|21583|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||15170||15170|21583||1
048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|4670|7367|lyfalmen|||1|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4670||4670|7367||1
048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1957|3656|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1957||1957|3656||1
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|*|0|ROC|0|0|0|100|DKK|67267|83267|lyfalmen|V0187|59682|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||64320||64320|83267||2
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|0|0|100|XEU|1078897|1355898|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1078897||1078897|1355898||1
048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|526|1698|lyfalmen|V0230|1601|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||526||526|1698||1
049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|2673|4635|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2673||2673|4635||1
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|18921|26291|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||18921||18921|26291||2
049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|2615|4556|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2615||2615|4556||1
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|7103|10695|lyfalmen|||1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||7103||7103|10695||2
049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1059|2060|lyfalmen|V0108|1469|2|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||790||790|2060||2
049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1154|2278|lyfalmen|V0109|1603|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||950||950|2278||2
049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1827|2551|lyfalmen|V0110|1991|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1149||1149|2551||2
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|3314|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999||1
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1307|2752|lyfalmen|V0496|2750|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1296||1296|2752||1
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2692|3886|lyfalmen|||2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2125||2125|3886||1
049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1
049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1
049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417||1
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|*|0|ROC|0|0|0|100|DKK|67267|86965|lyfalmen|V0470|81840|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||67267||67267|86965||2
050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.12.2012||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|3602|4079|lyfalmen|V0445|4079|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríđ||2266||2266|4079||2
050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.12.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|XEU|4692|6932|lyfalmen|V0550|6932|2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||4352||4352|6932||2
050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|0|0|0|1|0|1|BAP|0|0|0|100|DKK|653609|822162|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||653609||653609|822162||2
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|78323|100178|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||78323|100178||1
050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|7624|3671|lyfalmen|V0012|2862|2|56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1968||1968|3671||2
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3443|5689|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3443||3443|5689||1
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14618|20891|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||14618||14618|20891||1
050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6007|5541|lyfalmen|V0042|5001|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3335||3335|5541||1
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|4615|5247|lyfalmen|V0002|5247|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5247||1
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|4435|3852|lyfalmen|V0006|3831|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2100||2100|3852||1
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|10567|5077|lyfalmen|||2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2996||2996|5077||1
051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|1861|3525|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1861||1861|3525||1
051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|1922|3608|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1922||1922|3608||1
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1613|2789|lyfalmen|V0363|2789|2|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1323||1323|2789||1
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|4387|6038|lyfalmen|V0365|6038|2|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3698||3698|6038||1
051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|33108|43433|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||33108||33108|43433||1
051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|1721|2045|lyfalmen|V0056|1711|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||779||779|2045||2
051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|2913|2555|lyfalmen|V0057|2101|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1152||1152|2555||2
051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|B|0|AZD|0|0|1|100|SEK|1114|2503|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1114||1114|2503||1
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|242|1310|lyfalmen|V0047|1310|2|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||242||242|1310||1
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|570|1759|lyfalmen|V0305|1058|2|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||570||570|1759||1
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|374663|472085|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||374663||374663|472085||1
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|404|1532|lyfalmen|V0439|1532|2|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||404|1532||1
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1295|2750|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1295||1295|2750||1
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|831|2116|lyfalmen|V0305|2116|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||831||831|2116||1
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|782671|984135|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||782671||782671|984135||1
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|693693|872467|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||693693||693693|872467||1
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|4269|6819|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||4269||4269|6819||1
052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||||2
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|40520|52735|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||40520||40520|52735||2
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32940|43222|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||32940||32940|43222||2
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|34774|45524|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||34774||34774|45524||2
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29094|38395|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||29094||29094|38395||2
052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|39127|50987|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||39127||39127|50987||2
052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|36332|47479|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||36332||36332|47479||2
052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|16913|23771|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||16913||16913|23771||1
053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2695|4239|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2383||2383|4239||1
053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2584|4514|lyfalmen|V0134|3852|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2584||2584|4514||2
053043|J05AR1001|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AR10|01.11.2006||R|1|0|0|1|0|1|ABT|0|0|0|100|DKK|68129|87384|lyfsjukr|||1|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopínavír og ritónavír||68129||68129|87384||1
053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|6249|9527|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||6249||6249|9527||1
053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|13252|19176|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||13252||13252|19176||2
053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|39468|52077|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||39468||39468|52077||2
053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6607|10017|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||6607||6607|10017||2
053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1937|3623|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1933||1933|3623||2
053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6532|9914|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||6532||6532|9914||1
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|*|0|SDE|0|0|0|100|NOK|44094|57883|lyfalmen|V0453|47339|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||44094||44094|57883||1
053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|*|0|SDE|0|0|0|100|NOK|37013|48996|lyfalmen|V0454|42654|1|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||37013||37013|48996||1
053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|718|1429|lyfalmen|V0060|1096|2|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||329||329|1429||1
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|16691|23492|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16691||16691|23492||2
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1695|3298|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1695||1695|3298||1
053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1263|2707|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1263||1263|2707||1
054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|8568|8233|lyfalmen|V0490|7969|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||5303||5303|8233||1
054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4600|7271|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||4600||4600|7271||2
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2987|5065|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2987||2987|5065||1
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|4119|6613|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||4119||4119|6613||1
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|70727|90645|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||70727||70727|90645||2
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|1|100|SEK|1238|2672|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1238||1238|2672||1
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1865|3530|lyfalmen|V0061|3530|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1865||1865|3530||1
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|ALS|0|0|0|100|DKK|5255|10263|vetalmen|||0|10|0||Icepharma hf|Alstoe Limited|Buprenorphinhýdróklóríđ||||5255|10263||2
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|8510|14845|vetorma|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|Medroxyprogesteronum||8510||8510|14845||2
054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|6086|9304|lyfalmen|||1|60|0||Vistor hf|Almirall S.A.|Aclídínumbrómíđ||6086||6086|9304||1
055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|ALA|0|0|1|100|USD|1844|3501|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxacín||||1844|3501||1
055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|884|2188|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||884||884|2188||1
055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|10195|14925|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||10195||10195|14925||1
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|2064|2939|lyfalmen|V0467|2939|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939||1
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|4539|2449|lyfalmen|V0112|2449|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1075||1075|2449||1
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|6185|2005|lyfalmen|V0113|1964|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||750||750|2005||1
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|7867|3715|lyfalmen|V0114|3687|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||2000||2000|3715||1
056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|20740|28574|lyfalmen|V0459|27543|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||20740||20740|28574||1
056308|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|35529|47134|lyfalmen|V0016|47134|1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||35529||35529|47134||2
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|29888|52138|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||29888||29888|52138||2
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1438|2946|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1438||1438|2946||1
056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|B|0|AGP|0|0|0|100|XEU|4121|6616|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||4121|6616||1
056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|B|0|AGP|0|0|0|100|XEU|4121|6616|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||4121|6616||1
056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|3316|5515|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||3316||3316|5515||1
056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|EPI|0|0|0|100|XEU|257793|325413|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||257793||257793|325413||2
056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008|31.01.2013|R|1|0|0|1|0|1|POF|0|0|0|100|DKK|61137|78609|lyfsjukr|||2|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||61137||61137|78609||2
057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4059|6531|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||4059||4059|6531||1
057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12912|18750|lyfalmen|V0095|14927|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||12912||12912|18750||1
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|12998|18195|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12998||12998|18195||1
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|7474|10787|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||7474||7474|10787||1
057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|275712|347901|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||275712||275712|347901||2
057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|26390|35665|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||26390||26390|35665||2
057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5407|7804|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5407||5407|7804||2
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|4121|5948|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||4121||4121|5948||1
057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|380657|479607|lyfsjukr|||1|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||380657||380657|479607||1
057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|618163|777677|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||618163||618163|777677||1
057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|27397|36266|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||27397||27397|36266||2
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|22302|30534|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||22302|30534||1
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|E|0|BOI|0|0|0|100|DKK|471|1623|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||471||471|1623||1
058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|137709|174707|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||137709||137709|174707||1
058283|QI01AD040|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|179569|313249|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||179569|313249||2
058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|272782|475855|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||272782|475855||2
058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|19282|26744|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||19282||19282|26744||2
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1164|2571|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1164||1164|2571||1
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|110905|141068|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||110905||110905|141068||1
058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|47223|61810|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||47223||47223|61810||1
058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|1411|2909|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1411||1411|2909||1
058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|2631|4578|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2631||2631|4578||1
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|2374|2805|lyfalmen|V0006|2145|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1335||1335|2805||1
059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|1713|3322|lyfalmen|||1|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1713||1713|3322||1
059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|0|0|0|0|E|0|LOL|0|0|1|100|IKR|2297|4121|lyfalmen|||0|5|1||Lyfjaver ehf|Lyfjaver- óskráđ|Klóramfeníkól||2297||2297|4121||3
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|109896|140465|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||109896||109896|140465||1
059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|35281|46823|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||35281||35281|46823||1
059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008|31.01.2013|R|0|0|0|1|0|1|POF|0|0|0|100|DKK|95389|121596|lyfsjukr|||2|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||95389||95389|121596||2
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|1|0|0|0|E|0|BPC|0|0|0|100|SEK|46119|52877|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||40105||40105|52877||1
060114|N02AB0305|Fentanyl ratiopharm|forđapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|3005|4116|lyfalmen|V0219|4116|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||2293||2293|4116||2
060123|N02AB0305|Fentanyl ratiopharm|forđapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|4772|6779|lyfalmen|V0220|6779|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||4240||4240|6779||2
060132|N02AB0305|Fentanyl ratiopharm|forđapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|6186|8649|lyfalmen|V0221|8649|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||5607||5607|8649||2
060141|N02AB0305|Fentanyl ratiopharm|forđapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|7214|9873|lyfalmen|V0223|9873|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||6502||6502|9873||2
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|416558|525325|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||416558||416558|525325||1
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|208296|263957|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||208296||208296|263957||1
060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|6233|9505|lyfalmen|||1|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||6233||6233|9505||1
061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|0|0|0|100|DKK|3037|6004|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||3037|6004||2
061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|0|0|0|100|DKK|1592|3167|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||1592|3167||2
061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|1|0|0|100|DKK|9401|18224|vetalmen|||0|20|0||Icepharma hf|Pfizer Animal Health|||||9401|18224||2
061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|0|0|0|0|E|0|DAC|0|0|0|100|DKK|7721|11541|lyfalmen|V0133|11541|3|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7721||7721|11541||2
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|7722|11542|lyfalmen|V0133|11541|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7722||7722|11542||1
061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1881|3281|vetorma|||0|26|0||Icepharma hf|Pfizer Oy Animal Health|||1881||1881|3281||2
061715|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.05.2008||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|176749|223702|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||176749||176749|223702||1
061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|4907|7082|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4907||4907|7082||1
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|17522|23873|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||17522||17522|23873||1
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|24668|32841|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||24668||24668|32841||1
062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|507|1672|lyfalmen|V0307|1519|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||507||507|1672||1
062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|0|0|0|1|*|0|AGP|0|0|0|100|XEU|66010|59682|lyfalmen|V0187|59682|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||45527||45527|59682||1
062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|1823|3473|lyfalmen|||1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1823||1823|3473||1
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1023|2378|lyfalmen|V0308|2073|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1023||1023|2378||1
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|E|0|AGT|0|0|1|100|XEU|2046|3778|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2046||2046|3778||1
062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|19897|34709|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||19897||19897|34709||2
062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|45674|59203|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||45674||45674|59203||1
062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|55764|71866|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||55764||55764|71866||1
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|17490|17244|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11890||11890|17244||1
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|4652|7343|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4652||4652|7343||1
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3154||1
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2807|3341|lyfalmen|V0123|3314|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1727||1727|3341||1
063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|1|0|0|0|E|0|DAC|0|0|1|100|XEU|5007|6800|lyfalmen|V0458|5690|3|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||4255||4255|6800||2
063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|8598|12409|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||8598||8598|12409||1
063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|PAS|0|0|0|100|XEU|2806|4895|vetorma|||0|11,8|0||Vistor hf|Pfizer Oy Animal Health|||2806||2806|4895||1
063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1075|2449|lyfalmen|V0309|2143|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1075||1075|2449||1
063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2252|4060|lyfalmen|V0310|3105|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2252||2252|4060||1
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1200769|1508848|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1200769|1508848||2
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|480307|604668|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||480307|604668||2
064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2365|4214|lyfalmen|V0311|3105|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2365||2365|4214||1
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4803079|6029747|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4803079|6029747||2
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|2401541|3015816|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2401541|3015816||2
064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|2321|4154|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2321||2321|4154||1
064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|911|2225|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||911||911|2225||2
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|64679|83055|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||64679||64679|83055||1
064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|E|0|NPA|0|0|1|100|DKK|918|2235|lyfalmen|||2|50|0|6,6700|Vistor hf|Nycomed Pharma AS|Metóklópramíđ||918||918|2235||1
064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|E|0|NPA|0|0|1|100|DKK|528|1701|lyfalmen|||2|20|0|3,3300|Vistor hf|Nycomed Pharma AS|Metóklópramíđ||528||528|1701||1
065029|A03FA0102|Afipran|eţ-stíll|20|mg|5|stk|1|ţpakki||A03FA01|01.03.2013||R|0|0|0|0|E|0|NPA|0|0|1|100|DKK|270|1348|lyfalmen|||2|5|0|3,3300|Vistor hf|Nycomed Pharma AS|Metóklópramíđ||270||270|1348||1
065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|2157|3930|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2157||2157|3930||1
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17334|23637|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||17334||17334|23637||2
065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|2766|4012|lyfalmen|V0376|2328|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2217||2217|4012||1
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|*|0|LVR|0|0|0|100|SEK|68840|84320|lyfalmen|V0451|84320|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||65159||65159|84320||3
065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|8291|11824|lyfalmen|V0376|6984|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7928||7928|11824||1
065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1104|2185|lyfalmen|V0163|2185|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||882||882|2185||2
065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|5376|7759|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||5376||5376|7759||2
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4513|8838|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4513||4513|8838||2
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7383|11078|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||7383||7383|11078||1
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|36369|47526|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||36369||36369|47526||2
066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|936|2259|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||936||936|2259||2
066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066593|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|E|0|PEN|0|0|0|100|IKR|2100|3838|lyfalmen|V0006|3831|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2090||2090|3838||3
066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||1|120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603||2
066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|1|0|0|0|B|0|DAC|0|0|0|100|NOK|1715|3325|lyfalmen|V0036|3325|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1715||1715|3325||2
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|16923|23121|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||16923||16923|23121||1
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9542|13771|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||9542||9542|13771||2
067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|1|0|0|0|0|0|UCN|0|0|0|100|SEK|1651|3237|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1651||1651|3237||1
067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|0|0|0|0|*|0|APC|0|0|0|100|DKK|2049|2722|lyfalmen|V0376|2328|2|2,5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1274||1274|2722||1
067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|2075|lyfalmen|V0551|1991|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||801||801|2075||1
067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|5676|lyfalmen|V0552|5611|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||3434||3434|5676||1
067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0554|1768|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768||1
067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0555|1749|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749||1
067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|2828|lyfalmen|V0556|2783|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||1352||1352|2828||1
067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|13437|lyfalmen|V0419|13437|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13437||1
068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|0|0|1|0|0|0|VEQ|1|0|0|100|XEU|6752|13137|vetalmen|||0|50|0||Icepharma hf|Vétoquinol AG|||6752||6752|13137||2
068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|114198|145201|lyfsjukr|||1|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||114198||114198|145201||1
068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|GTS|0|0|0|100|GBP|84005|107309|lyfsjukr|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||84005||84005|107309||1
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|B|0|MEB|0|0|0|100|SEK|2021|3744|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||2021||2021|3744||1
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|B|0|MEB|0|0|0|100|SEK|6693|10135|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||6693||6693|10135||1
068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|29302|13516|lyfalmen|V0342|13516|2|98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||9165||9165|13516||2
068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|4099|6586|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||4099||4099|6586||2
068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2782|4015|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríđ||2782||2782|4015||1
068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|3462|4997|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríđ||3462||3462|4997||1
068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|15633|22165|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||15633||15633|22165||1
069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|49345|64473|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||49345||49345|64473||1
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|475|1625|lyfalmen|V0448|1625|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||472||472|1625||2
070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|20839|28698|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||20839|28698||1
070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|30141|40372|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||30141|40372||1
070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|39034|51533|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||39034|51533||1
070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1
070142|G04BD0704|Tolterodin Actavis|forđahlk|4|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|20711|27933|lyfalmen|V0589|27933|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||20229||20229|27933||1
070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|52520|67795|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||52520||52520|67795||2
070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006|31.12.2012|R|0|0|0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen|||0|100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355||1
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|14164|20321|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||14164||14164|20321||1
071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006|31.12.2012|R|0|0|0|0|0|0|PAB|0|0|0|100|SEK|6620|12884|vetalmen|||0|1250|0||Vistor hf|Pharmaxim AB|||6620||6620|12884||1
071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995|28.02.2013|R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|760|2019|lyfalmen|||2|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||760||760|2019||1
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|75152|96198|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||75152||75152|96198||1
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|375762|473464|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||375762||375762|473464||1
071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|9769|14342|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||9769|14342||1
071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|12025|10274|lyfalmen|V0144|9680|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||6795||6795|10274||2
071844|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|50|stk|1|ţpakki||M01AE01|01.03.2013||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Portfarma|Íbúprófen|||||||2
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|XEU|103361|131601|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||103361||103361|131601||1
072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|1|0|0|0|E|0|PSA|0|0|0|100|XEU|3487|2006|lyfalmen|V0009|2006|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||751||751|2006||2
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|7755|15063|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||7755||7755|15063||1
072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|1|0|0|0|E|0|PSA|0|0|0|100|XEU|10964|8568|lyfalmen|V0029|8555|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||5548||5548|8568||2
072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999|28.02.2013|R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|20790|28637|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||20790||20790|28637||1
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|737|1064|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||737||737|1064||1
072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|0|1|0|1|0|1|ABV|0|0|0|100|DKK|163667|207285|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||163667||163667|207285||1
072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|18271|25475|lyfalmen|||1|1,2|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||18271||18271|25475||2
072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|18271|25475|lyfalmen|||1|2,4|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||18271||18271|25475||2
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|84447|107863|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||84447||84447|107863||1
073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1164|2571|lyfalmen|V0008|2570|1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1164||1164|2571||1
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|4034|6497|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||4034||4034|6497||1
073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1812|3458|lyfalmen|V0028|3458|1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1812||1812|3458||1
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|56589|23671|lyfalmen|V0185|23645|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||16833||16833|23671||1
073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|792|2058|lyfalmen|V0066|2058|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||789||789|2058||2
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|337|1440|lyfalmen|V0047|1310|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||337||337|1440||1
073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|829|2113|lyfalmen|V0305|1058|1|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||829||829|2113||1
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1058|2426|lyfalmen|V0305|2116|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||1058||1058|2426||1
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|569|1757|lyfalmen|V0439|1532|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||569||569|1757||1
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1547|3095|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1547||1547|3095||1
073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4116|7180|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||4116||4116|7180||2
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|0|0|0|0|*|0|APT|0|0|0|100|GBP|1434|2941|lyfalmen|||1|50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1434||1434|2941||1
074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|1|0|0|0|0|0|DAC|0|0|0|100|DKK|5125|7990|lyfalmen|V0142|7990|3|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||5125||5125|7990||2
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NOE|0|0|0|100|DKK|3963|6400|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3963||3963|6400||1
074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|1|0|0|0|E|0|DAC|0|0|1|100|GBP|432|1564|lyfalmen|V0391|1564|3|28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||428||428|1564||2
074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19845|26788|lyfsjukr|||1|50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||19845||19845|26788||2
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|529|1703|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||529||529|1703||1
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|877|2179|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||877||877|2179||1
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|1189|2605|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1189||1189|2605||1
074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|22853|39866|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||22853||22853|39866||1
074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|1|0|0|0|B|0|AUK|0|0|0|100|GBP|442|1560|lyfalmen|V0510|1560|2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||425||425|1560||1
074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|1|0|0|0|B|0|AUK|0|0|0|100|GBP|807|2024|lyfalmen|V0512|2024|2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||764||764|2024||1
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|B|0|AEG|0|0|0|100|GBP|1022|2377|lyfalmen|||1|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||1022||1022|2377||1
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|B|0|APT|0|0|0|100|GBP|545|1724|lyfalmen|||1|100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||545||545|1724||1
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|0|0|0|0|*|0|APT|0|0|0|100|GBP|2730|4668|lyfalmen|||1|100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2697||2697|4668||1
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|0|0|NOE|0|0|1|100|DKK|5396|8360|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5396||5396|8360||1
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|16188|22861|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||16188||16188|22861||1
075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|2004|3720|lyfalmen|||1|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||2004||2004|3720||1
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|5396|8360|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5396||5396|8360||1
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|2217|3001|lyfalmen|V0363|2789|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1478||1478|3001||1
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|16188|22861|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||16188||16188|22861||1
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|XEU|2066|3805|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||2066||2066|3805||1
075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|NOK|3478|5737|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3478||3478|5737||1
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|XEU|2880|4919|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2880|4919||1
075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|1|0|0|0|E|0|LVR|0|0|1|100|DKK|14657|20940|lyfalmen|V0196|18106|3|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||14657||14657|20940||3
075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|19708|23871|lyfalmen|V0589|23464|3|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||16993||16993|23871||3
075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|22046|30213|lyfalmen|V0441|30213|3|90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||22046||22046|30213||3
075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|17950|25072|lyfalmen|V0440|25072|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||17950||17950|25072||3
075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|4536|4218|lyfalmen|V0445|4079|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||2368||2368|4218||2
075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|35117|45954|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||35117||35117|45954||1
075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|131806|167299|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||131806||131806|167299||1
075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075724|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|107995|137416|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||107995||107995|137416||2
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1056|2101|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1056||1056|2101||1
075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6699|9668|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6699||6699|9668||2
075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6699|9668|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6699||6699|9668||2
075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6699|9668|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6699||6699|9668||2
075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|473|1626|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||473||473|1626||1
075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|497|1659|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||497||497|1659||1
075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|987|2322|lyfalmen|V0449|2322|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||982||982|2322||2
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|7232|10872|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||7232||7232|10872||1
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|24630|33456|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||24630||24630|33456||1
076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|ţpakki||A10BH01|01.02.2013||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|25194|34164|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||25194||25194|34164||1
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|25209|34182|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||25209||25209|34182||1
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1588|lyfalmen|V0045|1588|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588||2
076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|1986|3099|lyfalmen|V0290|3099|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099||2
076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|1946|3373|lyfalmen|V0291|3373|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373||2
076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009|28.02.2013|R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|1340|2812|lyfalmen|||1|100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1340|2812||1
076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|1939|3631|lyfalmen|V0027|3631|1|100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1939|3631||1
076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|7881|13748|vetorma|||0|100|0||Vistor hf|Merial (MSD)|Ivermectinum||7881||7881|13748||1
076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||||2
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|254|1326|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||254||254|1326||1
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|749|2003|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||749||749|2003||1
077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|10964|8568|lyfalmen|V0029|8555|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||5548||5548|8568||1
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|845|2135|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||845||845|2135||1
078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||||2
078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12606|lyfalmen|V0419|12541|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12606||2
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|600|1800|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||600||600|1800||1
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|914|2229|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||914||914|2229||1
078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1540|3086|lyfalmen|V0560|3086|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1540||1540|3086||2
078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|2202|3991|lyfalmen|V0561|3991|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||2202||2202|3991||2
078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|0|0|0|1|0|1|SAG|0|0|0|100|DKK|142227|180377|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||142227||142227|180377||2
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9806|6607|lyfalmen|V0069|1882|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||4114||4114|6607||1
079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3468|5005|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||3468||3468|5005||2
079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6936|10010|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||6936||6936|10010||2
079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|13915|19346|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||13915||13915|19346||2
079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|4019|6477|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||4019||4019|6477||2
079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|*|0|SPL|0|0|0|100|DKK|20301|28023|lyfalmen|||1|10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||20301||20301|28023||1
079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3851|6247|lyfalmen|V0315|6247|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3851||3851|6247||1
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|2279|3289|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2279||2279|3289||1
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517||1
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852||1
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864||1
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577||1
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745||2
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|4420|8660|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4420|8660||2
080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|*|0|LYF|0|0|0|100|XEU|19416|18393|lyfalmen|V0421|18393|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||12628||12628|18393||2
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|11231|19592|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11231||11231|19592||2
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|*|0|RAT|0|0|0|100|XEU|18269|10817|lyfalmen|V0170|10817|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||7192||7192|10817||2
080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|*|0|RAT|0|0|0|100|XEU|40371|23645|lyfalmen|V0185|23645|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||16813||16813|23645||2
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|2473|4362|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2473||2473|4362||1
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|6342|9654|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6342||6342|9654||1
080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2923|3827|lyfalmen|V0143|2665|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2082||2082|3827||1
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3293|5484|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3293||3293|5484||1
080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|37614|65616|vetorma|||0|500|0||Vistor hf|Merial (MSD)|Ivermectinum||37614||37614|65616||1
080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8261|8007|lyfalmen|V0143|7994|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||5138||5138|8007||1
080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3227|3931|lyfalmen|V0144|3227|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2158||2158|3931||1
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|16454|22532|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||16454||16454|22532||1
080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|12026|10288|lyfalmen|V0144|9680|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6805||6805|10288||1
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|32439|42593|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||32439||32439|42593||1
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|8854|4787|lyfalmen|V0515|4687|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2784||2784|4787||2
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|5070|7914|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||5070||5070|7914||1
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|2008|2898|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||2008||2008|2898||2
081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|0|0|0|0|0|0|DAC|0|0|0|100|XEU|21562|16984|lyfalmen|V0456|8622|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||11700||11700|16984||2
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|*|0|SAA|0|0|0|100|NOK|6603|10011|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6603||6603|10011||1
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|*|0|SDE|0|0|0|100|NOK|9919|14548|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9919||9919|14548||1
082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|41807|14771|lyfalmen|V0184|14632|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||10082||10082|14771||1
082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2466|4352|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2466||2466|4352||1
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5
082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|3393|5116|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3024||3024|5116||1
082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|6014|9206|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6014||6014|9206||1
082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1048|2413|lyfalmen|||2|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1048||1048|2413||1
082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1
082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5333|8274|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5333||5333|8274||1
082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|6304|9602|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6304||6304|9602||1
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9889|13825|lyfalmen|V0080|13825|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||9391||9391|13825||1
082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|14412|20632|lyfalmen|||1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14412||14412|20632||1
083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|*|0|AZA|0|0|0|100|SEK|21346|29334|lyfalmen|V0186|8007|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||21346||21346|29334||1
083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|15052|21435|lyfalmen|V0344|15038|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||15052||15052|21435||1
083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|8331|12375|lyfalmen|||1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||8331||8331|12375||1
083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|84116|107448|lyfsjukr|||1|450|0|30,0000|Vistor hf|AbbVie Ltd.|Ritonavír||84116||84116|107448||1
083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|32663|43537|lyfalmen|V0346|32315|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||32663||32663|43537||1
083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1436|2943|lyfalmen|||1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1436||1436|2943||1
083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|9451|13640|lyfsjukr|||1|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9451||9451|13640||1
084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|2323|1882|lyfalmen|V0069|1882|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||660||660|1882||2
084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|294|1381|lyfalmen|||2|10|0|2,5000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||294||294|1381||1
084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|2232|3105|lyfalmen|V0311|3105|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1554||1554|3105||2
084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|568|1756|lyfalmen|||2|20|0|5,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||568||568|1756||1
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|80154|102476|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||80154||80154|102476||1
084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|67051|86032|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||67051||67051|86032||2
084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|87411|111583|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||87411||87411|111583||2
084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|108139|137597|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||108139||108139|137597||2
084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|22351|29933|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||22351||22351|29933||2
084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|34908|45692|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||34908||34908|45692||2
084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|44701|57982|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||44701||44701|57982||2
084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|13843|19255|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13843|19255||2
084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|52771|68110|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||52771|68110||2
084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|162529|205856|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||162529|205856||2
084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|1064|2434|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||1064||1064|2434||1
084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|12624|18388|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||12624||12624|18388||1
084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|41083|54104|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||41083||41083|54104||1
085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|16945|23811|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||16945||16945|23811||1
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|*|0|GAN|0|0|0|100|NOK|49017|64061|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||49017||49017|64061||2
085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2877|4914|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2877||2877|4914||2
085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|32663|43537|lyfalmen|V0345|32315|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||32663||32663|43537||1
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|821|2102|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||821||821|2102||1
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|22228|30441|lyfalmen|V0412|25455|1|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||22228||22228|30441||1
085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|38537|50909|lyfalmen|V0412|50909|1|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||38537||38537|50909||1
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|103201|131400|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||103201||103201|131400||2
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|ţpakki||N07XX02|01.11.2012||R|1|0|0|0|E|0|AGP|0|0|0|100|SEK|47319|61930|lyfalmen|V0579|61930|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||47319||47319|61930||1
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEU|0|0|0|100|DKK|43636|57308|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||43636||43636|57308||1
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|*|0|API|0|0|0|100|SEK|3329|5533|lyfalmen|V0465|4813|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||3329||3329|5533||1
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|*|0|API|0|0|0|100|SEK|9839|14438|lyfalmen|V0465|14438|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||9839||9839|14438||1
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|4605|5698|lyfalmen|V0364|5203|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3450||3450|5698||1
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|6236|6629|lyfalmen|V0365|6038|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||4130||4130|6629||1
086142|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|71059|91724|lyfalmen|V0019|91723|1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||71059||71059|91724||2
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8795|12693|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8795||8795|12693||1
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|15288|21069|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15288||15288|21069||1
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|33030|43998|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||33030||33030|43998||1
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|66061|85452|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||66061||66061|85452||1
086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|58614|75443|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||58614||58614|75443||1
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|20986|28883|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||20986||20986|28883||2
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|54971|70871|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||54971||54971|70871||2
087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|3261|5440|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3261||3261|5440||1
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|486|1644|lyfalmen|V0060|1644|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||486||486|1644||1
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|175984|222742|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||175984||175984|222742||1
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|330|1430|lyfalmen|V0312|459|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||330||330|1430||1
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|290|1376|lyfalmen|V0312|1376|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||290||290|1376||1
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2441|4318|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2441||2441|4318||1
087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586||1
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|0|0|0|0|E|0|MEC|0|0|0|100|SEK|991|2335|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||991||991|2335||2
087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|3834|1939|lyfalmen|V0009|1872|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||702||702|1939||1
087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|11752|7195|lyfalmen|V0420|7154|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||4544||4544|7195||1
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|34455|60105|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||34455||34455|60105||2
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1
087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|DKK|4860|9504|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4860||4860|9504||1
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|31657|55224|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||31657||31657|55224||2
088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|E|0|GGL|0|0|1|100|GBP|1429|2934|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1429||1429|2934||1
088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|1726|3340|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1726||1726|3340||1
088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|6661|10091|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6661||6661|10091||1
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|5539|8556|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5539||5539|8556||1
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|10700|15616|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10700||10700|15616||1
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|16417|23148|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||16417||16417|23148||1
088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|24933|18648|lyfalmen|V0421|18393|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||12831||12831|18648||1
088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|6966|6984|lyfalmen|V0376|6984|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4390||4390|6984||2
088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1913|3596|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1913||1913|3596||1
089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|25649|34735|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||25649||25649|34735||2
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674||1
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|175984|222742|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||175984||175984|222742||1
089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|1|0|0|0|E|0|MYD|0|0|0|100|SEK|4526|7170|lyfalmen|||2|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4526||4526|7170||1
089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2
089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2
089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|E|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2202|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2348||2
089533|V03AE0401|OsvaRen|filmhtfl|||180|stk|1|glas|435 mg / 235 mg|V03AE04|01.10.2012||R|1|0|0|0|0|0|FMC|0|0|0|100|XEU|7308|10976|lyfalmen|||1|180|0|30,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Kalsíum asetat og ţungt magnesíum karbón||7308||7308|10976||2
089801|B03AC0601|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|E|0|PAC|0|0|1|100|DKK|27065|36512|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||27065||27065|36512||1
089913|B03AC0601|Monofer|irl|100|mg/ml|5|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|E|0|PAC|0|0|1|100|DKK|146081|172374|lyfalmen|||1|25|0|25,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||135322||135322|172374||1
089936|B03AC0601|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC06|01.10.2012||R|0|0|0|0|E|0|PAC|0|0|1|100|DKK|108258|138409|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||108258||108258|138409||1
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1736|3354|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1736||1736|3354||2
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3448|5696|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3448||3448|5696||2
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1036|2396|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1036||1036|2396||2
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|6347|9160|lyfsjukr|||1|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||6347||6347|9160||2
090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|2009|3727|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||2009||2009|3727||1
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|ACK|0|0|0|100|USD|17362|23672|lyfsjukr|||1|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||17362|23672||1
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|3115|4496|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3115||3115|4496||1
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5384|7770|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||5384||5384|7770||1
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|15797|21708|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||15797||15797|21708||1
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|3667|5995|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3667||3667|5995||1
091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|*|0|BII|0|0|0|100|DKK|7159|10772|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||7159||7159|10772||1
091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|1962|2832|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1962|2832||1
091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|8028|11586|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||8028|11586||1
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|E|0|CHA|0|0|1|100|DKK|4327|6898|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||4327||4327|6898||1
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|1423|1893|lyfalmen|V0021|1893|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||668||668|1893||1
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|2459|2362|lyfalmen|V0022|2362|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1011||1011|2362||1
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|682|1912|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||682||682|1912||1
092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|4215|6745|lyfalmen|||1|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4215|6745||1
092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|9991|19357|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||9991||9991|19357||2
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|1|0|0|0|E|0|SBM|0|0|0|100|NOK|8944|12044|lyfalmen|V0009|1872|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||8089||8089|12044||1
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2475|4365|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2475||2475|4365||1
092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|*|0|DAC|0|0|0|100|DKK|10087|14777|lyfalmen|V0277|14777|3|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||10087||10087|14777||2
092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008|28.02.2013|R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|25723|34828|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||25723||25723|34828||1
092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|460|1608|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||460||460|1608||1
092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|599|1798|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||599||599|1798||1
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|3658|3887|lyfalmen|V0203|3843|2|12|0|84,0000|Portfarma ehf|Williams & Halls|Alendrónsýra||2126||2126|3887||2
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|1249|2687|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1249|2687||2
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|2867|4901|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2867|4901||2
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|5572|8601|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5572|8601||2
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7283|10942|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7283||7283|10942||1
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|B|0|NOH|0|0|0|100|DKK|1598|3165|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1598||1598|3165||1
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|28793|50228|vetorma|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|Medroxyprogesteronum||28793||28793|50228||2
093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|*|0|DAC|0|0|0|100|SEK|68840|86309|lyfalmen|V0451|84320|3|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||66744||66744|86309||2
093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|1|0|0|0|B|0|DAC|0|0|0|100|XEU|1295|2750|lyfalmen|V0496|2750|3|100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1295||1295|2750||2
093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|17560|24583|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||17560||17560|24583||2
093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|49554|64735|lyfalmen|V0588|51200|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||49554||49554|64735||2
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|620023|780011|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||620023||620023|780011||1
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|667732|839886|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||667732||667732|839886||1
094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|5761|8860|lyfalmen|V0236|8438|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5761||5761|8860||1
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|8537|12657|lyfalmen|V0236|12657|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||8537||8537|12657||1
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1940|3859|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1940||1940|3859||1
094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|14182|20344|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14182||14182|20344||1
094757|N04BC0406|Ropinirole Portfarma|forđatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|33804|32996|lyfalmen|V0534|32996|2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||24264||24264|32996||2
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|85732|109476|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||85732||85732|109476||1
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|51655|67372|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||51655|67372||1
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|7048|12295|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||7048||7048|12295||2
095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3136||1
095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|5506|5637|lyfalmen|V0143|5329|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3405||3405|5637||2
095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|E|0|AGT|0|0|0|100|DKK|6635|10055|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6635||6635|10055||1
095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|20134|27813|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||20134||20134|27813||1
095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|20134|27813|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||20134||20134|27813||1
095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2091|3018|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||2091||2091|3018||2
095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3275|4727|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3275||3275|4727||2
095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|20134|27813|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||20134||20134|27813||1
095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2745|3962|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2745|3962||2
095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3798|5481|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3798|5481||2
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|E|0|AGP|0|0|1|100|XEU|1161|1551|lyfalmen|V0225|1551|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||418||418|1551||1
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|3968|7792|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3968||3968|7792||2
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|5237|10228|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5237||5237|10228||2
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|9536|18483|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9536||9536|18483||2
096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|36652|47881|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||36652||36652|47881||2
096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl||J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|13916|19347|lyfsjukr|||1|10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||13916||13916|19347||1
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|108788|138411|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||108788||108788|138411||1
096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|2611|1942|lyfalmen|V0088|1942|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||704||704|1942||2
096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|XEU|2717|2099|lyfalmen|V0089|2099|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||819||819|2099||2
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|2159|3932|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2159||2159|3932||1
096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|17497|24504|lyfalmen|V0347|23137|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17497||17497|24504||1
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|747458|939942|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||747458||747458|939942||2
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|792345|996275|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||792345||792345|996275||2
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|833352|1047739|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||833352||833352|1047739||2
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|0|0|100|XEU|914575|1149674|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||914575||914575|1149674||2
096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|17497|24504|lyfalmen|V0349|23137|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17497||17497|24504||1
096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|E|0|SEV|0|0|0|100|DKK|1613|3185|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1613||1613|3185||2
096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|34996|46465|lyfalmen|||1|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||34996||34996|46465||1
096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|E|0|SNO|0|0|0|100|NOK|20903|28778|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||20903||20903|28778||1
097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|29646|39088|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||29646||29646|39088||1
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|79786|139183|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||79786||79786|139183||2
097080|R06AX2701|Aerius|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|1783|3418|lyfalmen|V0366|2607|1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1783||1783|3418||1
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|8805|17079|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8805|17079||2
097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2383|4217|lyfalmen|V0461|4217|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2367||2367|4217||2
097498|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|626|1835|lyfalmen|V0333|1835|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||626||626|1835||1
097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12066|17688|lyfalmen|V0334|5904|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||12066||12066|17688||1
097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|22909|31296|lyfalmen|V0335|5904|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||22909|31296||1
097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2636|4585|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2636||2636|4585||1
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|3530|2744|lyfalmen|V0023|2744|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1290||1290|2744||1
097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|E|0|AGP|0|0|0|100|IKR|2738|2780|lyfalmen|V0233|2719|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1317||1317|2780||
097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|E|0|AGP|0|0|0|100|IKR|1917|2211|lyfalmen|V0234|2211|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||901||901|2211||1
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1196|2593|lyfalmen|V0329|2593|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1180||1180|2593||1
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|7156|2127|lyfalmen|V0072|2127|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||839||839|2127||1
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|9170|2127|lyfalmen|V0073|2127|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||839||839|2127||1
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|B|0|BIG|0|0|1|100|SEK|676|1904|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||676||676|1904||2
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|B|0|BIG|0|0|1|100|SEK|676|1904|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||676||676|1904||2
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|IKR|1063|1820|lyfalmen|V0243|1820|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||615||615|1820||2
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|IKR|1812|2351|lyfalmen|V0244|2299|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1003||1003|2351||2
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|IKR|5116|4380|lyfalmen|V0245|4380|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||2486||2486|4380||2
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|IKR|9166|8950|lyfalmen|V0232|8950|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5827||5827|8950||2
098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|20303|27363|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||20303||20303|27363||1
098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|19085|26497|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||19085||19085|26497||2
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|110118|140081|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||110118||110118|140081||1
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|6128|2853|lyfalmen|V0284|2853|2|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||1370||1370|2853||1
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|14070|9187|lyfalmen|V0285|9187|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||6000||6000|9187||1
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|23001|19906|lyfalmen|V0286|19643|2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||13833||13833|19906||1
099705|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|3194|4259|lyfalmen|V0247|4259|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2398||2398|4259||1
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|4417|6522|lyfalmen|V0248|6522|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||4052||4052|6522||1
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|8972|10947|lyfalmen|V0249|10947|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||7287||7287|10947||1
099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|ţpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|0|0|100|DKK|201272|254479|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||201272||201272|254479||1
099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|756|2013|lyfalmen|||2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||756||756|2013|28.2.2013|1
100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|14299|20490|lyfalmen|||1|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14299|20490||2
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|14299|20490|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14299|20490||2
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2185|3964|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||2182||2182|3964||1
101034|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.10.2012||R|1|0|0|0|E|0|RGM|0|0|1|100|XEU|3826|6213|lyfalmen|V0458|5690|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||3826||3826|6213||2
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|13619|14355|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9778||9778|14355||1
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|18837|26186|lyfalmen|||1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||18837||18837|26186||1
101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|2281|4099|lyfalmen|||1|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2281|4099||2
101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|7362|11050|lyfalmen|V0084|11050|1|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||7362|11050||2
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1474|2995|lyfalmen|V0330|2995|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1474||1474|2995||1
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|B|0|AGP|0|0|0|100|XEU|3353|5566|lyfalmen|V0331|5566|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3353||3353|5566||1
101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|4206|1991|lyfalmen|V0088|1982|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||740||740|1991||1
101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|6004|9192|lyfalmen|V0332|9192|2|96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||6004||6004|9192||1
101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|4879|2148|lyfalmen|V0089|2142|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||855||855|2148||1
101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|1|0|1|0|E|0|DAC|0|0|1|100|DKK|5576|8607|lyfalmen|V0227|8032|3|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5576||5576|8607||2
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|SEK|19444|37508|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||||19444|37508||1
101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|1|0|0|0|E|0|APR|0|0|0|100|DKK|3475|5733|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3475|5733||1
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|7711|11527|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||7711||7711|11527||2
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|23130|31573|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||23130||23130|31573||2
102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1163|2570|lyfalmen|V0008|2570|1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1163||1163|2570||1
102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1812|3458|lyfalmen|V0028|3458|1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1812||1812|3458||1
102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|ţpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|455|1601|lyfalmen|V0230|1601|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||455||455|1601||1
102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|4195|6717|lyfalmen|V0041|3991|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||4195||4195|6717||1
102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|2103|3035|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||2103||2103|3035||1
102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|3418|4933|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||3418||3418|4933||1
103610|L01DB0105|Doxorubicin Actavis|irţ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|9978|14401|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||9978||9978|14401||1
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|3503|2709|lyfalmen|V0088|1942|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1265||1265|2709||2
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4280|3014|lyfalmen|V0089|2099|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1488||1488|3014||2
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|2992|2340|lyfalmen|V0069|1882|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||995||995|2340||2
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|E|0|POF|0|0|1|100|GBP|2696|2132|lyfalmen|V0033|2132|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||843||843|2132||2
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|E|0|POF|0|0|1|100|GBP|10664|8846|lyfalmen|V0182|8800|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5751||5751|8846||2
103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4454|6024|lyfalmen|V0334|6024|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024||2
103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|7148|6024|lyfalmen|V0335|6024|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024||2
103806|N02AB0305|Fentanyl ratiopharm|forđapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|E|0|RGM|0|0|0|100|XEU|2276|4053|lyfalmen|V0222|4053|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||2247||2247|4053||2
103813|B02BC0001|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|387226|487851|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Lyf til ađ minnka stađbundna blćđingu||387226||387226|487851||2
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|4320|8468|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||4320||4320|8468||1
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1990||1
103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15306|21092|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15306||15306|21092||2
104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|3321|2255|lyfalmen|V0073|2127|2|98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||933||933|2255||2
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|3413|5648|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3413||3413|5648||1
104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|1|0|0|0|0|0|NER|0|0|1|100|DKK|2347|4189|lyfalmen|V0574|3560|1|21|0|21,0000|Vistor hf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2347||2347|4189||1
104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|8998|13288|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8998||8998|13288||1
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|5053|7891|lyfalmen|V0017|7891|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5053||5053|7891||1
104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|B|0|FER|0|0|0|100|DKK|5719|8802|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5719||5719|8802||1
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|139741|177257|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||139741|177257||1
105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|DAC|0|0|0|100|DKK|29626|2867|lyfalmen|V0545|2867|3|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og ethinylestradíól||1380||1380|2867||2
105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|4291|6849|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4291||4291|6849||1
105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|14918|21267|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14918||14918|21267||1
105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|4946|7745|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4946||4946|7745||1
105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|17207|24140|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||17207||17207|24140||1
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2728|4711|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2728||2728|4711||1
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3225|5391|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||3225||3225|5391||1
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|2002|3718|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||2002||2002|3718||2
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|4005|6458|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||4005||4005|6458||2
106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|2898|4943|lyfalmen|||1|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2898||2898|4943||1
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|19814|26749|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19814||19814|26749||1
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|10958|15635|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10958||10958|15635||1
106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|*|0|TEV|0|0|0|100|XEU|10098|13072|lyfalmen|V0572|11864|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||8840||8840|13072||2
107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|2207|1771|lyfalmen|V0278|1771|2|28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||579||579|1771||1
107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|1699|3303|lyfalmen|||2|100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1699||1699|3303||1
107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1708|3315|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1708||1708|3315||1
107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1678|2927|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1678||1678|2927||2
107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|1007|2356|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||1007||1007|2356||1
108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|3253|5429|lyfalmen|V0082|5429|1|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||3253|5429||2
108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|3583|5880|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3583||3583|5880||1
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|10635|15527|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||10635||10635|15527||1
108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|13890|6504|lyfalmen|||3|56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||4009||4039|6504||2
108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|1319|2783|lyfalmen|V0446|2783|1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1319||1319|2783||1
108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|1830|3482|lyfalmen|V0443|3480|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1830||1830|3482||1
109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2382|2083|lyfalmen|V0004|2066|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||807||807|2083||1
109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|26363|35631|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||26363||26363|35631||1
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|21106|29033|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||21106||21106|29033||1
109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999|31.12.2012|R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
109515|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013|31.01.2013|R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|36970|48942|lyfalmen|||2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||36970||36970|48942||2
109569|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|3991|6438|lyfalmen|V0584|6438|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||3991||3991|6438||2
109578|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|11756|17061|lyfalmen|V0585|17061|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||11756||11756|17061||2
109588|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|7636|11425|lyfalmen|V0586|11425|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||7636||7636|11425||2
109597|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|20384|28127|lyfalmen|V0587|28127|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||20384||20384|28127||2
109615|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|E|0|RGM|0|0|0|100|XEU|38827|51200|lyfalmen|V0588|51200|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||38769||38769|51200||2
109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983|28.02.2013|L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||||1
109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992|28.02.2013|L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1
109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981|28.02.2013|R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|448|1592|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||448||448|1592||1
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|564|1750|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||564||564|1750||2
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5
110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1672|3266|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1672||1672|3266||1
110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5
110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|B|0|ORC|0|0|0|100|DKK|4275|6827|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4275||4275|6827||1
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|122525|155651|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||122525||122525|155651||1
111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|6390|7882|lyfalmen|V0373|7882|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||5046||5046|7882||2
111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|814|2092|lyfalmen|||1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||814||814|2092||1
112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|23621|32189|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||23621||23621|32189||1
112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|18259|25460|lyfalmen|||1|180|0||Vistor hf|Almirall S.A.|Aclídínumbrómíđ||18259||18259|25460||1
112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|IKR|2094|3843|lyfalmen|V0203|3843|2|12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2094||2094|3843||1
113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||||2
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|9239|13617|lyfalmen|V0024|12337|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||9239||9239|13617||1
113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|27464|37012|lyfalmen|V0024|37012|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||27464||27464|37012||1
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|9360|13783|lyfalmen|V0025|12471|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||9360||9360|13783||1
113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|2522|3640|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||2522||2522|3640||2
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|4226|6760|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4226||4226|6760||1
113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|27784|37414|lyfalmen|V0025|37414|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||27784||27784|37414||1
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|7241|10884|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7241||7241|10884||1
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|723718|910149|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||723718||723718|910149||1
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|806|2081|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||806||806|2081||1
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1024|2380|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1024||1024|2380||1
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1563|3117|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1563||1563|3117||1
114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|999|2345|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||999||999|2345||1
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|57134|73586|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||57134||57134|73586||2
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4487|7117|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4487||4487|7117||1
114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|2560|4481|lyfalmen|V0373|2627|1|5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2560||2560|4481||1
114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2408|4273|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2408||2408|4273||2
114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|6990|10541|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6990||6990|10541||2
114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|2705|1848|lyfalmen|V0278|1771|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||635||635|1848||2
114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|3538|2437|lyfalmen|V0279|2159|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1066||1066|2437||2
114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|12276|7966|lyfalmen|V0280|7966|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5108||5108|7966||2
114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|12918|6281|lyfalmen|V0282|5492|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3876||3876|6281||2
114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|8019|7304|lyfalmen|V0457|4460|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4624||4624|7304||2
115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|15704|15207|lyfalmen|V0456|8622|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10401||10401|15207||2
115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|25685|16643|lyfalmen|V0475|16545|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||11451||11451|16643||2
115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|*|0|KNM|0|0|0|100|XEU|39599|32727|lyfalmen|V0540|32727|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||24049||24049|32727||2
115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|2068|3808|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||2068||2068|3808||1
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|9639|13911|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||9639||9639|13911||1
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1761|3388|lyfalmen|V0158|2854|2|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1761||1761|3388||1
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|12407|18116|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||12407||12407|18116||1
115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|2068|3808|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||2068||2068|3808||1
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|12407|18116|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||12407||12407|18116||1
115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|2060|3797|lyfalmen|V0369|3155|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||2060||2060|3797||1
115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|3936|6363|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3936||3936|6363||1
115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||||2
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|3953|5705|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3953||3953|5705||1
116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|2066|2982|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2066||2066|2982||1
116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|1153|1711|lyfalmen|V0056|1711|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||535||535|1711||2
116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|1826|2101|lyfalmen|V0057|2101|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||820||820|2101||2
116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||||2
116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2822|4839|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2822||2822|4839||1
116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3242|5414|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||3242||3242|5414||1
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|825|2094|lyfalmen|V0562|2080|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||815||815|2094||1
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|411|1523|lyfalmen|V0563|1522|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||398||398|1523||1
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|1001|2335|lyfalmen|V0564|2321|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||991||991|2335||1
116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|19232|26681|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19232||19232|26681||1
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8218|11656|lyfalmen|V0081|11656|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||7805||7805|11656||1
116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|6553|9943|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6553||6553|9943||1
116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|7037|10605|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||7037||7037|10605||1
116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|20776|28619|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||20776||20776|28619||1
116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|0|1|0|0|0|0|IPI|0|0|0|100|DKK|8964|13241|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8964||8964|13241||1
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|11850|22926|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum međ D-vítamíni/eđa öđrum efnum||11850||11850|22926||2
117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|3635|5951|lyfalmen|||1|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3635||3635|5951||1
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|4924|7715|lyfalmen|V0435|7601|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4924||4924|7715||2
117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|16622|23406|lyfalmen|||1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||16622|23406||1
117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|29377|39413|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||29377|39413||1
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|1745|3366|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1745||1745|3366||2
117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|5080|7928|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||5080|7928||1
117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|50797|66295|lyfalmen|||1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||50797|66295||1
117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|58754|76281|lyfalmen|||1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||58754|76281||1
117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|74755|95700|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||74755||74755|95700||1
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10557|18416|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||10557||10557|18416||2
117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|2656|4612|lyfalmen|V0085|4612|1|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2656|4612||2
117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|6350|9665|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||6350|9665||2
117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|9507|13984|lyfalmen|V0086|13984|1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||9507|13984||2
117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|8277|16066|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||8277||8277|16066||2
117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|14518|28049|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||14518||14518|28049||2
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|4347|1860|lyfalmen|V0278|1771|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||644||644|1860||1
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|6179|2456|lyfalmen|V0279|2159|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1080||1080|2456||1
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|23964|6295|lyfalmen|V0282|5492|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3886||3886|6295||1
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|18307|7958|lyfalmen|V0283|7853|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5102||5102|7958||1
118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2354|4199|lyfalmen|||1|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2354||2354|4199||1
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728||5
118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|18840|7994|lyfalmen|V0280|7966|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5128||5128|7994||1
118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998|31.12.2012|R|0|0|0|0|B|0|FER|0|0|0|100|DKK|7589|11360|lyfalmen|||1|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7589||7589|11360||1
118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|25116|34066|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||25116||25116|34066||1
118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008|28.02.2013|R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|2883|4923|lyfalmen|||3|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||2883||2883|4923||3
118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008|28.02.2013|R|1|0|0|0|*|0|LVR|0|0|0|100|DKK|9593|14102|lyfalmen|||3|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9593||9593|14102||3
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|1|0|0|0|B|0|AEG|0|0|0|100|XEU|532|1707|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||532||532|1707||1
119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|84025|107334|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||84025||84025|107334||1
119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1048|2143|lyfalmen|V0309|2143|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||851||851|2143||2
119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||||2
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|0|0|100|GBP|472064|594323|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||472064||472064|594323||1
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|0|0|100|GBP|472064|594323|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||472064||472064|594323||1
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|E|0|SAL|0|0|0|100|USD|1031|2389|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1031||1031|2389||1
120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|0|0|100|XEU|52388|67629|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||52388||52388|67629||2
120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012|28.02.2013|L|1|0|0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen|||||||1
120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|34526|45213|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||34526||34526|45213||1
120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008|31.12.2012|R|1|0|0|0|0|0|LVR|0|0|0|100|DKK|17959|25084|lyfalmen|||3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||17959||17959|25084||3
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|6323|9628|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6323||6323|9628||1
121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|10301|14810|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||10301||10301|14810||1
121302|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|467|1618|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1618||1
121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|8128|5155|lyfalmen|V0011|5009|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5155||2
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|432|1567|lyfalmen|V0391|1564|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||430||430|1567||1
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|1914|3597|lyfalmen|V0314|3194|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1914||1914|3597||1
121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|288|1373|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||288||288|1373||1
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747||1
122577|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|3396|5014|lyfalmen|V0381|5014|2|10|0|2,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2950||2950|5014||2
122588|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|16756|20772|lyfalmen|||2|50|0|12,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||14523||14523|20772||2
122610|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|3879|4492|lyfalmen|V0384|4492|2|10|0|5,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2568||2568|4492||2
122643|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|16756|20772|lyfalmen|||2|50|0|25,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||14523||14523|20772||2
123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|910|2224|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||910||910|2224||1
123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1229|2660|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1229||1229|2660||1
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|28283|49338|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||28283||28283|49338||2
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|267|1344|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||267|1344||1
123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|2324|2470|lyfalmen|V0317|2470|2|100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1090||1090|2470||2
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|1|0|0|0|E|0|AVS|0|0|0|100|NOK|51384|67032|lyfalmen|V0579|61930|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||51384||51384|67032||1
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1982|3943|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1982|3943||2
124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|42888|56370|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||42888|56370||1
124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|XEU|2079|2216|lyfalmen|V0234|2211|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||904||904|2216||2
124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|XEU|2969|2764|lyfalmen|V0233|2719|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1305||1305|2764||2
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1086|2464|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1086||1086|2464||1
124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|556|1739|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||556||556|1739||1
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|11053|16099|lyfalmen|V0464|16099|0|7,5|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||11053||11053|16099||1
124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999|31.01.2013|R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|1362|1966|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1362||1362|1966||1
125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|915|2062|lyfalmen|V0066|2058|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||792||792|2062||1
125973|D01BA0205|Terbinafin BMM Pharma|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|1|0|0|0|0|0|BMM|0|0|0|100|XEU|2699|3314|lyfalmen|V0123|3314|2|28|0|28,0000|LYFIS ehf|BMM Pharma AB|Terbínafín||1707||1707|3314||2
126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1
126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|120187|152717|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||120187|152717||1
126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|30844|40592|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||30844|40592||1
126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|27590|36508|lyfsjukr|||1|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||27590||27590|36508||2
126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|9196|13272|lyfsjukr|||1|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||9196||9196|13272||2
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|52791|68135|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||52791||52791|68135||2
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|105609|134422|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||105609||105609|134422||2
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|211144|266868|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||211144||211144|266868||2
126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|42794|56252|lyfalmen|||1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||42794|56252||2
126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|1|0|0|0|E|0|MCS|0|0|0|100|SEK|1160|2566|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1160||1160|2566||1
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||||2
128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|9483|6661|lyfalmen|V0279|2159|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4154||4154|6661||2
128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|13350|25807|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||13350||13350|25807||1
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|E|0|LEP|0|0|0|100|DKK|1338|2809|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1338||1338|2809||1
128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4467|6447|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||4467||4467|6447||2
129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|34190|32486|lyfalmen|V0280|7966|1|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23857||23857|32486||2
129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|37161|24996|lyfalmen|V0282|5492|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||17889||17889|24996||2
129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|242|1310|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||242||242|1310||1
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3484||1
129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|B|0|BOI|0|0|0|100|DKK|4756|7485|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4756||4756|7485||1
130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|20794|25317|lyfalmen|V0285|9187|1|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||18145||18145|25317||1
130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|32916|38593|lyfalmen|V0286|19643|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||28723||28723|38593||1
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2614|4555|lyfalmen|||2|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2614||2614|4555||1
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|15181|29322|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||15181||15181|29322||1
130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|4341|6917|lyfalmen|||2|125|0|31,2500|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||4341||4341|6917||1
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2043|3774|lyfalmen|||2|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||2043||2043|3774||1
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|12352|18047|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||12352|18047||1
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|72545|118357|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||72545|118357||1
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|3746|6103|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3746|6103||1
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|528|1701|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||528||528|1701||1
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|832|2117|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||832||832|2117||1
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1109|2496|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||1109||1109|2496||1
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1228|2659|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||1228||1228|2659||1
131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|2840|3092|lyfalmen|V0009|1872|3|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1545||1545|3092||3
131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|6326|9633|lyfalmen|V0132|9633|1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||6326||6326|9633||1
131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
131817|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|4268|6817|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||4268||4268|6817||2
131828|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|12803|18613|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||12803||12803|18613||2
131840|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|42509|55894|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||42509||42509|55894||2
132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|8942|13211|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||8942||8942|13211||2
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|10080|3257|lyfalmen|V0581|3209|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1665||1665|3257||1
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|8078|3257|lyfalmen|V0580|3209|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1665||1665|3257||1
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|E|0|REP|0|0|1|100|SEK|1660|3250|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1660||1660|3250||1
132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|8689|12865|lyfalmen|||1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||8689||8689|12865||1
132761|D08AG0201|Betadine|húđlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|1175|2586|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1175||1175|2586||1
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1
132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1546|3094|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1546||1546|3094||1
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|31606|41548|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||31606||31606|41548||1
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|42042|54645|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||42042||42042|54645||1
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|54934|70825|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||54934|70825||1
133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|VIO|0|0|0|100|DKK|297070|374705|lyfsjukr|||1|2|0||Williams & Halls efh|ViroPharma SPRL|C1 hemill||297070||297070|374705||2
133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|9345|13487|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||9345||9345|13487||1
133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|7362|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||7377||1
134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008|31.12.2012|R|1|0|0|0|0|1|DAC|0|0|0|100|DKK|89738|114504|lyfsjukr|||3|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||89738||89738|114504||2
134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|0|0|0|0|0|0|ABS|0|0|1|100|DKK|1643|3226|lyfalmen|||1|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1643||1643|3226||1
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|4346|6924|lyfalmen|V0378|6298|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||4346||4346|6924||2
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|13028|18895|lyfalmen|V0378|18895|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||13028||13028|18895||2
134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|5133|7408|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||5133||5133|7408||1
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|76197|97510|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||76197||76197|97510||1
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSI|0|0|0|100|DKK|141182|179066|lyfsjukr|||1|30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||141182||141182|179066||3
135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|57391|73908|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||57391||57391|73908||1
135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|2865|4898|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2865||2865|4898||1
135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1130|2525|lyfalmen|||2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1130||1130|2525||1
135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2379|4233|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2379||2379|4233||1
136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1861|3525|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1861||1861|3525||1
136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|*|0|IPI|0|0|0|100|DKK|36822|48757|lyfalmen|V0582|48757|1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||36822||36822|48757||2
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|7753|11585|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||7753||7753|11585||1
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|80154|102476|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||80154||80154|102476||1
136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|498|1519|lyfalmen|V0307|1519|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||395||395|1519||2
136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|21784|3675|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2546||2546|3675||2
136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|68232|11506|lyfsjukr|||2|16,7|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7972||7972|11506||2
136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|50289|8479|lyfsjukr|||2|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5875||5875|8479||2
136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|78391|13217|lyfsjukr|||2|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||9158||9158|13217||2
137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6438|9292|lyfsjukr|||2|20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||6438||6438|9292||2
137218|G03AC0902|Gestrina|filmhtfl|75|mcg|168|stk|1|ţpakki|6x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|3638|5956|lyfalmen|||2|168|0|168,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||3638||3638|5956||1
137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|0|0|0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1734||1
137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|0|0|0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||2144||1
137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|200546|31285|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||23428||23428|31285||2
137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|6811|9830|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6811||6811|9830||2
137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|11434|16232|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||11434||11434|16232||2
137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|57557|9706|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6725||6725|9706||2
137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|807|1165|lyfsjukr|||2|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||807||807|1165||2
138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|12208|2364|lyfsjukr|||2|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1638||1638|2364||2
138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3633|5949|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3633||3633|5949||2
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1838|3493|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1838||1838|3493||2
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|5117|7882|lyfalmen|V0373|7882|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||5046||5046|7882||1
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||||1
140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|148229|187910|lyfsjukr|||1|20|0||Vistor hf|N.V. Organon|Sugammadex||148229||148229|187910||1
140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|370452|466800|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Sugammadex||370452||370452|466800||1
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|1570|3127|lyfalmen|V0266|1329|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1570||1570|3127||1
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|12699|17820|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12699||12699|17820||1
140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|DES|0|0|0|100|DKK|688|993|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||688||688|993||3
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|1|0|0|100|NOK|105090|201961|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||105090||105090|201961||1
140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1341|2813|lyfalmen|V0413|2508|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1341||1341|2813||1
141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|0|0|0|0|0|1|DAC|0|0|0|100|DKK|4781|6714|lyfsjukr|||3|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4652||4652|6714||2
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4163|6008|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||4163||4163|6008||2
141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|2967|5038|lyfalmen|||1|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2967||2967|5038||1
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|22687|31017|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||22687||22687|31017||2
141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|B|0|VIO|0|0|1|100|DKK|56718|73726|lyfalmen|||1|50|0|8,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||56718||56718|73726||2
141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5394|8358|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||5394|8358||2
141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.02.2013||R|1|0|0|0|B|0|TEV|0|0|0|100|XEU|14522|16649|lyfalmen|V0492|16649|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||11455||11455|16649||2
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|9300|13701|lyfalmen|V0267|2686|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||9300||9300|13701||1
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|3001|3880|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2121||2121|3880||1
142203|QS02QA0301|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|fyrir ketti|QS02QA03|01.10.2012||L|0|0|0|0|0|0|LEV|1|0|0|100|XEU|1797|3135|vetorma|||0|10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||||1797|3135||2
142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3682|5314|lyfsjukr|||1|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3682||3682|5314||1
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1207|2630|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1207||1207|2630||1
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|3220|5384|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||3220||3220|5384||1
143139|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1560|3113|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1560||1560|3113||1
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2450|3536|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2450||2450|3536||1
143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|4039|6504|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4039||4039|6504||1
143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|635|1705|lyfalmen|V0542|1704|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||531||531|1705||1
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|971|2307|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||971||971|2307||1
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1592|3157|lyfalmen|||1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1592||1592|3157||1
143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|*|0|MLD|0|0|0|100|DKK|7140|10746|lyfalmen|V0387|9616|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||7140||7140|10746||1
143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|1435|2942|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1435||1435|2942||1
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|9104|13433|lyfalmen|V0386|10227|1|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||9104||9104|13433||1
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|655|1875|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||655||655|1875||1
143800|N05AN0101|Litarex|forđatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|*|0|AGT|0|0|0|100|DKK|1300|2757|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1300||1300|2757||1
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2189|3973|lyfalmen|V0174|3332|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2189||2189|3973||1
144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|E|0|MSD|0|0|0|100|DKK|2257|4066|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2257||2257|4066||1
144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|24812|33684|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||24812||24812|33684||1
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|87135|111237|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||87135||87135|111237||1
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|65125|83614|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||65125||65125|83614||1
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|40465|52666|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||40465||40465|52666||1
144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|708|1947|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||708||708|1947||1
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|92144|117523|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||92144||92144|117523||1
145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2397|4258|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2397||2397|4258||1
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1
145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|22244|21463|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||15074||15074|21463||2
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|32531|42709|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||32531||32531|42709||1
146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|3289|4747|lyfsjukr|||2|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||3289||3289|4747||2
146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6681|9642|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6681||6681|9642||2
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|ţpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|19471|26981|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||19471||19471|26981||2
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|982|2322|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||982||982|2322||1
147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2727|3936|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2727||2727|3936||2
147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1690|2439|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1690||1690|2439||2
147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012|31.12.2012|L|0|0|0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól|||||||3
148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|122146|155838|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||122146||122146|155838||2
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1306|2415|lyfalmen|V0577|2415|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||1050||1050|2415||2
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1943|3637|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1943||1943|3637||2
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|6965|9679|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||6360||6360|9679||2
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|90147|115680|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||90147||90147|115680||1
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|90147|115680|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||90147||90147|115680||1
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|1|0|0|0|*|0|LFS|0|0|0|100|DKK|923|2242|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||923||923|2242||1
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814||5
148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|60737|10240|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||7095||7095|10240||2
148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|127327|20551|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||14875||14875|20551||2
148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|HOS|0|0|0|100|XEU|272382|41818|lyfsjukr|||1|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||31821||31821|41818||2
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3934|7726|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3934||3934|7726||2
149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|2360|4207|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2360||2360|4207||1
149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|2354|2722|lyfalmen|V0376|2328|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1274||1274|2722||2
150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|5899|9048|lyfalmen|V0583|9048|1|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5899||5899|9048||1
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|56777|73138|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||56777|73138||1
150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009|28.02.2013|R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|4040|6505|lyfalmen|||1|28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||4040|6505||1
150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009|28.02.2013|R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|6702|10147|lyfalmen|||1|56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6702|10147||1
150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3857|6255|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3857|6255||1
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|7111|10706|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7111||7111|10706||1
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1324|2790|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1324||1324|2790||1
151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|17268|24216|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||17268|24216||1
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|53320|66275|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||50781||50781|66275||1
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|5708|8787|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5708||5708|8787||2
151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|6008|4337|lyfalmen|V0148|3002|2|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2455||2455|4337||1
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1706|3313|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1706||1706|3313||1
151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|IKR|4359|3831|lyfalmen|V0006|3831|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2085||2085|3831||2
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|2175|3139|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2175||2175|3139||1
152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|DAC|0|0|0|100|XEU|2807|3440|lyfalmen|V0123|3314|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||1799||1799|3440||2
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|4382|6254|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3856||3856|6254||1
152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|6404|9739|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6404||6404|9739||1
152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|B|0|ASZ|0|0|0|100|SEK|11750|17052|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||11750||11750|17052||1
152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1
152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|20440|21350|lyfalmen|V0269|21350|3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||14984||14984|21350||2
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1399|2893|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1399||1399|2893||1
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2005|3722|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||2005||2005|3722||1
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|43120|55998|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||43120|55998||1
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2532|4443|lyfalmen|V0561|3991|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2532||2532|4443||1
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1771|3402|lyfalmen|V0560|3086|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1771||1771|3402||1
153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|2486|4038|lyfalmen|V0575|4038|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2236||2236|4038||1
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GIS|0|0|0|100|DKK|248124|313278|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||248124||248124|313278||3
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|592|1789|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||592|1789||1
153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|38154|50428|lyfalmen|V0452|50428|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||38154||38154|50428||1
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4833|7590|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4833||4833|7590||1
153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|348|1455|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||348||348|1455||1
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|577|1768|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||577||577|1768||1
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|10216|14954|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||10216||10216|14954||1
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1146|2547|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1146||1146|2547||1
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31621|41567|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||31621||31621|41567||2
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|41428|53875|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||41428||41428|53875||2
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|45518|59008|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||45518||45518|59008||2
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33689|44162|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||33689||33689|44162||2
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|41442|53892|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||41442||41442|53892||2
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29689|39142|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||29689||29689|39142||2
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|4111|6603|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4111||4111|6603||1
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|38711|50465|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||38711||38711|50465||2
154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1656|3244|lyfalmen|||2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1656||1656|3244||1
154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003|31.12.2012|R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|7706|11520|lyfalmen|||1|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7706||7706|11520||1
154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|4707|5998|lyfalmen|V0334|5904|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3669||3669|5998||1
154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|7555|5998|lyfalmen|V0335|5904|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3669||3669|5998||1
154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|488009|614996|lyfalmen|||1|252|0|28,0300|Vistor hf|InterMune Europe Ltd.|Pírfenidon||488009||488009|614996||1
155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|*|0|ATL|0|0|0|100|XEU|1709|3317|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Chlorambucíl||1709||1709|3317||1
155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|2406|4259|lyfalmen|V0247|4259|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2398||2398|4259||2
155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|4055|6522|lyfalmen|V0248|6522|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||4052||4052|6522||2
155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|7291|10947|lyfalmen|V0249|10947|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||7287||7287|10947||2
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1650|3236|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1650||1650|3236||1
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|707|1946|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||707||707|1946||1
155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1819|3467|lyfalmen|V0590|3467|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1819||1819|3467||1
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|7546|11301|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||7546||7546|11301||1
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|6371|9694|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||6371||6371|9694||2
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|6425|9768|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6425||6425|9768||2
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|486|1644|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||486||486|1644||1
156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2556|3689|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2556||2556|3689||2
156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1498|2162|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1498||1498|2162||2
156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|7001|10104|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||7001||7001|10104||2
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|10267|15024|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||10267||10267|15024||2
156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|9378|13535|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||9378||9378|13535||2
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|975|2313|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||975||975|2313||1
156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775||2
157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992|31.12.2012|R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|7338|12801|vetorma|||0|260|0||Icepharma hf|Pfizer Oy Animal Health|||7338||7338|12801||2
157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|2952|2159|lyfalmen|V0279|2159|2|28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||863||863|2159||1
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1654|3241|lyfalmen|V0239|3241|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1654||1654|3241||1
157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|7653|11448|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||7653||7653|11448||1
158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1767|3396|lyfalmen|||1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1767|3396||1
158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|32563|43412|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||32563|43412||1
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1031|2389|lyfalmen|V0239|1621|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1031||1031|2389||1
158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|112217|142715|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||112217|142715||1
158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|224436|283550|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||224436|283550||1
158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|636382|800542|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||636382|800542||1
158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|57462|73997|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||57462|73997||1
158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|81972|104757|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||81972||81972|104757||1
158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|0|0|0|0|E|0|DES|0|0|0|100|DKK|889|2195|lyfalmen|||1|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||889||889|2195||3
158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1155|2559|lyfalmen|V0469|2559|2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1155|2559||1
159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|3667|4144|lyfalmen|V0219|4116|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||2314||2314|4144||1
159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|6313|6806|lyfalmen|V0220|6779|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4260||4260|6806||1
159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|8189|8676|lyfalmen|V0221|8649|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5627||5627|8676||1
159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|9542|9901|lyfalmen|V0223|9873|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||6522||6522|9901||1
159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|ţpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|3218|3209|lyfalmen|V0581|3209|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1630||1630|3209||2
159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5627|4986|lyfalmen|V0318|1460|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2929||2929|4986||1
159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14428|13318|lyfalmen|V0320|2839|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9020||9020|13318||1
159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2040|2787|lyfalmen|V0062|1373|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1322||1322|2787||1
159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3532|3932|lyfalmen|V0067|1373|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2159||2159|3932||1
159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7278|5250|lyfalmen|V0071|2164|1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3122||3122|5250||1
159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|E|0|MYL|0|0|1|100|SEK|592|1789|lyfalmen|||2|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||592||592|1789||1
159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|E|0|MYL|0|0|1|100|SEK|1795|3434|lyfalmen|||2|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1795||1795|3434||1
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|109387|139163|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||109387||109387|139163||1
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4572|8951|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4572||4572|8951||2
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|2078|2939|lyfalmen|V0010|2938|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939||1
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2467|3560|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2467||2467|3560||1
160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40855|53156|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||40855||40855|53156||2
160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59486|76537|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||59486||59486|76537||2
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|1121|2512|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1121||1121|2512||1
160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|2569|4493|lyfalmen|||1|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2569||2569|4493||1
160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|79358|101477|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||79358||79358|101477||2
160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|E|0|BOI|0|0|1|100|DKK|1305|2764|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1305||1305|2764||1
161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009|31.01.2013|R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|79833|102073|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||79833||79833|102073||1
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|645|1861|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||645||645|1861||1
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1001|1445|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||1001||1001|1445||1
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|909|1312|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||909||909|1312||1
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|659|1880|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||659||659|1880||1
161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|5620|8667|lyfalmen|V0131|8667|1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5620||5620|8667||1
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|65508|84758|lyfalmen|V0452|50428|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||65508||65508|84758||1
161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|15437|21137|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||15342||15342|21137||1
162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|172630|218533|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||172630||172630|218533||1
162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|846|2136|lyfalmen|V0512|2065|1|100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||846||846|2136||1
162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|471|1623|lyfalmen|V0510|1592|1|100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||471||471|1623||1
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|592979|746734|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||592979||592979|746734||1
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|2085|3831|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||2085||2085|3831||1
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5921|11542|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5921|11542||2
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|480|1574|lyfalmen|V0500|1574|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||435||435|1574||2
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|779|2045|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||779||779|2045||2
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|960|2292|lyfalmen|||2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||960||960|2292||2
162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|743|1499|lyfalmen|V0108|1499|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||380||380|1499||2
162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|836|1636|lyfalmen|V0109|1636|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||480||480|1636||2
162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|1347|1991|lyfalmen|V0110|1991|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||740||740|1991||2
162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|1785|3345|lyfalmen|V0373|2627|2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1730||1730|3345||1
162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|XEU|5174|3882|lyfalmen|V0148|3336|2|100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2122||2122|3882||1
162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|2379|4233|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2379||2379|4233||1
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|1245|2682|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1245||1245|2682||1
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1889|3563|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1889||1889|3563||1
163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|1|0|0|0|E|0|AEA|0|0|0|100|XEU|221|1281|lyfalmen|||2|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||221|1281||1
163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|3517|5116|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3024||3024|5116||1
163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|761|1882|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||660||660|1882||2
163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|E|0|ROY|0|0|1|100|XEU|1827|3132|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1574||1574|3132||2
163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114||1
164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|390328|491744|lyfsjukr|||1|42|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||390328||390328|491744||1
164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|0|0|0|0|*|0|ATL|0|0|0|100|XEU|3766|6131|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Merkaptópúrín||3766||3766|6131||1
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4221|6092|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4221||4221|6092||2
164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|3369|5588|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3369|5588||1
164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|11107|16173|lyfalmen|||2|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||11107||11107|16173||1
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1370|2853|lyfalmen|||2|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1370||1370|2853||1
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1619|3194|lyfalmen|V0314|3194|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1619||1619|3194||1
164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|B|0|TIL|0|0|0|100|SEK|8229|12236|lyfalmen|V0014|12236|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||8229|12236||2
165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1
165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|912|2226|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||912||912|2226||1
165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|7533|14637|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||7533||7533|14637||2
165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|5701|8778|lyfalmen|V0059|6276|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5701||5701|8778||1
165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3679|6012|lyfalmen|V0058|5183|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3679||3679|6012||1
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|299582|377858|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||299582||299582|377858||2
165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40855|53156|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||40855||40855|53156||2
165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59486|76537|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||59486||59486|76537||2
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|E|0|UCN|0|0|1|100|SEK|789|2058|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||789||789|2058||1
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|E|0|UCN|0|0|1|100|SEK|228|1291|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||228||228|1291||1
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1
165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|26524|12080|lyfalmen|V0341|12080|2|98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||8115||8115|12080||2
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4461|6438|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4461||4461|6438||2
165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|79358|101477|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||79358||79358|101477||2
165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|269012|339493|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||269012||269012|339493||2
166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|5091|9948|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||5091|9948||1
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|2132|3895|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2132||2132|3895||1
166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|E|0|PER|0|0|0|100|DKK|16532|23293|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||16532||16532|23293||1
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2497|4395|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2497||2497|4395||1
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|4726|7444|lyfalmen|V0428|7444|2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4726||4726|7444||1
166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|XEU|5321|6946|lyfalmen|V0550|6932|2|90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||4362||4362|6946||1
166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|E|0|IPI|0|0|0|100|DKK|142247|181065|lyfalmen|||1|1|0|1,0000|Icepharma hf|Pfizer Limited|Clostridíum||142247||142247|181065||1
166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1
167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|482|1638|lyfalmen|||2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||482||482|1638|28.2.2013|1
168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|1|0|0|0|E|0|AUK|0|0|0|100|GBP|662|1884|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||662|1884||1
168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|4452|5144|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3045||3045|5144||1
168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|2781|4783|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2781||2781|4783||2
168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|2979|5054|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2979||2979|5054||2
168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3273|5456|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3273||3273|5456||2
168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3700|6040|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3700||3700|6040||2
168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3896|6308|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3896||3896|6308||2
168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|3321|5522|lyfalmen|V0240|5520|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3321||3321|5522||1
168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|6129|9363|lyfalmen|V0433|9360|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||6129||6129|9363||1
168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|60694|78053|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||60694||60694|78053||1
169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|263885|333058|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||263885||263885|333058||1
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|23609|31512|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||23609||23609|31512||2
169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5668|8732|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5668||5668|8732||1
169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827||2
169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|||2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196||2
169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577||2
169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864||2
169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852||2
169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517||2
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3320|5520|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3320||3320|5520||1
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3574|5868|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3574||3574|5868||1
170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|26430|35052|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||26430|35052||2
170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|65595|84204|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||65595|84204||2
170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6094|9315|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||6094||6094|9315||1
170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|123990|157490|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||123990||123990|157490||2
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|ţpakki||J04AB02|01.07.2012||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|17457|24454|lyfalmen|V0571|24454|1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||17457||17457|24454||2
170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|B|0|ABS|0|0|0|100|DKK|4244|6784|lyfalmen|||1|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||4244||4244|6784||1
170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|B|0|ABS|0|0|0|100|DKK|7428|11140|lyfalmen|||1|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||7428||7428|11140||1
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2717|4696|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2717||2717|4696||1
170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|12457|17516|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||12457||12457|17516||1
170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|29966|39490|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||29966||29966|39490||1
170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|44949|58293|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||44949||44949|58293||1
170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|3658|3887|lyfalmen|V0203|3843|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2126||2126|3887||1
170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|12363|2340|lyfalmen|V0207|2340|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||995||995|2340||2
170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|0|0|100|XEU|62739|80620|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||62739||62739|80620||2
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|1|0|0|100|DKK|2980|5895|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2980||2980|5895||1
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4116|6609|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||4116||4116|6609||1
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4435|7046|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||4435||4435|7046||1
171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|0|0|0|0|0|0|LDR|0|0|0|100|NOK|1753|3377|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1753||1753|3377||2
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|5025|7853|lyfalmen|V0247|4259|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||5025||5025|7853||1
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|8271|12293|lyfalmen|V0248|6522|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8271||8271|12293||1
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|48736|63046|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||48736||48736|63046||2
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|32492|42660|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||32492||32492|42660||2
172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488||2
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|14937|21291|lyfalmen|V0249|10947|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||14937||14937|21291||1
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|28033|37727|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||28033||28033|37727||1
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|74730|95669|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||74730||74730|95669||2
172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|32702|32315|lyfalmen|V0346|32315|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||23721||23721|32315||2
172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|0|0|0|1|*|0|ATL|0|0|0|100|XEU|3804|6183|lyfalmen|||1|100|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Búsúlfan||3804||3804|6183||1
172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|13078|18958|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||13078||13078|18958||1
172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|6923|10449|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6923||6923|10449||2
172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|12861|18686|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||12861||12861|18686||2
172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|22313|30548|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||22313||22313|30548||2
172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|1|0|0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|780|3|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114||3
172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|666078|838473|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||666078||666078|838473||1
172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|29097|39062|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||29097||29097|39062||2
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|DKK|467|1618|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||467||467|1618||1
173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11597|16843|lyfalmen|V0118|16843|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||11597||11597|16843||1
173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|3911|6329|lyfalmen|||2|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||3911||3911|6329||1
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3802||1
173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|6919|10444|lyfalmen|||2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6919||6919|10444||1
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|18079|24432|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||17968||17968|24432||1
173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001|28.02.2013|R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|390|1512|lyfalmen|||2|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||390||390|1512||1
173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|17264|23549|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||17264||17264|23549||1
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1648|2378|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1648||1648|2378||1
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|759|2017|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||759||759|2017||1
174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1495|3024|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1495||1495|3024||1
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|776|2040|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||776||776|2040||1
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|2004|3720|lyfalmen|V0368|3006|1|5|0|25,0000|Vistor hf|Allergan|Brímónidín||2004||2004|3720||1
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|5877|9018|lyfalmen|V0368|9018|1|15|0|75,0000|Vistor hf|Allergan|Brímónidín||5877||5877|9018||1
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|2695|2295|lyfalmen|V0033|2132|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||962||962|2295||1
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5
176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|7225|5318|lyfalmen|V0278|1771|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3172||3172|5318||2
176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|E|0|WHE|0|0|1|100|XEU|6435|9782|lyfalmen|V0429|9782|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||6435||6435|9782||2
176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|3002|5085|lyfalmen|V0574|5085|2|30|0|30,0000|Nycomed Danmark ApS|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||3002||3002|5085||1
178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968||1
178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|5438|5069|lyfalmen|V0320|5069|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||2990||2990|5069||2
179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|181623|229819|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||181623||181623|229819||1
179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|13996|7416|lyfalmen|V0253|7416|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||4706||4706|7416||2
179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|12028|17640|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||12028|17640||2
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|141827|179875|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||141827||141827|179875||2
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|B|0|UCB|0|0|0|100|DKK|6098|9321|lyfalmen|||1|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||6098||6098|9321||1
180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.12.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|2836|3336|lyfalmen|V0148|3336|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1723||1723|3336||2
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|868|2166|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||868||868|2166||1
181219|J04AB0201|Rimactan|hylki|300|mg|60|stk|1|ţpakki||J04AB02|01.02.2013||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|10475|15308|lyfalmen|V0571|14672|1|60|0|30,0000|Icepharma hf|Sandoz GmbH|Rífampicín||10475||10475|15308||2
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DD12|01.10.1995||R|0|0|0|0|0|0|PFV|0|0|0|100|DKK|8757|16987|vetalmen|||0|100|0||Icepharma hf|Pfizer vet.|Cefoperazone||8757||8757|16987||2
181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|10646|15243|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||10646||10646|15243||1
182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|0|0|0|0|0|0|IBV|0|0|0|100|SEK|6605|12855|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||6605||6605|12855||1
182307|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.11.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|14095|20234|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14095||14095|20234||1
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5871|11446|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5871||5871|11446||1
183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.03.2013||R|1|0|0|0|E|0|BLP|0|0|0|100|XEU|2079|2231|lyfalmen|V0234|2211|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||915||915|2231||2
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|B|0|ALK|0|0|1|100|DKK|6303|9601|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||6303|9601||1
183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|1561303|1961318|lyfsjukr|||1|168|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1561303||1561303|1961318||1
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|B|0|BRS|0|0|0|100|DKK|1294|2749|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1294||1294|2749||1
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|533|1708|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||533||533|1708||1
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121||1
184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996|28.02.2013|R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|666|1890|lyfalmen|||2|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||666||666|1890||1
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|B|0|TIL|0|0|0|100|SEK|5539|8556|lyfalmen|V0017|7891|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5539|8556||2
184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|23660|32238|lyfalmen|V0170|10817|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||23660||23660|32238||1
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|60130|78008|lyfalmen|V0185|23645|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||60130||60130|78008||1
184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1287|2739|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1287||1287|2739||1
184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|E|0|AZA|0|0|0|100|SEK|5990|9173|lyfalmen|||1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5990||5990|9173||1
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|5594|8631|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||5594||5594|8631||1
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|WTE|0|0|0|100|DKK|84034|107345|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||84034||84034|107345||2
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|E|0|DEA|0|0|0|100|XEU|3195|5350|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3195||3195|5350||1
188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|1|0|0|0|*|0|MPH|0|0|0|100|USD|2112|3868|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíđ||2112||2112|3868||2
189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|10510|15073|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||10510||10510|15073||2
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|7795|11250|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7795||7795|11250||1
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|2716|4694|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2716||2716|4694||1
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1118|2508|lyfalmen|V0413|2508|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1118||1118|2508||1
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|541|1719|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||541||541|1719||1
189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|501|723|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||501||501|723||1
190425|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|B|0|BGB|0|0|0|100|DKK|9507|13984|lyfalmen|V0086|13984|1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||9507|13984||2
190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|1086|2464|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1086||1086|2464||1
190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|959|2291|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||959||959|2291||1
191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4205|6069|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||4205||4205|6069||2
191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7634|11422|lyfalmen|V0117|11422|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||7634||7634|11422||1
191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4006|5782|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||4006||4006|5782||2
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4133|5965|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||4133||4133|5965||2
191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|5047|7883|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5047||5047|7883||1
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|559|1744|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||559||559|1744|28.2.2013|1
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|B|0|AGP|0|0|0|100|XEU|4176|6691|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||4176||4176|6691||1
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|E|0|LEP|0|0|0|100|DKK|1749|3371|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1749||1749|3371||1
192826|L01DB0103|Caelyx|irţ|2|mg/ml|25|ml|1|hgl||L01DB01|01.10.2012|31.12.2012|R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|163849|207513|lyfsjukr|||1|25|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||163849||163849|207513||1
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|0|0|100|SEK|209892|265960|lyfalmen|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||209892||209892|265960||1
193583|L01XE1801|Jakavi|töflur|5|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|354276|446499|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||354276||354276|446499||1
193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233||1
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|B|0|MYL|0|0|0|100|SEK|2063|3801|lyfalmen|||2|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||2063||2063|3801||1
195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|2690|4659|lyfalmen|||2|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2690||2690|4659||1
195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972|28.02.2013|R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|842|2131|lyfalmen|||2|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||842||842|2131||1
195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|13844|7920|lyfalmen|V0012|5009|2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||5074||5074|7920||2
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|99861|127208|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||99861||99861|127208||2
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|181623|229819|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||181623||181623|229819||1
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|850|2142|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||850||850|2142||1
195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|435|1574|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||435||435|1574||1
195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|922|2240|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||922||922|2240||1
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|B|0|MYL|0|0|0|100|SEK|2636|4585|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2636||2636|4585||1
196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1674|3269|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1674||1674|3269||2
196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|B|0|ATL|0|0|0|100|GBP|6246|9523|lyfalmen|||1|100|0|0,8333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||6246||6246|9523||1
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|28929|38188|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||28929|38188||1
197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|2783|5516|vetalmen|||0|10|0||Vistor hf|Intervet International BV|||2783||2783|5516||1
197554|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|150|skammtar|1|fl|1 x 150 úđaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|927|2247|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||927||927|2247||1
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3034|5129|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||3034||3034|5129||1
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2439|4315|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2439||2439|4315||1
198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|0|0|0|1|*|0|ATL|0|0|0|100|XEU|2298|4117|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Melphalan||2294||2294|4117||1
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7764|11205|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7764||7764|11205||1
198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975|28.02.2013|R|0|0|0|0|0|1|LFS|0|0|0|100|DKK|434|626|lyfsjukr|||1|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||434||434|626||1
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|39018|51513|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||39018||39018|51513||1
199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|9235|4715|lyfalmen|V0515|4687|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2731||2731|4715||1
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|684|1915|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||684||684|1915||1
199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|7641|5012|lyfalmen|V0011|5009|2|98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012||1
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|101895|129761|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||101895|129761||1
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|5052|7890|lyfalmen|V0126|7890|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||5052||5052|7890||1
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|60999|78436|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||60999||60999|78436||0
199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|0|0|100|DKK|2960111|3716817|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2960107||2960107|3716817||1
300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|ţpakki||A05AA02|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5687|8575|lyfalmen|||0|60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5553||5553|8575||1
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|730|1054|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||730||730|1054||2
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|33530|64555|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||33530||33530|64555||1
370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1589|2854|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1371||1371|2854||2
370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|11531|5012|lyfalmen|V0012|5009|2|98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012||1
370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|635|916|lyfsjukr|||1|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||635||635|916||2
371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|11131|16206|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||11131||11131|16206||1
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||11051||1
371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|7143|10750|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||7143||7143|10750||1
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|E|0|ROC|0|0|0|100|DKK|3958|6393|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3958||3958|6393||2
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372283|N06AB1006|Escitalopram Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4922|4170|lyfalmen|V0325|4112|2|100|0|100,0000|Portfarma ehf|Portfarma|Escítalópram||2333||2333|4170||2
373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2714|4692|lyfalmen|||1|66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||2714||2714|4692||1
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|21487|29511|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||21487||21487|29511||1
373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|4356|6938|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4356||4356|6938||1
373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|7195|10821|lyfalmen|V0436|10820|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7195||7195|10821||1
373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|9933|14567|lyfalmen|V0437|14565|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9933||9933|14567||1
373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|*|0|MED|0|0|0|100|XEU|8065|7154|lyfalmen|V0420|7154|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||4514||4514|7154||2
373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|505|1655|lyfalmen|V0541|1653|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||494||494|1655||1
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|1710|3318|lyfalmen|V0126|1973|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1710||1710|3318||1
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|436933|550233|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||436933||436933|550233||1
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|1|0|0|0|*|0|MCK|0|0|0|100|SEK|768|2029|lyfalmen|V0500|1574|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||768||768|2029||2
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6204|8954|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||6204||6204|8954||2
374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|4987|7801|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4987||4987|7801||1
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|12151|17795|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12151||12151|17795||1
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|10133|14840|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10133||10133|14840||1
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|12026|17638|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12026||12026|17638||1
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|14050|20178|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||14050||14050|20178||1
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|34843|46273|lyfalmen|V0459|46273|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||34843||34843|46273||1
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|22040|30205|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||22040||22040|30205||1
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|100991|129289|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||100991||100991|129289||1
377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|4640|7326|lyfalmen|||1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4640||4640|7326||1
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|11769|9392|lyfalmen|V0182|9240|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6150||6150|9392||1
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|17751|24823|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||17751||17751|24823||1
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|160287|203043|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||160287||160287|203043||1
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|124453|158071|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||124453||124453|158071||1
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|175347|221943|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||175347||175347|221943||1
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|222010|280505|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||222010||222010|280505||1
379796|N04BC0406|Ropinirole Portfarma|forđatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|9954|10006|lyfalmen|V0532|10006|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||6599||6599|10006||2
379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1634|3214|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1634||1634|3214||1
379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|2020|3742|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2020||2020|3742||1
380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|9084|4687|lyfalmen|V0515|4687|2|100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||2711||2711|4687||2
381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|6071|9284|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6071||6071|9284||2
381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|8260|7994|lyfalmen|V0143|7994|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||5128||5128|7994||2
382162|N04BC0406|Ropinirole Portfarma|forđatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|17592|17707|lyfalmen|V0533|17707|2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||12081||12081|17707||2
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|7844|11709|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7844||7844|11709||1
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1392|2428|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1392|2428||2
383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8387|14631|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||8387||8387|14631||2
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383445|J05AG0101|Viramune|forđatfl|400|mg|30|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|46116|59758|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||46116||46116|59758||1
383933|L01XE1801|Jakavi|töflur|15|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|708540|891100|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||708540||708540|891100||1
386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|6680|6453|lyfalmen|V0144|6453|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4002||4002|6453||2
386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|*|0|AZA|0|0|0|100|SEK|64773|83835|lyfalmen|V0184|14632|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||64773||64773|83835||1
387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1007|2073|lyfalmen|V0308|2073|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||800||800|2073||2
387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|0|0|0|0|0|0|ICE|0|0|0|100|XEU|794|1579|vetalmen|||0|100|0||Icepharma hf|Icepharma hf|||794||794|1579||2
387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|0|0|0|0|0|1|CEP|0|0|0|100|DKK|217617|274992|lyfsjukr|||1|200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||217617||217617|274992||1
387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|B|0|TEV|0|0|0|100|XEU|14522|15236|lyfalmen|V0491|15236|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||10422||10422|15236||2
388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|176749|223702|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||176749||176749|223702||1
388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3729|6080|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3729||3729|6080||1
388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4700|7408|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4700||4700|7408||1
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|9121|13456|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||9121||9121|13456||1
388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|871|1622|lyfalmen|V0466|1622|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||470||470|1622||1
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|E|0|BIP|0|0|0|100|SEK|3160|5302|lyfalmen|V0410|5302|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||3160||3160|5302||1
389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|E|0|BIP|0|0|0|100|DKK|2354|4199|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2354||2354|4199||1
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|E|0|BIP|0|0|0|100|SEK|932|2254|lyfalmen|V0128|2254|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||932||932|2254||1
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|E|0|BIP|0|0|0|100|DKK|691|1924|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||691||691|1924||1
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|E|0|NOL|0|0|1|100|SEK|1054|2421|lyfalmen|V0367|1864|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1054||1054|2421||1
389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2922|3813|lyfalmen|V0143|2665|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2072||2072|3813||2
389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|5668|2686|lyfalmen|V0267|2686|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1248||1248|2686||2
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|65379|84596|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||65379||65379|84596||2
389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|20315|28040|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||20315||20315|28040||1
390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|89138|113751|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||89138||89138|113751||1
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|E|0|BRS|0|0|1|100|DKK|3174|5321|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||3174||3174|5321||1
390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|*|0|TEV|0|0|0|100|XEU|3305|5500|lyfalmen|||2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||3305||3305|5500||2
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|7606|11384|lyfalmen|V0429|9782|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7606||7606|11384||1
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|3004|5088|lyfalmen|V0037|4455|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||3004||3004|5088||1
391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|33997|45211|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||33997||33997|45211||2
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|14658|20941|lyfalmen|V0196|18106|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||14658||14658|20941||1
391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3003|5087|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||3003||3003|5087||1
392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|269012|339493|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||269012||269012|339493||2
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|4962|6992|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4396||4396|6992||1
392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|10721|15645|lyfalmen|||1|50|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||10721||10721|15645||1
393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|*|0|OPF|0|0|0|100|IKR|20927|20743|lyfalmen|V0286|19643|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||14500||14500|20743||2
393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|B|0|VIO|0|0|1|100|DKK|93294|119629|lyfalmen|||1|50|0|33,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||93294||93294|119629||2
393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|6108|11901|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||6108||6108|11901||2
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|4775|3975|lyfalmen|V0327|3975|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2190||2190|3975||2
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|161600|203427|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||160593||160593|203427||1
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|0|0|LVR|0|0|0|100|SEK|30978|41423|lyfalmen|V0356|41423|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||30978|41423||
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|194948|246542|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||194948||194948|246542||2
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|4402|7001|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4402||4402|7001||1
397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1376|2861|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1376||1376|2861||1
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|0|0|100|SEK|40792|53076|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||40792||40792|53076||2
397567|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|1383|1996|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1383||1383|1996||1
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|10759|15385|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||10759||10759|15385||2
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|61690|79303|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||61690||61690|79303||2
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||||1
398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3287|lyfalmen|V0012|2862|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1687||1687|3287||2
399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|3833|1924|lyfalmen|V0009|1872|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||691||691|1924||2
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|444|1586|lyfalmen|V0225|1551|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||444||444|1586||1
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|2049|2620|lyfalmen|V0244|2575|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1200||1200|2620||1
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|9807|14394|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9807||9807|14394||1
399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|45674|59203|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||45674||45674|59203||1
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1
399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|123966|157460|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||123966||123966|157460||2
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|1682|3280|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1682||1682|3280||1
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5601|8641|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5601||5601|8641||1
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|243|1311|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||243||243|1311||1
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|441|1582|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||441||441|1582||1
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|210|1266|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||210||210|1266||1
401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|E|0|WHE|0|0|1|100|XEU|2541|4455|lyfalmen|V0037|4455|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2541||2541|4455||2
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|12038|17653|lyfalmen|V0459|15424|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||12038||12038|17653||1
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|824|2106|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||824||824|2106||1
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|1319|2783|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1319||1319|2783||1
401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1298|2754|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1298||1298|2754||1
401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2084|3830|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2084||2084|3830||1
402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|710|1950|lyfalmen|||1|0,5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||710||710|1950||1
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1816|3612|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1816||1816|3612||1
402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|E|0|LVR|0|0|0|100|DKK|16408|23137|lyfalmen|V0349|23137|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16408||16408|23137||3
403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|1|0|0|1|*|0|LYF|0|0|0|100|XEU|22434|27280|lyfalmen|V0470|27280|3|100|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||19709||19709|27280||2
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5585|10897|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5585||5585|10897||1
403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|6378|9704|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||6378||6378|9704||1
403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|40186|52316|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||40186|52316||1
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1605|3174|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1605||1605|3174||1
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1934||2
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|70780|90711|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||70780||70780|90711||1
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|743|1072|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||743||743|1072||2
405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|8846|17158|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8846||8846|17158||2
405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1892|3567|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1892||1892|3567||1
405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|20165|27852|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||20165||20165|27852||1
405677|J01DD0401|Rocephalin|irţ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4591|6626|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||4591||4591|6626||2
405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19699|27267|lyfalmen|||1|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19699||19699|27267||1
406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813||2
406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|22474|30750|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22474||22474|30750||1
406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|24633|33460|lyfalmen|||1|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||24633||24633|33460||1
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|22220|30431|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22220||22220|30431||1
406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901||2
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|66996|86625|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||66996||66996|86625||1
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|78647|101247|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||78647||78647|101247||1
406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|89169|114452|lyfalmen|||1|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||89169||89169|114452||1
406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6800|10281|lyfalmen|||1|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6800||6800|10281||1
406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|86318|110212|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||86318||86318|110212||1
407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|3633|2242|lyfalmen|V0072|2127|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||923||923|2242||2
407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|2457|4340|lyfalmen|||1|100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2457||2457|4340||1
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|182|1228|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||182||182|1228||1
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|396|1521|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||396||396|1521||1
408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|2128|3105|lyfalmen|V0310|3105|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1554||1554|3105||2
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3121|5248|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||3121||3121|5248||1
408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2447|4326|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2447||2447|4326||1
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|4643|7330|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4643||4643|7330||1
409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|4038|6503|lyfalmen|||1|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||4038||4038|6503||1
409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|4762|7493|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4762||4762|7493||1
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|13521|19514|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||13521||13521|19514||1
409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|3225|5391|lyfalmen|||1|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3225||3225|5391||1
409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|87486|112340|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||87486||87486|112340||1
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|10956|15966|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10956||10956|15966||1
409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|E|0|WHE|0|0|1|100|XEU|12399|18106|lyfalmen|V0196|18106|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||12399||12399|18106||2
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1277|2726|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1277||1277|2726||1
410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|872|2172|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||872||872|2172||1
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|763|2023|lyfalmen|||2|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||763||763|2023||1
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5297|7645|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5297||5297|7645||2
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|26803|35520|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||26803||26803|35520||1
411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7841|11705|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7841||7841|11705||1
412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|*|0|AZA|0|0|0|100|SEK|25519|34571|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||25519||25519|34571||1
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|4219|6089|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4219||4219|6089||1
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|DKK|9261|17955|vetalmen|||0|100|0||Vistor hf|Merial|||9261||9261|17955||1
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|139226|176611|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||139226||139226|176611||2
412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|68042|87938|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||68042||68042|87938||1
412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|*|0|MYL|0|0|0|100|SEK|3835|6225|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3835||3835|6225||1
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|*|0|MYL|0|0|0|100|SEK|4711|7423|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4711||4711|7423||1
413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|890|1471|lyfalmen|V0062|1471|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||360||360|1471||2
414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|30969|14196|lyfalmen|V0342|13516|2|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||9662||9662|14196||2
414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|E|0|SEV|0|0|0|100|DKK|4675|7374|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4675||4675|7374||2
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1436|2943|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1436||1436|2943||1
415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|2319|4151|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2319||2319|4151||1
415556|B03AC0204|Venofer  (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|0|0|0|0|E|0|DAC|0|0|1|100|CHF|15955|20062|lyfalmen|V0034|20008|3|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||13958||13958|20062||2
415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2063|3801|lyfalmen|||1|15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2063||2063|3801||1
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|13996|7490|lyfalmen|V0253|7416|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||4760||4760|7490||2
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|10317|10285|lyfalmen|V0088|1942|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6803||6803|10285||1
416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4213|2466|lyfalmen|V0005|2114|2|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1087||1087|2466||2
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|4899|7680|lyfalmen|||1|300|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||4899||4899|7680||1
416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011|31.01.2013|R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|5073|7322|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||5073||5073|7322||1
416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|E|0|GOG|0|0|1|100|XEU|3147|5284|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||3147||3147|5284||2
416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|0|0|0|0|E|0|GOG|0|0|1|100|DKK|28242|37989|lyfalmen|||1|150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||28242||28242|37989||2
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1410|2908|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1410||1410|2908||2
417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|*|0|OPF|0|0|0|100|IKR|10510|9871|lyfalmen|V0285|9187|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||6500||6500|9871||2
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|43870|56939|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||43870||43870|56939||1
417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|107995|137416|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||107995||107995|137416||1
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|37221|49257|lyfalmen|V0460|49257|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||37221|49257||1
418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|5457|8444|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5457||5457|8444||1
418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|146346|185547|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||146346||146346|185547||1
418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1739|3358|lyfalmen|||1|50|0||Vistor hf|Schering-Plough Europe|Betametasón||1739||1739|3358||1
418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|B|0|SNO|0|0|0|100|NOK|8312|12349|lyfalmen|V0014|12236|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||8312||8312|12349||1
418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|23815|19417|lyfalmen|||3|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||13044||13444|19417||2
418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|E|0|APC|0|0|1|100|XEU|4255|5690|lyfalmen|V0458|5690|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||3444||3444|5690||1
418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2223|4422|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2223||2223|4422||1
418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2885|5712|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2885||2885|5712||1
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|B|0|LEP|0|0|0|100|DKK|3615|5924|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3615||3615|5924||1
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|B|0|LEP|0|0|0|100|DKK|7730|11553|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7730||7730|11553||1
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|56758|73114|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||56758||56758|73114||1
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|43069|55934|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||43069||43069|55934||3
419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|886|2191|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||886||886|2191||1
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|13104|18991|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||13104||13104|18991||1
420678|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|5327|7688|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||5327||5327|7688||1
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1716|3326|lyfalmen|V0036|3325|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1716||1716|3326||1
422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|1701|3306|lyfalmen|V0051|3135|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1701||1701|3306||1
422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3887|6296|lyfalmen|V0049|4461|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3887||3887|6296||1
422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|6699|10143|lyfalmen|V0054|8189|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6699||6699|10143||1
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|82433|105336|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||82433||82433|105336||2
423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|6383|3530|lyfalmen|V0011|2862|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1865||1865|3530||2
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|23811|31765|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||23811||23811|31765||1
424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1762|3074|vetorma|||0|24|0||Vistor hf|Intervet International BV|||1762||1762|3074||1
425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|1210|2634|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||1210||1210|2634||1
425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|5187|7436|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||5152||5152|7436||1
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2248|3884|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2124||2124|3884||1
426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|759|2017|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||759||759|2017||1
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|991|2335|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||991||991|2335||1
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738||1
428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|934|2257|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||934||934|2257||1
428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1097|2480|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1097||1097|2480||1
428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|55764|71866|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||55764||55764|71866||1
428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|6185|2345|lyfalmen|V0113|1964|2|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||999||999|2345||2
428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|30075|30076|lyfalmen|V0344|30076|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||21937||21937|30076||2
429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4598|7269|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4598||4598|7269||2
429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|45237|59318|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||45237||45237|59318||2
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|109695|139550|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||109695||109695|139550||1
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4440|7053|lyfalmen|||1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4440||4440|7053||1
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|1913|2761|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1913||1913|2761||1
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1567|2262|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1567||1567|2262||2
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4862|9508|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4862||4862|9508||1
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|0|0|0|0|*|0|WIH|0|0|0|100|XEU|31880|14771|lyfalmen|V0184|14632|2|98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||10082||10082|14771||2
430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|35630|47261|lyfalmen|||1|84|0|37,3300|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||35630||35630|47261||1
430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|3226|3917|lyfalmen|V0144|3227|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2148||2148|3917||2
430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2668|4629|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2668||2668|4629||2
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|827|2110|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||827||827|2110||1
431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|1308|2768|lyfalmen|||1|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1308||1308|2768||1
431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|263613|332717|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||263613||263613|332717||1
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1536|3080|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1536|3080||1
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|5208|8103|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||5208||5208|8103||1
432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|0|0|0|0|E|0|NDR|0|0|0|100|SEK|42271|55595|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||42271|55595||1
432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981|28.02.2013|R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1232|2664|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1232||1232|2664||1
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4035|7920|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||4035||4035|7920||2
433194|N05AD0301|Buronil|húđuđtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|*|0|MEV|0|0|0|100|DKK|1924|3611|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1924||1924|3611||1
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|12017|17626|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||12017||12017|17626||1
433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2811|4824|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2811||2811|4824||1
433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|6153|9396|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||6153||6153|9396||1
433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998|31.12.2012|R|1|0|1|0|E|0|PER|0|0|0|100|DKK|8712|12896|lyfalmen|||1|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8712||8712|12896||1
433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|581|1774|lyfalmen|||2|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||581||581|1774|31.12.2012|2
434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|215091|271822|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||215091||215091|271822||2
434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|B|0|TEV|0|0|0|100|XEU|7596|7810|lyfalmen|V0490|7810|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||4994||4994|7810||2
434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1234|2153|vetorma|||0|10|0||Vistor hf|Intervet International BV|||||1234|2153||1
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|1008|2358|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||1008||1008|2358||1
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|B|0|MEB|0|0|1|100|DKK|6303|9601|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6303||6303|9601||1
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|B|0|MEB|0|0|1|100|DKK|6303|9601|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6303||6303|9601||1
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|11185|16279|lyfalmen|V0315|6247|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||11185||11185|16279||2
435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|1|0|0|0|E|0|ASZ|0|0|0|100|SEK|7547|11303|lyfalmen|||1|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||7547||7547|11303||1
435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|1|0|0|0|E|0|ASZ|0|0|0|100|SEK|5237|8143|lyfalmen|||1|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5237||5237|8143||1
435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|9313|12091|lyfalmen|V0284|2853|1|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||8123||8123|12091||1
435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|929|2073|lyfalmen|V0284|1712|3|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||800||800|2073||3
435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|3151|5289|lyfalmen|||1|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||3151||3151|5289||1
436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|256574|323883|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||256574||256574|323883||2
436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3844|6237|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3844||3844|6237||1
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||||1
436394|H01BA0202|Octostim|nefúđi|0,15|mg/sk|2,5|ml|1|úđagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|46873|60708|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||46873||46873|60708||1
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|805|2080|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||805||805|2080||1
436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|263125|332104|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||263125||263125|332104||2
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|1076|2451|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||1076||1076|2451||1
436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|3936|6363|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3936||3936|6363||1
437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|10963|8555|lyfalmen|V0029|8555|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||5538||5538|8555||2
437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|73751|94440|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||73751||73751|94440||2
438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|35529|47134|lyfalmen|V0016|47134|1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||35529||35529|47134||2
438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998|31.12.2012|R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6214|9479|lyfalmen|||1|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6214||6214|9479||1
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|1299|2756|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1299||1299|2756||1
438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998|31.12.2012|R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3255|5432|lyfalmen|||1|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3255||3255|5432||1
438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12066|17688|lyfalmen|V0334|5904|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||12066||12066|17688||1
438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|376658|474588|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||376658||376658|474588||2
438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||||1
438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|1|0|0|0|0|0|SCP|0|0|1|100|DKK|2044|3775|lyfalmen|||1|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||2044||2044|3775||1
438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|6436|9783|lyfalmen|V0362|2202|1|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||6436||6436|9783||1
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|178819|226300|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||178819||178819|226300||1
439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2910|4960|lyfalmen|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2910||2910|4960||1
439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|9622|14141|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||9622||9622|14141||1
439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen|V0163|2185|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437||1
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1609|2322|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1609||1609|2322||1
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2540|3666|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2540||2540|3666||1
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|1005|2354|lyfalmen|V0046|2354|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||1005||1005|2354||1
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1413|2912|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1413||1413|2912||1
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|136186|172796|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||136186||136186|172796||3
441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|0|0|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||0|59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||||1
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|ţpakki||G03DC02|01.12.1972||R|0|0|0|0|E|0|BAP|0|0|0|100|DKK|1143|2542|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1143||1143|2542||2
442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|*|0|KNM|0|0|0|100|XEU|15722|7929|lyfalmen|V0283|7853|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5081||5081|7929||2
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|12407|18116|lyfalmen|V0460|16419|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||12407|18116||1
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|0|0|0|0|*|0|NAS|0|0|1|100|DKK|3747|6105|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3747||3747|6105||1
443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|28564|38393|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||28564||28564|38393||1
444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|8271|12293|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||8271||8271|12293||1
444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|ICE|0|0|0|100|GBP|1056|2423|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||1056||1056|2423||2
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|3395|5623|lyfalmen|V0061|3530|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3395||3395|5623||2
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|E|0|ROC|0|0|0|100|DKK|2472|4360|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2472||2472|4360||2
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|B|0|LEO|0|0|1|100|DKK|1725|3339|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1725||1725|3339||1
445479|N04BC0407|Ropinirol Actavis|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|9379|10946|lyfalmen|V0532|10006|2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||7286||7286|10946||1
446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1571|3125|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||1571||1571|3125||1
446268|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|B|0|BGB|0|0|0|100|DKK|7362|11050|lyfalmen|V0084|11050|1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||7362|11050||2
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|21898|30027|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||21898||21898|30027||1
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|11503|16714|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||11503||11503|16714||1
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|6555|9946|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6555||6555|9946||1
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|8114|12078|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||8114||8114|12078||1
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|9656|14188|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9656||9656|14188||1
448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|B|0|BGB|0|0|0|100|DKK|3253|5429|lyfalmen|V0082|5429|1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||3253|5429||2
448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|724|1969|lyfalmen|||1|10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||724||724|1969||2
448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1415|2915|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1415||1415|2915||2
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|2299|4124|lyfalmen|V0202|3889|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2299||2299|4124||1
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1248|1801|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1248||1248|1801||1
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1568|3124|lyfalmen|||2|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1568||1568|3124||1
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|6024|8694|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||6024||6024|8694||1
449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|*|0|ELI|0|0|0|100|XEU|5860|8995|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5860||5860|8995||2
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|5081|9929|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||5081||5081|9929||2
450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|1911|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382||1
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|3433|4488|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2565||2565|4488||1
450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|8109|14146|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||8109||8109|14146||2
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|61873|79533|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||61873||61873|79533||2
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|92810|118359|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||92810||92810|118359||2
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|123746|157184|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||123746||123746|157184||2
451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6219|8637|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5598||5598|8637||1
451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16425|23159|lyfalmen|||1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||16425||16425|23159||1
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|E|0|ROA|0|0|1|100|DKK|1262|2705|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1262||1262|2705||2
452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|12149|21193|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||12149||12149|21193||2
452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|13383|19341|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||13383||13383|19341||1
452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|9388|13549|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||9388||9388|13549||2
452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2547|4463|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2547||2547|4463||1
452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|2582|4511|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2582||2582|4511||2
452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|7589|11360|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7589||7589|11360||2
452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|4984|7797|lyfalmen|V0584|6438|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4984||4984|7797||2
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1605|2800|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1605||1605|2800||1
453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|14697|20990|lyfalmen|V0585|17061|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||14697||14697|20990||2
453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|9539|14028|lyfalmen|V0586|11425|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||9539||9539|14028||2
453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|26788|36164|lyfalmen|V0587|28127|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||26788||26788|36164||2
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2992|4318|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2992||2992|4318||1
453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2503|4403|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2503||2503|4403||2
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|16670|23466|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||16670||16670|23466||1
454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|47295|42139|lyfalmen|V0341|12080|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||31549||31549|42139||1
454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|2138|2105|lyfalmen|V0004|2066|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2105||2
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|18713|26030|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||18713||18713|26030||1
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|52107|46985|lyfalmen|V0342|13516|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||35410||35410|46985||1
454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|56527|72824|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||56527||56527|72824||1
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1248|2482|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1248||1248|2482||1
454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1878|3548|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1878||1878|3548||1
455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|*|0|BGB|0|0|0|100|DKK|1167|2575|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||1167||1167|2575||2
455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|*|0|BGB|0|0|0|100|DKK|4192|6713|lyfalmen|||1|120|0|20,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||4192||4192|6713||2
455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|23834|32457|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||23834||23834|32457||1
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1003|2351|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1003||1003|2351||1
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1135|2532|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1135||1135|2532||1
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|2352|4196|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2352||2352|4196||1
457615|N06AB1006|Escitalopram Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4787|4046|lyfalmen|V0327|3975|2|100|0|200,0000|Portfarma ehf|Portfarma|Escítalópram||2242||2242|4046||2
457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|3957|6392|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3957||3957|6392||2
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|871|1622|lyfalmen|V0003|1622|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||470||470|1622||1
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|SEK|1320|2785|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1320||1320|2785||1
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1567|3122|lyfalmen|V0577|2415|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1567||1567|3122||1
458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|E|0|XEL|0|0|1|100|DKK|26322|35579|lyfalmen|||2|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||26322||26322|35579||1
459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|2508|1846|lyfalmen|||3|28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||634||634|1846||2
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|931|1344|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||931||931|1344||1
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1705|2461|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1705||1705|2461||1
459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|8271|12293|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||8271||8271|12293||1
459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|2465|4351|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2465||2465|4351||1
459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|5005|7825|lyfalmen|||1|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||5005||5005|7825||1
460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4377|6966|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4377||4377|6966||2
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|8948|13219|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8948||8948|13219||2
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7756|15065|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7756||7756|15065||2
460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|6096|9318|lyfalmen|||1|5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||6096||6096|9318||1
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|205|1259|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||205||205|1259||1
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|708|1947|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||708||708|1947||1
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|708|1947|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||708||708|1947||1
462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|B|0|BGB|0|0|0|100|DKK|4086|6568|lyfalmen|V0083|6568|1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||4086|6568||2
462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|8563|12693|lyfalmen|V0591|12691|1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||8563||8563|12693||1
462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|E|0|XEL|0|0|1|100|DKK|13143|19040|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||13143||13143|19040||1
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|7288|14167|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||||7288|14167||2
463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|9518|13999|lyfalmen|||1|84|0|9,3300|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9518||9518|13999||1
463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5813|11334|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||5813||5813|11334||2
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2
464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972|31.01.2013|R|1|0|0|0|*|0|MEV|0|0|0|100|DKK|1832|3485|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1832||1832|3485||1
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|*|0|APC|0|0|0|100|DKK|4433|6984|lyfalmen|V0376|6984|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4390||4390|6984||1
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1291|2568|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1291||1291|2568||1
465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|1219|2425|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1219||1219|2425||1
465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1307|2600|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1307||1307|2600||1
465278|QJ51RC2301|Nafpenzal DC,  vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|0|0|0|0|0|0|IBV|0|0|0|100|XEU|690|1373|vetalmen|||0|12|0||Vistor hf|Intervet International BV|Prókaínpenicillín í blöndum međ öđrum sýklalyfjum||690||690|1373||1
465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|*|0|WIL|0|0|0|100|SEK|4342|6919|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||4342||4342|6919||2
466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|1601|2066|lyfalmen|V0038|2066|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||795||795|2066||2
466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|4767|3564|lyfalmen|V0039|3564|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||1890||1890|3564||2
466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|725|1971|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||725||725|1971||1
466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2245|4050|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2245||2245|4050||1
466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|1607|3177|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1607||1607|3177||1
466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|6280|9570|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||6280||6280|9570||1
466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2988|5066|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2988||2988|5066||1
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|8605|12750|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8605||8605|12750||1
466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|4915|7702|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4915||4915|7702||1
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|1|0|0|0|B|0|MAS|0|0|0|100|SEK|5109|7968|lyfalmen|V0063|6798|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||5109||5109|7968||1
467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|16600|22716|lyfsjukr|||1|0,5|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||16600||16600|22716||1
467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|25438|33807|lyfsjukr|||1|0,5|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||25438||25438|33807||1
467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|20092|26263|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||19427||19427|26263||1
467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|0|0|0|1|*|0|WTE|0|0|0|100|DKK|36822|48757|lyfalmen|V0582|48757|1|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||36822||36822|48757||2
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|16787|23613|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16787||16787|23613||1
467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|60270|75015|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||58273||58273|75015||1
467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|8150|12128|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||8150||8150|12128||2
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|31964|42660|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||31964||31964|42660||1
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|569|821|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||569||569|821||1
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6966|7152|lyfalmen|V0317|2470|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4513||4513|7152||1
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|432|623|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||432||432|623||1
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|10143|6810|lyfalmen|V0318|2607|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4263||4263|6810||1
468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|25629|13802|lyfalmen|V0320|5069|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9374||9374|13802||1
468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|4530|2340|lyfalmen|V0207|2340|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||995||995|2340||1
468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|4172|5077|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5077|28.2.2013|1
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6124|9356|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||6124||6124|9356||1
469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|13167|7490|lyfalmen|V0253|7416|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4760||4760|7490||1
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8247|11902|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8247||8247|11902||2
469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|E|0|GRU|0|0|1|100|DKK|6859|10362|lyfalmen|V0228|9612|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6859||6859|10362||2
469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|E|0|GRU|0|0|1|100|DKK|5577|8608|lyfalmen|V0227|8032|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5577||5577|8608||2
469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|E|0|GRU|0|0|1|100|DKK|3641|5960|lyfalmen|V0226|5235|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3641||3641|5960||2
470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|6235|9508|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6235||6235|9508||1
470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|33599|44049|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||33599||33599|44049||1
470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8064|11638|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Jóhexól||8064||8064|11638||2
471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10763|15390|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||10763||10763|15390||2
471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371||2
471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10753|15378|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||10753||10753|15378||2
471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15442|21262|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||15442||15442|21262||2
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|1|0|0|0|*|0|PER|0|0|0|100|DKK|1324|2790|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1324||1324|2790||1
471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2310|4030|vetorma|||0|20|0||Vistor hf|Intervet International BV|||||2310|4030||1
471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|0|0|0|0|*|0|BAM|0|0|0|100|SEK|3745|6102|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3745||3745|6102||2
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|5175|10109|vetalmen|||0|10|0||Vistor hf|Orion Corporation|||5175||5175|10109||1
472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2388|4246|lyfalmen|V0048|2920|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2388||2388|4246||1
472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3326|5529|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3326||3326|5529||1
472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|IKR|13009|5009|lyfalmen|V0012|5009|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2946||2946|5009||2
472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|4993|7809|lyfalmen|V0458|5690|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4993||4993|7809||1
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|17428|23755|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||17428||17428|23755||1
474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|5743|8289|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5743||5743|8289||1
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1149|2551|lyfalmen|||1|30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1149||1149|2551||1
474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|39710|51719|lyfsjukr|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||39710||39710|51719||1
474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|14560|9608|lyfalmen|||3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6008||6308|9608||2
474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|E|0|SPL|0|0|1|100|DKK|2012|3731|lyfalmen|||1|140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||2012||2012|3731||1
474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|30043|57860|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||30043|57860||2
474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|870|1329|lyfalmen|V0266|1329|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||256||256|1329||2
475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1100|2484|lyfalmen|||2|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||1100||1100|2484||1
475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|3585|5883|lyfalmen|V0130|5883|1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3585||3585|5883||1
475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|322|1419|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||322||322|1419||1
475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|393|1517|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||393||393|1517||1
475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|ACA|0|0|1|100|NOK|1099|2482|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1099||1099|2482||1
475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4129|6627|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||4129||4129|6627||1
475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|5440|8421|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||5440||5440|8421||1
475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|6072|9285|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||6072||6072|9285||2
476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|0|0|0|0|*|0|ELI|0|0|0|100|XEU|6561|9954|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6561||6561|9954||2
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|84211|107567|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||84211|107567||1
476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|1200|2538|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1140||1140|2538||1
476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|12918|5492|lyfalmen|V0282|5492|2|56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||3299||3299|5492||1
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5477|8471|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5477||5477|8471||1
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|*|0|APC|0|0|0|100|XEU|539|1581|lyfalmen|V0500|1574|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||440||440|1581||1
479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|*|0|WIL|0|0|0|100|XEU|31959|42654|lyfalmen|V0454|42654|2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||31959||31959|42654||2
480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|28509|12760|lyfalmen|V0341|12080|2|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||8612||8612|12760||2
480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|0|0|0|0|E|0|DSG|0|0|0|100|SEK|14249|20428|lyfalmen|||1|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||14249||14249|20428||1
481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|14766|21076|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14766||14766|21076||1
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|374|1491|lyfalmen|V0055|1294|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||374||374|1491||1
482457|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
483104|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|84025|107334|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||84025||84025|107334||1
483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|41939|55179|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||41939|55179||2
483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|7511|10840|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||7511||7511|10840||2
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|3013|4349|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||3013||3013|4349||1
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|E|0|SHS|0|0|1|100|DKK|3841|6233|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3841||3841|6233||1
483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5201|7506|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||5201||5201|7506||1
483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|2634|4582|lyfalmen|V0374|4582|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2634||2634|4582||2
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|1|0|1|0|E|0|AGP|0|0|1|100|XEU|317|1294|lyfalmen|V0055|1294|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||230||230|1294||1
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|62156|79888|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||62156||62156|79888||1
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|6459|9814|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||6459||6459|9814||1
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|166356|210659|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||166356||166356|210659||1
484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|E|0|MEB|0|0|1|100|SEK|1548|3096|lyfalmen|||1|300|0||Vistor hf|Meda AB (V)|Benzýdamín||1548||1548|3096||1
484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|60945|79031|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||60945||60945|79031||1
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|E|0|ANS|0|0|1|100|XEU|1353|2830|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1353||1353|2830||1
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||||1
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|496|1657|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||496||496|1657||1
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|708|1947|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||708||708|1947||1
487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|*|0|APC|0|0|0|100|XEU|21412|25650|lyfalmen|V0573|25650|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||18410||18410|25650||1
487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|4775|4273|lyfalmen|V0326|4273|2|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2408||2408|4273||2
487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|38611|50339|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||38611||38611|50339||1
487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|60270|77521|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||60270||60270|77521||1
487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|*|0|WIL|0|0|0|100|XEU|35692|47339|lyfalmen|V0453|47339|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||35692||35692|47339||2
488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|1071|2444|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||1071||1071|2444||1
488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|2977|5051|lyfalmen|V0198|4187|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2977||2977|5051||1
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|B|0|APC|0|0|0|100|DKK|6828|10319|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6828||6828|10319||1
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|B|0|APC|0|0|0|100|DKK|12280|17957|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||12280||12280|17957||1
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|112252|142759|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||112252|142759||1
489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|497|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242||1
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1491|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618||1
490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|2679|4644|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2679||2679|4644||1
490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|2823|4841|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2823||2823|4841||1
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4299|6860|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4299||4299|6860||1
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11767|11416|lyfalmen|V0112|2449|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7630||7630|11416||1
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5716|8798|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5716||5716|8798||1
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16700|15507|lyfalmen|V0113|1964|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10620||10620|15507||1
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|21239|19362|lyfalmen|V0114|3687|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||13400||13400|19362||1
491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|45674|59203|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||45674||45674|59203||1
491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|53660|69226|lyfsjukr|||1|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||53660||53660|69226||1
492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|3568|5860|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3568||3568|5860||2
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14154|20308|lyfalmen|V0002|5247|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||14154||14154|20308||1
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
493313|G04BD0704|Tolterodin Actavis|forđahlk|2|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|19806|27402|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||19806||19806|27402||1
493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|26101|14771|lyfalmen|V0516|14743|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||10082||10082|14771||1
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1583|3144|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1583||1583|3144||1
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|2682|4648|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2682||2682|4648||1
494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|87847|112130|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||87847||87847|112130||2
494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|219618|277503|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||219618||219618|277503||2
494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2189|3973|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2189||2189|3973||1
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2455|4337|lyfalmen|V0128|2254|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2455||2455|4337||1
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3568|5860|lyfalmen|V0410|5302|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3568||3568|5860||1
494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|E|0|BII|0|0|0|100|DKK|2028|3753|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||2028||2028|3753||1
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|19685|7088|lyfalmen|V0384|6738|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4466||4466|7088||1
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7656|6730|lyfalmen|V0382|6730|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4204||4204|6730||1
495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991|31.12.2012|R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|10805|10373|lyfalmen|||1|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7038||6867|10373||1
495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3004|5088|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||3004||3004|5088||1
496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|32702|32315|lyfalmen|V0345|32315|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||23721||23721|32315||2
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4592|8990|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4592|8990||2
496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|*|0|APC|0|0|0|100|XEU|13844|11864|lyfalmen|V0572|11864|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||7957||7957|11864||1
496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|0|0|0|0|B|0|ATL|0|0|0|100|GBP|6246|9523|lyfalmen|||1|100|0|0,8333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||6246||6246|9523||1
496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|1|0|0|0|B|0|ATL|0|0|0|100|GBP|1095|2477|lyfalmen|||1|50|0|8,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||1095||1095|2477||1
496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|0|0|100|DKK|93417|119121|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||93417||93417|119121||3
496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|1|0|0|0|B|0|ATL|0|0|0|100|GBP|3437|5681|lyfalmen|||1|100|0|33,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||3437||3437|5681||1
496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|E|0|PER|0|0|0|100|DKK|509|1675|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||509||509|1675||1
496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|920|2237|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||920||920|2237||1
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|269530|340143|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||269530||269530|340143||1
497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|3508|5778|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3508||3508|5778||1
497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|370|1485|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||370||370|1485||1
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|548|1630|lyfalmen|V0448|1625|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||476||476|1630||1
497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1140|2328|lyfalmen|V0449|2322|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||986||986|2328||1
497983|N04BC0407|Ropinirol Actavis|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|16389|18511|lyfalmen|V0533|17707|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||12722||12722|18511||1
497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|1638|3155|lyfalmen|V0369|3155|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1591||1591|3155||2
498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1479|3002|lyfalmen|||1|2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1479||1479|3002||1
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|18427|25671|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18427||18427|25671||1
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|19656|27213|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||19656||19656|27213||1
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|24485|33274|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||24485||24485|33274||1
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|29580|39668|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||29580||29580|39668||1
499070|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|1319|2783|lyfalmen|V0446|2783|1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1319||1319|2783||1
499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|12028|17640|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||12028|17640||2
501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|ţpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|4880|3746|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||2023||2023|3746||2
501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000|31.12.2012|R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|2810|4823|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2810||2810|4823||1
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|3326|5529|lyfalmen|V0434|4746|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3326||3326|5529||2
502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|1|0|0|0|B|0|AML|0|0|0|100|DKK|3243|5415|lyfalmen|||1|100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||3243||3243|5415||1
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|32707|42930|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||32707||32707|42930||1
503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|7211|7642|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||4871||4871|7642||2
503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
504014|N04BC0407|Ropinirol Actavis|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|32103|34021|lyfalmen|V0534|32996|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||25080||25080|34021||1
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|1800|3070|lyfalmen|V0494|3053|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1529||1529|3070||1
504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|2219|4014|lyfalmen|||1|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2219||2219|4014||1
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1261|2704|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1261||1261|2704||2
505647|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|300|skammtar|1|fl|2 x 150 úđaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|1|0|0|0|B|0|AML|0|0|0|100|DKK|8921|13182|lyfalmen|||1|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8921||8921|13182||1
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1961|2830|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1961||1961|2830||1
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3916|5652|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3916||3916|5652||1
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8937|12898|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8937||8937|12898||1
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|2678|4642|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2678||2678|4642||1
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|435|1574|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||435||435|1574||1
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|716|1249|vetorma|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||||716|1249||2
507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995|31.12.2012|L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||0|120|0||Icepharma hf|Pfizer Oy Animal Health|||||2824|4926||2
507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|17474|30483|vetorma|||0|1000|0||Vistor hf|Intervet International BV|||17474||17474|30483||1
508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|2778|4779|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2778||2778|4779||1
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5553|10835|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5553|10835||2
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4453|8723|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4453||4453|8723||2
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|13777|26626|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||13777||13777|26626||2
508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SOF|0|0|0|100|NOK|810239|1018732|lyfsjukr|||1|15|0||Vistor hf|SANOFI|Cabazitaxel||810239||810239|1018732||1
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|9882|14497|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9882||9882|14497||1
509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|0|0|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2980||1
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|50913|65778|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||50913||50913|65778||1
510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|18080|24573|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||18080||18080|24573||2
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|27064|35848|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||27064||27064|35848||2
510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|44394|57597|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||44394||44394|57597||2
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|87792|112061|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||87792||87792|112061||2
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|203842|257704|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||203842|257704||1
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|4536|4218|lyfalmen|V0445|4079|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||2368||2368|4218||1
511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2944|5006|lyfalmen|||1|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2944||2944|5006||1
511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|36715|31239|lyfalmen|||3|28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||22864||22864|31239||2
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2925|4980|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2925||2925|4980||1
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|26218|34786|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||26218||26218|34786||1
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|16401|22466|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||16401||16401|22466||1
512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|4775|4112|lyfalmen|V0325|4112|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2290||2290|4112||2
512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5710|8241|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5710||5710|8241||2
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1
513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|24812|33684|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||24812||24812|33684||1
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|2306|4587|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2306||2306|4587||2
514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|B|0|AZD|0|0|1|100|SEK|2297|4121|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2297||2297|4121||1
514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|4225|6758|lyfalmen|||2|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||4225||4225|6758||1
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|1|0|0|0|B|0|PER|0|0|0|100|IKR|4301|4222|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4222||1
515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2707||1
515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2720||1
516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|5839|7252|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||5025||5025|7252||2
517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|5112|6293|lyfalmen|||2|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3885||3885|6293|28.2.2013|1
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3210|5370|lyfalmen|V0462|2904|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3210||3210|5370||1
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3495|5760|lyfalmen|V0471|3046|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3495||3495|5760||1
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3758|6120|lyfalmen|V0472|3293|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3758||3758|6120||1
517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|1|0|0|0|E|0|AGT|0|0|1|100|DKK|997|2343|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||997||997|2343||1
518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|1|0|0|0|E|0|AGT|0|0|1|100|DKK|3754|6114|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3754||3754|6114||1
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2265|4077|lyfalmen|V0590|3467|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2265||2265|4077||1
518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|12890|12333|lyfalmen|V0286|11786|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||8300||8300|12333||3
518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|*|0|BII|0|0|0|100|DKK|20925|28806|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||20925||20925|28806||1
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1242|2678|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1242||1242|2678||1
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AUG|0|0|1|100|SEK|1860|3523|lyfalmen|||1|100|0|2,5000|Aspen Europe GmbH|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1860||1860|3523||1
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|7889|11771|lyfalmen|V0431|10240|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7889||7889|11771||1
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5230|8133|lyfalmen|V0142|7990|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5230||5230|8133||1
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5906|9058|lyfalmen|V0143|2665|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5906||5906|9058||1
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16641|23430|lyfalmen|V0143|7994|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16641||16641|23430||1
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6334|9643|lyfalmen|V0144|3227|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||6334||6334|9643||1
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17526|24540|lyfalmen|V0144|9680|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||17526||17526|24540||1
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1355|1724|lyfalmen|V0056|1711|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||545||545|1724||1
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2163|2114|lyfalmen|V0057|2101|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||830||830|2114||1
520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|1|0|0|0|E|0|MEB|0|0|1|100|SEK|400|1526|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||400||400|1526||1
520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1778||1
520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1789||1
521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|34835|46263|lyfalmen|V0269|21350|1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||34835||34835|46263||1
521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|18589|25874|lyfalmen|||1|84|0|18,6700|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||18589||18589|25874||1
521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|3046|3046|lyfalmen|V0471|3046|3|90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1511||1511|3046||2
522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|9114|17673|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|||9114||9114|17673||1
522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2487|4381|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2487||2487|4381||2
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|202059|255467|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||202059||202059|255467||1
522730|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|374|1491|lyfalmen|V0055|1294|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||374||374|1491||1
522771|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|E|0|GLP|0|0|1|100|SEK|444|1586|lyfalmen|V0225|1551|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||444||444|1586||1
522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|E|0|GLP|0|0|1|100|DKK|3008|5094|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||3008||3008|5094||1
522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|0|0|1|0|E|0|GLP|0|0|1|100|DKK|428|1564|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||428||428|1564||1
523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|502|1666|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||502||502|1666||1
523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|0|0|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395||1
523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|ţpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|426468|537100|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||426468||426468|537100||1
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|1421|2923|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1421||1421|2923||1
524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|500|1663|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||500||500|1663||1
524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3152|5291|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3152||3152|5291||1
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5142|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951||1
524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|INI|0|0|0|100|DKK|2064|4106|vetalmen|||0|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||2064||2064|4106||2
525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|1|0|0|0|E|0|MEB|0|0|1|100|SEK|982|2322|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||982||982|2322||1
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|NOH|0|0|0|100|DKK|840|2128|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||840||840|2128||1
525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas||A02BC01|01.02.2012|31.12.2012|R|0|0|0|0|E|0|LVR|0|0|0|100|IKR|4621|4194|lyfalmen|||3|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||2350||2350|4194||3
525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|1623|3199|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1623||1623|3199||1
525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|5410|8380|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5410||5410|8380||1
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|1|0|0|0|0|0|CPA|0|0|0|100|DKK|11769|17078|lyfalmen|||1|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||11769||11769|17078||1
525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|42794|56252|lyfalmen|||1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||42794|56252||2
525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5900|8515|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5900||5900|8515||1
525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5372|7753|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríđ||5372||5372|7753||1
525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|4841|7601|lyfalmen|V0435|7601|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4841||4841|7601||2
526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|4517|7158|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4517||4517|7158||1
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|3864|6265|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3864||3864|6265||1
527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|17175|23437|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||17175||17175|23437||1
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|E|0|ALC|0|0|0|100|USD|1311|2772|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Emedastín||1311||1311|2772||1
528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|E|0|BGB|0|0|0|100|DKK|19723|27298|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||19723||19723|27298||2
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|0|0|LVR|0|0|0|100|SEK|11028|15107|lyfalmen|V0356|13808|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10328||10328|15107||3
528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|B|0|FEL|0|0|0|100|DKK|7464|11189|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||7464||7464|11189||1
529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4878|9539|vetalmen|||0|72|0||Icepharma hf|Pfizer Oy Animal Health|||4878||4878|9539||2
529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5186|10130|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||5186||5186|10130||2
529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|74457|95326|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||74457||74457|95326||1
529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|30944|14632|lyfalmen|V0184|14632|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||9981||9981|14632||2
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|7362|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7362||1
530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|12778|8007|lyfalmen|V0186|8007|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||5138||5138|8007||2
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3368|5586|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3368||3368|5586||1
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6473|9342|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6473||6473|9342||2
531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3338|5545|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3338||3338|5545||1
531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|8901|12846|lyfsjukr|||1|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8901||8901|12846||1
532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|1|0|0|1|*|0|LYF|0|0|0|100|XEU|22002|22403|lyfalmen|V0187|19894|3|50|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||15823||15823|22403||2
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|738|1988|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||738||738|1988||1
532504|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2012||R|1|0|0|0|E|0|RGM|0|0|1|100|XEU|1323|2789|lyfalmen|V0366|2607|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||1323||1323|2789||2
532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|390|1512|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||390||390|1512||1
532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1133|2529|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1133||1133|2529||1
532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|313|1407|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||313||313|1407||1
532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1996|3709|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1996||1996|3709||1
533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|14577|7921|lyfalmen|||3|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5015||5075|7921||2
533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2263|4075|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2263||2263|4075||1
533779|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3
534183|N05AH0308|Lazapix|filmhtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2013||R|1|0|0|0|*|0|POF|0|0|0|100|XEU|16517|23274|lyfalmen|V0281|23274|2|28|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||16517||16517|23274||2
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|0|0|0|1|*|0|IPI|0|0|0|100|DKK|63731|82528|lyfalmen|V0567|82528|1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||63731||63731|82528||1
535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2
535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|3280|2434|lyfalmen|||3|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1064||1064|2434||2
535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|7352|11036|lyfalmen|||1|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||7352||7352|11036||1
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|*|0|SAL|0|0|0|100|USD|462|1611|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||462||462|1611||1
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|*|0|SAL|0|0|0|100|USD|589|1785|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||589||589|1785||1
536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|12900|6451|lyfalmen|V0115|6423|2|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||4000||4000|6451||2
536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|ţpakki||A10BA02|01.11.2012||R|1|0|0|0|*|0|APC|0|0|0|100|XEU|440|1581|lyfalmen|V0502|1581|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||440||440|1581||1
536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|32406|42552|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||32406||32406|42552||1
536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|121319|154800|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||121319||121319|154800||1
536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|71058|91723|lyfalmen|V0019|91723|1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||71058||71058|91723||2
537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995|31.12.2012|L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|593|1034|vetorma|||0|2|0||Icepharma hf|Pfizer Oy Animal Health|||||593|1034||2
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6856|9895|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6856||6856|9895||2
537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2533||1
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|151576|192110|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||151576||151576|192110||2
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|1|0|0|1|E|0|SNO|0|0|0|100|NOK|11785|17100|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||11785||11785|17100||1
539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|5863|5904|lyfalmen|V0285|5512|3|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||3600||3600|5904||3
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|239|1306|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||239||239|1306||1
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|696|1931|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||696||696|1931||1
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|1950|3646|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1950||1950|3646||1
540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|3028|5121|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||3028||3028|5121||2
540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|PAS|0|0|0|100|XEU|2806|4895|vetorma|||0|11,8|0||Vistor hf|Pfizer Oy Animal Health|||2806||2806|4895||1
540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|6387|9716|lyfalmen|V0373|7882|1|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||6387||6387|9716||1
541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|10327|15106|lyfalmen|V0199|15106|1|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||10327||10327|15106||3
541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|16727|23538|lyfalmen|V0200|23538|1|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||16727||16727|23538||3
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|6390|9222|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||6390||6390|9222||1
542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen|||0|100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485||2
543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|792|2062|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||792||792|2062||1
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|3157|5298|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||3157||3157|5298||1
543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|2409|3345|lyfalmen|V0373|2627|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1730||1730|3345||2
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1
543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|7435|4875|lyfalmen|||3|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||2728||2848|4875||2
543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|557802|701924|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||557802||557802|701924||1
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|14144|20296|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||14144||14144|20296||1
544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|951|2280|lyfalmen|||2|7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||951||951|2280|31.12.2012|2
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|2100|3852|lyfalmen|V0134|3852|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||2100||2100|3852||2
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1037|2397|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1037||1037|2397||1
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|983|2324|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||983||983|2324||1
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|2425|4296|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2425||2425|4296||1
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|32824|43739|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||32824||32824|43739||1
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|26464|35757|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||26464||26464|35757||1
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|33017|43981|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||33017||33017|43981||1
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|28050|37748|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||28050||28050|37748||1
546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1
546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1240|2675|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1240||1240|2675||1
546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|ţpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|IKR|3218|3209|lyfalmen|V0580|3209|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1630||1630|3209||2
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|3141|5247|lyfalmen|V0010|5247|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3120||3120|5247||1
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791||1
547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|3215|2066|lyfalmen|V0004|2066|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||795||795|2066||2
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|10872|15527|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10872||10872|15527||1
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3583|5171|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3583||3583|5171||1
547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|8469|12564|lyfalmen|||1|0,5|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||8469||8469|12564||1
548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|622|1704|lyfalmen|V0542|1704|2|100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||530||530|1704||2
548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
548894|B02BC0001|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|198738|251299|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Lyf til ađ minnka stađbundna blćđingu||198738||198738|251299||2
549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|102677|130742|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||102677||102677|130742||1
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|10664|15567|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||10664||10664|15567||1
549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|152044|192698|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||152044||152044|192698||1
549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|41939|55179|lyfalmen|||1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||41939|55179||2
550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592||1
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011|31.12.2012|R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|11382|7921|lyfalmen|||3|56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5035||5075|7921||2
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10178|14656|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||10178||10178|14656||2
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|E|0|AZA|0|0|0|100|SEK|11833|17166|lyfalmen|||1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||11833||11833|17166|28.2.2013|1
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|B|0|MAB|0|0|1|100|SEK|2055|3790|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||2055||2055|3790||1
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|4386|6979|lyfalmen|V0198|6979|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4386||4386|6979||1
551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988||2
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1622|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752||1
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|2939|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432||1
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1008|lyfalmen|V0003|811|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1008||1
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1622|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752||1
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|2938|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432||1
551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|26101|14743|lyfalmen|V0516|14743|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||10062||10062|14743||2
552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|4086|6568|lyfalmen|V0083|6568|1|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||4086|6568||2
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1
552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|5655|8715|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5655||5655|8715||1
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|3573|5867|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3573||3573|5867||1
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|13035|18904|lyfalmen|V0237|18904|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||13035|18904||1
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4458|7077|lyfalmen|V0237|6301|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4458||4458|7077||1
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8262|16037|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||8262||8262|16037||1
555235|N05AB0303|Peratsin|húđuđtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|*|0|ORC|0|0|0|100|DKK|2467|4354|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2467||2467|4354||1
555268|N05AB0303|Peratsin|húđuđtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|*|0|ORC|0|0|0|100|DKK|2812|4826|lyfalmen|V0027|3631|2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2812||2812|4826||1
555292|N05AB0303|Peratsin|húđuđtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|*|0|ORC|0|0|0|100|DKK|2122|3882|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||2122||2122|3882||1
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|29983|39511|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||29983||29983|39511||2
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|5294|8221|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5294||5294|8221||1
556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|7201|10830|lyfalmen|V0242|7550|1|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7201||7201|10830||1
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|10322|15099|lyfalmen|V0242|15099|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||10322||10322|15099||1
557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1737|3355|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1737||1737|3355||1
557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|E|0|WHE|0|0|1|100|XEU|3122|5250|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3122||3122|5250||2
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|304773|384373|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||304773|384373||1
559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|920|2237|lyfalmen|||1|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||920||920|2237||1
559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|2110|3865|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2110||2110|3865||1
559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994|28.02.2013|R|0|0|1|0|E|0|GRU|0|0|1|100|DKK|706|1945|lyfalmen|||1|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||706||706|1945||2
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1700|3304|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1700||1700|3304||2
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|6216|9482|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||6216||6216|9482||1
559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|0|0|0|0|B|0|MEB|0|0|0|100|SEK|3926|6349|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3926||3926|6349||1
559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|15348|21144|lyfsjukr|||1|240|0||Icepharma hf|Baxter|Desflúran||15348||15348|21144||2
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1460||1
560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|791|1471|lyfalmen|V0067|1471|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||360||360|1471||2
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|3239|5410|lyfalmen|||1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3239||3239|5410||1
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|1612|3184|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1612||1612|3184||1
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|6173|9423|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6173||6173|9423||1
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|6694|10136|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6694||6694|10136||1
560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|108842|138479|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||108842||108842|138479||1
560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|503362|633602|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||503362||503362|633602||1
560761|C10AA0505|Atorvastatin Bluefish|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9323|6423|lyfalmen|V0115|6423|2|100|0|400,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||3980||3980|6423||2
561145|N03AX2101|Trobalt|filmhtfl|||63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|5982|9162|lyfalmen|||1|63|0|5,8400|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5982||5982|9162||1
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1866|3531|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1866||1866|3531||2
562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|2716|4694|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2716||2716|4694||1
562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|54076|69748|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||54076||54076|69748||2
562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|*|0|THA|0|0|0|100|SEK|5580|8612|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||5580||5580|8612||1
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|108439|137973|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||108439||108439|137973||1
563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|124635|158962|lyfalmen|||1|63|0|7,0000|Vistor hf|InterMune Europe Ltd.|Pírfenidon||124635||124635|158962||1
563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|22979|31384|lyfalmen|V0431|30720|2|6|0|17,1667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||22979||22979|31384||1
563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|38769|51200|lyfalmen|V0431|51200|2|10|0|28,6111|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||38769||38769|51200||1
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|797|2069|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||797||797|2069||1
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|720|1964|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||720||720|1964||1
563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|1500|3031|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1500||1500|3031||1
563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|223524|283068|lyfalmen|||2|60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||223524||223524|283068||1
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3894|6306|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3894||3894|6306||2
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|4037|6501|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||4037||4037|6501||2
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|504032|635105|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||504032||504032|635105||1
563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|2323|3510|lyfalmen|V0207|2340|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||1850||1850|3510||2
563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|12361|21563|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||12361||12361|21563||2
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|SCP|0|0|0|100|DKK|88909|113463|lyfsjukr|||1|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||88909||88909|113463||1
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|1199|2619|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1199||1199|2619||1
565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|B|0|UCB|0|0|0|100|DKK|12542|18285|lyfalmen|||1|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||12542||12542|18285||1
565982|H01BA0401|Glypressin|stl|1|mg|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|39414|51347|lyfsjukr|||1|42,5|0|3,5500|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||39414||39414|51347||1
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|1464|2982|lyfalmen|V0444|2296|0|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1464||1464|2982||1
566373|N05AA0201|Nozinan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|5888|9033|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5888||5888|9033||1
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|218846|276534|lyfsjukr|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||218846||218846|276534||1
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|B|0|ALK|0|0|1|100|DKK|6303|9601|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||6303|9601||1
567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|3771|6137|lyfalmen|V0291|3373|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3771||3771|6137||1
567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|7633|11420|lyfalmen|V0292|5566|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||7633||7633|11420||1
567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|11156|16240|lyfalmen|V0293|8178|1|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||11156||11156|16240||1
567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|14651|20932|lyfalmen|V0294|10467|1|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||14651||14651|20932||1
567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1158|2563|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1158||1158|2563||1
568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3157|5289|lyfalmen|V0058|5289|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||3151||3151|5289||1
568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3972|6404|lyfalmen|V0059|6404|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3966||3966|6404||1
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|18666|25308|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||18666||18666|25308||1
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|21463|28819|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||21463||21463|28819||1
571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|91411|117266|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||91411||91411|117266||1
572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|13996|7444|lyfalmen|V0253|7416|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4726||4726|7444||1
572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001|31.01.2013|R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|169752|214921|lyfsjukr|||1|5|0||Icepharma hf|Baxter|Fíbrínógen manna||169752||169752|214921||2
572776|B02BC1001|Tisseel Duo Quick|vefjalím|||1|ml|10|stk|samsett pk|B02BC10|01.03.2001|31.01.2013|R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|201422|254667|lyfsjukr|||1|10|0||Icepharma hf|Baxter|Fíbrínógen manna||201422||201422|254667||2
572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001|31.01.2013|R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|424160|534203|lyfsjukr|||1|20|0||Icepharma hf|Baxter|Fíbrínógen manna||424160||424160|534203||2
572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|IKR|9783|5009|lyfalmen|V0011|5009|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2946||2946|5009||2
573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|5300|4403|lyfalmen|V0245|4292|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||2503||2503|4403||1
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|3756|6117|lyfalmen|V0464|5366|0|2,5|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3756||3756|6117||1
573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|3638|5956|lyfalmen|V0129|5956|1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3638||3638|5956||1
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|104929|133568|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||104929||104929|133568||2
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|26887|35626|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||26887||26887|35626||1
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|45525|59016|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||45525||45525|59016||1
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2322|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659||1
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2686|2202|lyfalmen|V0151|1773|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||894||894|2202||1
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8369|7448|lyfalmen|V0322|3514|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4729||4729|7448||1
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4954|2202|lyfalmen|V0152|1972|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||894||894|2202||1
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14832|7448|lyfalmen|V0323|5328|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4729||4729|7448||1
575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|40|0||Icepharma hf|Norpharma |Malatíón|||||||2
575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007|31.12.2012|R|0|0|0|0|0|1|SAA|0|0|0|100|NOK|7206|10400|lyfsjukr|||1|12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||7206||7206|10400||1
575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1719|2340|lyfalmen|V0159|2340|2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||995||995|2340||2
575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1838|2965|lyfalmen|V0160|2965|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1452||1452|2965||2
575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1735|2854|lyfalmen|V0158|2854|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1371||1371|2854||2
576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1150|1789|lyfalmen|V0243|1529|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||592||592|1789||1
576122|L01XE1801|Jakavi|töflur|20|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|708540|891100|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||708540||708540|891100||1
576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|*|0|ATL|0|0|0|100|XEU|3766|6131|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Merkaptópúrín||3766||3766|6131||1
578259|A04AA0106|Ondansetron Mylan|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|4154|4511|lyfalmen|V0384|4492|2|10|0|5,0000|Actavis Group PTC ehf|Mylan AB|Ondansetrón||2582||2582|4511||1
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|6018|10498|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||6018||6018|10498||2
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|1449|2961|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1449||1449|2961||1
579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4499|2114|lyfalmen|V0005|2114|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||830||830|2114||2
579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|767|2028|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||767||767|2028||1
580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|IKR|2800|3258|lyfalmen|V0324|3258|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1666||1666|3258||2
580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|2938|2904|lyfalmen|V0462|2904|3|90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1407||1407|2904||2
581328|C10AA0505|Atorvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|IKR|2837|1964|lyfalmen|V0113|1964|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||720||720|1964||2
581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|IKR|3390|3293|lyfalmen|V0472|3293|3|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1692||1692|3293||2
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|15654|30231|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||15654||15654|30231||2
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|2444|4322|lyfalmen|||0|2,5|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2444||2444|4322||1
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|30584|40265|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||30584||30584|40265||2
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|59023|75956|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||59023||59023|75956||2
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|118044|150028|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||118044||118044|150028||2
582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|74224|95034|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||74224||74224|95034||2
582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|5393|9408|vetorma|||0|50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||5393||5393|9408||2
582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|20323|35452|vetorma|||0|200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||20323||20323|35452||2
582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4597|3741|lyfalmen|V0011|2862|2|56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||2019||2019|3741||2
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|49910|64520|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||49910||49910|64520||2
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|113547|144384|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||113547||113547|144384||2
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|55019|70931|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||55019||55019|70931||2
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|59916|77077|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||59916||59916|77077||2
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|109411|139193|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||109411||109411|139193||2
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1235|2668|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1235||1235|2668||1
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|130592|165775|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||130592||130592|165775||2
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59631|76719|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||59631||59631|76719||2
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|122837|156043|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||122837||122837|156043||2
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|134276|170399|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||134276||134276|170399||2
583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4129|5959|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||4129||4129|5959||2
584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2501|3610|lyfsjukr|||2|9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2501||2501|3610||2
584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|20092|27098|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||20092||20092|27098||1
584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|1|0|0|0|B|0|MAS|0|0|0|100|SEK|2077|3820|lyfalmen|V0064|3278|1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||2077||2077|3820||1
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4964|7164|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4964||4964|7164||1
585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4693|7399|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4693||4693|7399||1
585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|509|1653|lyfalmen|V0541|1653|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||493||493|1653||2
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|35279|46820|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||35279||35279|46820||1
586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1885|3557|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1885||1885|3557||1
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|15373|21176|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||15373||15373|21176||1
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|410215|516702|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||410215||410215|516702||1
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|10972|15232|lyfalmen|V0095|15232|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||10419||10419|15232||1
588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|4885|7661|lyfalmen|||1|84|0|4,6700|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4885||4885|7661||1
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2369|4220|lyfalmen|V0461|4217|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2369||2369|4220||1
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|10769|15710|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||10769||10769|15710||1
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|10169|11420|lyfalmen|V0282|9807|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||7633||7633|11420||1
589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|6601|11515|vetorma|||0|3|0||Icepharma hf|Pfizer Animal Health|Selamectinum||6601||6601|11515||2
589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|2558|4462|vetorma|||0|0,75|0||Icepharma hf|Pfizer Animal Health|Selamectinum||2558||2558|4462||2
589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|6369|11110|vetorma|||0|6|0||Icepharma hf|Pfizer Animal Health|Selamectinum||6369||6369|11110||2
589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|3440|6001|vetorma|||0|0,75|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3440||3440|6001||2
589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|3573|6233|vetorma|||0|1,5|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3573||3573|6233||2
589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|DKK|3439|5999|vetorma|||0|2,25|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3439||3439|5999||2
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2
590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2202|3991|lyfalmen|V0041|3991|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2202||2202|3991||1
590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|24822|33697|lyfalmen|||1|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||24822||24822|33697||1
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|194932|246522|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||194932||194932|246522||1
591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|E|0|LVR|0|0|0|100|DKK|16408|23137|lyfalmen|V0347|23137|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16408||16408|23137||3
592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||||1
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|891535|1120759|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||891535||891535|1120759||1
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|560|1745|lyfalmen|V0238|779|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||560||560|1745||2
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|992|2336|lyfalmen|V0238|2336|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||992||992|2336||2
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|1463|2980|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1463||1463|2980||2
593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|B|0|MAB|0|0|1|100|SEK|23329|31823|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||23329||23329|31823||1
594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|7867|3715|lyfalmen|V0114|3687|2|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||2000||2000|3715||2
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|366|638|vetorma|||0|10|0||Icepharma hf|Pfizer Oy Animal Health|||||366|638||2
594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995|31.12.2012|L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||||2824|4926||2
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|6461|9325|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||6461||6461|9325||1
595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|655|1875|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||655||655|1875||1
596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||||1
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|70274|90076|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||70274|90076||1
596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|21000|28238|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||21000||21000|28238||1
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2531|4441|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2531||2531|4441||1
597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|0|0|100|DKK|740034|930625|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||740034||740034|930625||1
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|509|1675|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||509||509|1675||1
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|4457|7076|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4457|7076||1
916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|ţpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|3102|5222|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||3102||3102|5222||1
923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen|||0|3,5|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636||1
938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6531|9913|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6531||6531|9913||2
938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|18763|26093|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||18763||18763|26093||2
940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|3061|5166|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||3061||3061|5166||1
944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5857|8991|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5857||5857|8991||1
944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1447||2
944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887||2
945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116||1
947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7864||2
948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen|||0|100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701||2
951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5857|8991|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5857||5857|8991||1
954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537||2
954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763||2
961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|ţpakki||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660||2
961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|ţpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510||2
961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9503|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||6231||6231|9503||2
962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen|||0|100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5700||2
962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207||2
965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen|||0|120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579||2
967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|1200|2073|lyfalmen|V0284|1712|2|60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2073||2
967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|6800|5630|lyfalmen|V0285|5512|2|60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||3400||3400|5630||2
967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|12500|11786|lyfalmen|V0286|11786|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||7900||7900|11786||2
967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|IKR|25000|26767|lyfalmen|V0287|26767|2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|26767||2